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Inert but biocompatible metals and biodegradable polymers are currently used as orthopedic 
fixations devices to achieve bone healing. However, the high stiffness of permanent metals such 
as stainless steel (SS), cobalt-chromium (Co-Cr), and titanium (Ti) alloys can cause stress 
shielding and loosening of the surrounding bone. Long term use of these devices can also result 
in wear related debris and associated risks of metallosis requiring secondary removal surgeries 
causing further complications. Inferior strength and acidic degradation products of biodegradable 
polymers on the other hand, also limit their use as orthopedic devices. Recently, biodegradable 
magnesium (Mg) and Mg-based alloys have received wide attention and have become the target 
of intense research due to the benefit of degradability, suitable mechanical properties matching 
natural bone and the desired biocompatibility. The degradation mechanism of biodegradable 
magnesium is primarily corrosion which tends to be highly rapid for pure Mg and most Mg 
based alloys resulting in rapid evolution of unwanted hydrogen gas pockets.  Hence, controlling 
the corrosion of magnesium has been the key challenge limiting the technological development, 
thwarting the accelerated progress of implementation of Mg based alloys for various biomedical 
applications. Rapid corrosion of magnesium in the body and the associated hydrogen gas 
evolution results in device failure, and consequent risks of pain and potential infection. 
Alteration of alloy composition and the associated microstructure has been typically employed to 
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improve the corrosion resistance and achieve the desired mechanical properties while 
maintaining the essential biocompatibility suitable for a desired biomedical application.  
In this work, Mg-Zn based alloys were developed for biodegradable orthopedic fixation 
device applications. Magnesium-zinc alloys have the advantage of using zinc as a major alloying 
element that is considered biocompatible up to a daily dose of 11 mg. Mg-Zn-Zr was thus 
selected as the alloy system that was accordingly processed systematically varying the elemental 
composition, and characterizing the resultant system for phase, structure, microstructure, in-vitro 
corrosion and cytocompatibility properties yielding promising preliminary results. Results of 
characterization showed that the processing related Mg-Zn intermetallic precipitates formed at 
the grain boundaries acting as initiation centers for corrosion leading to reduction in the 
corrosion resistance. Thus, strontium and cerium were selected and added as micro alloying 
elements to improve the corrosion resistance due to alteration of the alloy phase dynamics and 
thermodynamic stability of the precipitates. In addition, the osteogenic attributes of Mg, Sr, and 
Ce ions were studied using human mesenchymal stem cells. 
Furthermore, to demonstrate the biosafety of Mg-Zn alloys, Mg-Zn-Sr-Zr pins were 
implanted in a rat femoral fracture model. The model was selectively designed to result in 
extreme stress on the machined Mg-Zn pin hardware and also test their biocompatibility under 
load-bearing conditions. As intended, higher degradation rates and device failures were observed 
in the micro-computed tomography (micro-CT) images. Despite the pre-designed extreme stress 
assisted corrosion observed, normal fracture healing response was still exhibited in the micro-CT 
images and bone histology demonstrating the efficacy of the alloy system. Moreover, no 
systemic or local tissue toxicity were detected from blood, liver and kidney assessments further 
validating the beneficial aspects of this alloys system for orthopedic applications. 
 vi 
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1.0  INTRODUCTION 
1.1 ORTHOPEDIC FRACTURE RECONSTRUCTION AND REPAIR 
Orthopedic fractures are common injuries resulting from debilitating diseases, sports related 
accidents, occupational injuries, traumatic car accidents, etc. arising from normal daily activities 
of individuals. The increase in life expectancy of global population is also related to the growing 
demand for orthopedic treatment (1). In the United States alone, the total orthopedic device 
market has witnessed an increase from US$ 9.7 billion in 2003 to US$ 29.2 billion in 2013 at the 
compounded annual growth rate of 11.6% (2).  
In the clinic, the fracture fixation and repair is primarily focused on the reunion of bone 
fragments using fixation devices (3) (4). On the other hand, bone grafting is required additionally 
to fill a critical-sized defect (CSD) which is typically beyond the capability of natural bone 
healing process due to the size of the detect itself (5). Regardless of the need for bone grafting, 
use of the appropriate bone fixation devices is critical to anatomically align the remaining 
fragments or bone graft to fit the defect size, shape and configuration in most cases to avoid 
loosening and other post-surgery related complications due to improper fitting of the hardware 
(6).  
Bone fixation is the first step in a typical bone reconstruction process associated with 
surgical remediation and intervention that is needed to address the loss and complicated bone 
 2 
injuries sustained by individuals either in the battlefield or due to normal aging as well as 
traumatic accidents. In all cases, stable fixation contributes to low and moderate inter-
fragmentary movements required for tissue differentiation during the fracture healing process 
(7). Initial inflammatory phase of fracture healing process depends on systematic inflammatory 
factors such as trauma-induced inflammatory response, sepsis, leukocytosis/leukocyte activation, 
diabetes, and autoimmune diseases as well as the local inflammatory factor, fracture stability (8). 
Unstable fixation will inevitably lead to the inhibition of the fracture healing process causing an 
avalanche of problems, and hence, the effectiveness of fixation device is extremely important 
(9).  
 
Figure 1.1 The fracture fixation and healing process (6). 
 
It is normal that following fixation of bone fragments as shown in Figure 1.1, bleeding or 
hematoma formation, revascularization, and inflammation processes continue with recruitment 
of the related cells, cytokines and growth factors. Gradually in time, callus and fibrocartilage 
tissue forms, wrapping around the fracture site. Osteoblastic differentiation of mesenchymal 
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stem cells then occurs in the callus to bridge the bones by the mineralization of osteoblasts. 
Osteoclast activity is then known to remodel the mineralized tissue at the wounded site to 
complete the repair and modeling of new bone formation.  
1.2 CURRENT CLINICAL SOLUTION AND ITS LIMITATION 
1.2.1 Inert metal implants 
 
Figure 1.2 CT scan image showing the intraspinal migration of one K-wire (10). 
 
The remediation or medical intervention processes currently in vogue for addressing complex 
fractures involving bone defects greater than the critical size outlined above require 
incorporation of hardware devices that are essentially belonging to either synthetic materials, 
autografts or allografts (11). The latter two involving grafts taken from another site of the patient 
of from a cadaver suffer from limitations of infections and risk of transmitted diseases. The 
synthetic implant materials are by far the most common mode of treatment of complex fractures 
 4 
comprising CSD conditions. The synthetic materials systems typically comprise three major 
classes of biomaterials: metals, ceramics, and polymers, the metals have gained popularity for 
load-bearing applications due to their high stiffness and mechanical strength, compared to 
polymers and ceramic materials (12). Thus, metallic implants based on titanium alloy (Ti6Al4V) 
and stainless steel (SS316L) have been used for more than a decade by clinicians for orthopedic 
reconstruction. These biocompatible but inert metals are designed to be corrosion resistant and 
biologically inactive in the body. However, use of orthopedic devices made of these inert metals 
has some limitations and can lead to several long-term side effects.   
  A most common problem is the strong mismatch between the elastic moduli and tensile 
strength of the metals and the bone causing stress shielding effect resulting in the weakening of 
the surrounding bone. Bone resorption is often observed at the interface between the bone tissue 
and the inert metal devices such as fixation plates and femoral rod (13, 14). High stiffness of the 
inert metal device with a sharp tip also induces a dangerous migration as shown in Figure 1.2 
(15). 
  In addition, the long term use of current inert metal implants often requires invasive 
secondary surgery to prevent the side effects from corrosion and wear debris causing metallosis 
(16-18). Furthermore, immuno-inflammatory response is often observed in stainless steel or 
titanium plate and screws when used in human patients. The presence of T-lymphocytes, B-
lymphocytes, and macrophages near these implant devices proves that the inert biometals has 
some involvement in tissue reaction. Immuno-inflammatory response can result in causing 
osteolysis and aseptic loosening at the interface between the bone and implant device.  
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No significant toxicity has been detected experimentally or reported clinically due to the 
accumulation of titanium or iron at a systematic level or in specific organs. Therefore, most often, 
surgical removal has been the preferred solution to treat these complications arising from use of 
inert metal fixation devices. However, a removal surgery places the patient at a higher risk of 
infection with accrual of additional cost. Hence, there is a need for further improvement or the 
development of new concepts to provide better clinical care in treating orthopedic fractures. 
1.2.2 Polymeric implants  
In addition to the inert biometals, biodegradable polymeric materials are also widely used in 
clinics for bone tissue engineering applications. Poly (glycolic acid) (PGA), Poly (lactic acid) 
(PLA), and their blends have been investigated and commercialized for orthopedic fixation 
devices. Poly (glycolic acid) was the first biodegradable polymer that was approved by the U.S 
Food and Drug Administration in 1969 (20). Although PGA was initially approved as sutures, its 
use was extended to bone fixation device due to its high crystallinity (45-55%) resulting in 
suitable mechanical properties (21). Poly (lactic acid) on the other hand, is synthesized in two 
optically active isomers; L-lactide and D-lactide. PLA exhibits ~37% crystallinity, high tensile 
strength, low extension, high modulus, and slow degradation. Due to these characteristics, PLA 
has been used for orthopedic applications in load-bearing conditions. The blends of PGA and 
PLA were synthesized to optimize the mechanical and degradation properties required for each 
application. Table 1.1 summarizes the biodegradable polymer attributes for orthopedic 
applications such as tensile strength, compressive strength, modulus, elongation, degradation 
time, degradation product, and the various application areas. 
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Despite the advantage of biodegradability, acidic degradation products cause low pH in 
the local tissue and hence, adverse tissue reaction is often observed to result in swelling and pain. 
More number of such cases have been reported of late from the clinical use of PGA. PLA is also 
reported for its slow degradation and some cases exhibited delayed inflammatory response after 
4 or 5 years. The amount of biodegradable polymers implanted in patient is highly correlated 
with the risk of having a foreign body reaction (FBR). In addition, exposure of the material to 
different tissue environment is another factor that determines the probability of inflammatory 
response. Therefore, the use of biodegradable polymers as bone fixation device requires further 
improvement in mechanical strength and biocompatibility to obtain clinical versatility. Another 
limitation of biodegradable polymers for orthopedic applications is its lack of osteogenic 
potential or ability to induce mineralization. Hence, the polymers are often required to be further 
augmented with ability to deliver growth factors to induce bone regeneration via encapsulation 
of microspheres or microparticles carrying growth factors (22, 23). Although, the approach has 
merit, often the use of large doses of signaling molecules such as BMP-2 can induce 
complications of severe side reactions that can pose significant risks (24, 25).  
1.2.3 Recent development in orthopedic biomaterials 
Calcium phosphate bone cements (CPCs) have been used as bone scaffold or bone void fillers in 
clinics due to their similarity with the inorganic mineral component of bone tissue (26). 
Unfortunately, calcium phosphate (CaP) alone does not mimic the mechanical properties of 
mineralized bone tissue. The composites of biopolymer and ceramic are reported to exhibit 
improved mechanical stability and tissue interaction (27). Compression screws and medical 
scaffolds of biodegradable polymer-ceramic composite have been approved by the U.S. Food 
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and Drug Administration. As alternatives to inert metal devices, these devices have been 
available for the patients for more than 5 year. However, clinical studies did not show any 
significant difference of clinical outcome between bioabsorbable polymer screws and 
biocomposite screws (28). Moreover, the use of biodegradable composite was not as robust as 
biometals in bone fixation due to the low mechanical strength. 
Polyetheretherketone (PEEK) and polyetherketoneketone (PEKK) have been developed 
for their enhanced mechanical properties (see Table 1.1) to replace titanium or stainless steel in 
bone applications (29) (30). PEEK and PEKK are non-degradable polymers that result in no 
acidic degradation products. These inert polymers with excellent mechanical strength can resolve 
the stress shielding and potential metal ion release of titanium or stainless steel. 
In recent years, effort has been made to minimize the stress shielding effect of titanium 
by adjusting the Young’s modulus of Ti. By employing porous designs or altering the 
crystallographic phase, a decrease in Young’s modulus of titanium has been achieved to cause 
less stress shielding effect in bone fixation (31-33). However, despite this, the immuno-
inflammatory response issues of titanium implants due to the inert biological properties of Ti will 
still persist and is not anticipated to be resolved by both methods.   
1.3 NEED FOR BIODEGRADABLE METALS 
As outlined above, in current clinical practice, biodegradable polymers are used to design 
degradable orthopedic devices such as interference screws, ACL screws, and fracture fixation 
devices. However, the initial strength of these polymers is lower than the natural human bone 
and degradation products of the polymers can cause undesired swelling in the long term (34, 35). 
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Resorbable calcium phosphate (CaP) as mentioned above, is another viable clinical option 
preferred for vertebral compression fractures (36). Injectable form of calcium phosphate has 
been shown to provide a versatile solution (37).  However, the degradation rate and mechanical 
stability are not sufficient to warrant its widespread use replacing the currently used preferred 
embodiment of bio-inert metallic implant devices. Of late however, the concept of degradable 
metallic systems in particular, magnesium (Mg) and magnesium (Mg) alloys has received 
considerable attention with meteoric rise in the sheer volume of research publications over the 
last few years. Magnesium alloys exhibits the density and mechanical properties similar to 
human bone (see Table 1.2).  
Table 1.2 Physical and mechanical properties of various implant materials in comparison to natural bone (38). 
 
 
  Biodegradable Mg alloys therefore are expected to cause minor stress shielding effect and 
also lead to minimal cytotoxicity from the degradation products since the primary by product of 
degradation is Mg(OH)2 which is easily excreted through the urine and feces (39, 40). Therefore, 
the development of biodegradable metal implants to overcome the limitations of current clinical 
solutions is of high interest in the field of orthopedics and regenerative medicine. With the 
current use of state of the art inert metallic implants, adult patients are likely to undergo 
secondary removal surgery only in the event of any undesirable complication. On the other hand, 
pediatric patients are highly likely to require secondary surgeries to remove the implants 
interrupting bone growth. Biodegradable Mg implant devices as mentioned above, will likely 
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resolve the limitations of current metallic implants while keeping the advantage of higher 
stiffness and mechanical strength. 
1.4 DEVELOPMENT OF BIODEGRADABLE MAGNESIUM 
Biodegradation of Mg-based alloys has been demonstrated in vivo using animal models showing 
the degradation and replacement of the implanted devices with recovery of bone tissue (41-44). 
Research in the field of biodegradable Mg-based alloys is recently gathering much attention due 
to the possible advantage of promoting bone growth and avoiding painful second surgery as 
outlined above. Despite the significant interest and much progress made in the field of Mg alloys 
for biological applications there is still a need for improvement in biodegradable Mg alloys 
particularly, due to the highly reactive nature of Mg resulting in rapid corrosion in the body 
environment resulting in generation of hydrogen gas causing gas pockets in and around the 
implanted region of the animal. Much of the research that is being carried out involves 
controlling the rapid corrosion of Mg and Mg alloys to prevent hydrogen gas evolution and 
consequently the onset of premature mechanical failure. Additionally, demonstration of the 
biocompatibility of biodegradable magnesium and validation of the completely non-toxic nature 
of all of the alloying elements in the final implanted alloy is another hurdle that needs to be 
overcome for the technology to make the much needed translation to bring the technology to the 
clinics. 
Hence, over the past decade or so the field has witnessed a phenomenal growth largely 
focused at designing new alloy systems that can be considered safe exhibiting the desired 
degradability and the much needed device efficacy in the implanted tissue site. In addition to 
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alloy development, another component of Mg alloys that has received vibrant interest is the area 
of coatings and surface engineering strategies to control the corrosion of Mg. In this regards,  
calcium phosphate (45-48), use of various polymers (49), and the development of passivation 
layer (50-53) coatings have been researched to augment corrosion resistance of the 
biodegradable Mg alloys. Despite much advances made, further studies are still very much 
needed to accomplish the degradation of Mg implant devices to prevent hydrogen gas evolution 
and the accompanying mechanical failure. 
1.4.1 Magnesium Alloys: State of the art  
As mentioned above, there has been considerable progress in the area of degradable Mg alloys 
over the past decade. In particular, there have been advances made in clinical translation arena as 
well. Accordingly, human clinical trials have been reported to date for 3 biodegradable Mg-
based devices; a cardiovascular stent from BIOTRONIK (Berlin, Germany), a compression 
screw from Syntellix (Hannover, Germany), and a bone screw from U&I Corporation 
(Uijeongbu, South Korea), schematic of which is shown in Figure 1.3.  A common aspect in all 
these three cases is that these biodegradable Mg-based devices have demonstrated their biosafety 
and efficacy in the clinical trials and have all obtained regulatory approvals in Europe and South 
Korea.  
BIOTRONIK has been developing a drug eluting absorbable metal scaffold (DREAMS) 
made of a magnesium-based alloy containing 93% of pure magnesium and 7% of rare earth 
elements (54). The first generation of DREAMS is named as BIOSOLVE-I and has been tested 
in 46 human patients. In the first round clinical trial, BIOSOLVE-I exhibited good 
biocompatibility and angiographic performance (55). The second generation of DREAMS, 
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BIOSOLVE II, involves a modified design to add tantalum radiographic markers combined with 
replacement of Paclitaxel with Sirolimus for drug delivery. The testing of the BIOSOLVE-II 
platform technology has led to recruitment of more than 100 patients for the next clinical trial 
(56). 
 
Figure 1.3 Biodegradable Mg-based medical devices used in clinical trials.  
 
Syntellix obtained the CE mark of approval for MAGNEZIX bone compression screw in 
2014.  MAGNEZIX compression screw is manufactured using the metal injection casting of Mg-
Y-RE-Zr alloy powders (57).  The clinical trial for MAGNEZIX was performed using titanium 
screw as the control. 26 patients were accordingly involved in the trial and there were no 
significant differences noted in the clinical outcome between the patient group with MAGNEZIX 
screw and the other group with titanium screw (58). Also, no elevated magnesium level was 
observed in the blood, urine, and renal analysis with no adverse effect being reported as well. 
1.4.2 Preferred alloying element for magnesium alloys 
In keeping with the concept of development of new compositions for controlling the corrosion of 
the Mg alloys, various alloy systems including Mg-Zn (59-62), Mg-FAl (49, 63-65), Mg-Y(66, 
67), and Mg-Y (67-70) have been investigated to date. The purpose of adding alloying elements 
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to Mg as discussed earlier is mainly to increase the corrosion resistance and mechanical 
properties of pure Mg. Combination of different alloying elements results in a synergy that 
favorably affects both corrosion and mechanical properties.  
Aluminum (Al) is the most effective alloying element considered to date for Mg alloys. It 
improves the strength, hardness, and ductility. Commercial Mg-Al alloys contain up to 9 wt. % 
of Al in most cases and these alloys have been investigated as potential biodegradable Mg alloys 
for implantable devices. Although aluminum is a favorable alloying element for Mg alloys, a 
constant exposure is reported to cause renal function impairment and bone disease (71, 72). 
Higher concentration of aluminum is also observed in brain tissues of the patients with 
Alzheimer’s disease (73). The effect of aluminum exposure on neuropyschiatric symptoms is 
being researched to identify any significant correlation (74). There has therefore been 
considerable negative attributes to the role of Al additions to Mg. Hence, it is essential that 
complete local and systemic safety of aluminum has to be first demonstrated prior to the use of 
Mg-Al alloys as biodegradable metal. 
Zinc (Zn) is also the second most effective alloying element and often used with 
aluminum in commercial alloys such as AZ31 and AZ91. Zinc can improve precipitation 
hardening and strength at room temperature (75). Zinc can also reduce the corrosive effect of 
impurities such as iron and nickel (76). Mg-Zn-Zr system is thus a commercial alloy series that 
has been explored and considered for good strength and corrosion resistance characteristics. 
Thus, it is also widely investigated as a potential biodegradable metal. 
Yttrium (Y) is an effective alloying element that is often alloyed with zirconium and 
other rare earth elements such as neodymium, cerium, lanthanum, and etc. Mg-Y based alloys 
are comparable to Mg-Al and Mg-Zn alloys in terms of corrosion resistance (77) and mechanical 
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properties (78). In this family, WE43 is one of the most widely used form of Mg-Y alloys and 
there are two CE-marked biodegradable devices made of WE43 that are already deployed in 
European clinics. 
In contrast to the above insoluble iron, nickel, and copper are regarded as impurity ions 
that are known to negatively affect the properties of Mg alloys.  
1.4.3 Importance of post-processing 
In addition to alloy design strategy implemented during melting and casting post processing 
methodologies such as heat treatment and engineered bulk processing are also used to improve 
the quality of the Mg alloys. It is well-known that microstructure of Mg alloys is highly 
correlated with the mechanical properties and corrosion resistance of the Mg alloys. Thus, the 
post-processing methods accordingly are focused on altering the microstructure of biodegradable 
Mg alloys to fulfill the required properties desired depending on the different medical device 
applications. 
Heat treatment of Mg alloys is focused primarily on homogenizing the alloying elements 
within the parent Mg matrix phase. Segregated alloying elements are often embedded in the 
parent Mg matrix phase, or present along the grain boundary. These segregated precipitates or 
secondary phase(s) can induce galvanic corrosion with the primary Mg matrix phase due to their 
difference in electrochemical work potentials. Thus, in order to homogenize the Mg alloys, 
heating time and temperatures need to be suitably altered and optimized depending on the 
alloying element. Although heat treatments can increase the grain size of the alloys, the approach 
is routinely employed to improve solubility of the alloying elements and thus purify and refine 
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the grains and the grain boundaries to enhance corrosion resistance while also simultaneously 
improving the ductility.  
Equal channel angular pressing (ECAP), extrusion, combined with hot and cold rolling 
shown in Figure 1.4 are three most popular bulk processing techniques employed to improve the 
corrosion and mechanical properties of these alloy systems (79, 80). These processing methods 
are often applied to heat-treated Mg alloys to reduce the grain size. Grain size reduction is well-
correlated with mechanical strength of Mg alloys. This is normally achieved by using the Hall-
Petch relation which explains that grain boundaries of crystalline solids act as pinning points to 
impede dislocation movements, thus correspondingly influencing the yield strength. Hence, grain 
size reduction via post processing in the bulk enhances mechanical strength of Mg alloys. In 
addition, improved corrosion resistance has been reported to be achieved due to the elimination 
of casting defect such as voids or suitably modifying the dislocation density following bulk 
processing methods such as extrusion (81).  
 
Figure 1.4 Bulk working methods such as (a) ECAP, (b) extrusion, and (c) rolling for magnesium alloys. 
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1.5 MAGNESIUM-ZINC: A USEFUL BIODEGRADABLE METAL 
Magnesium metal was first discovered in 1880. The metallurgy of magnesium metal has since 
advanced with identification of suitable alloying elements that have been widely researched 
primarily with the goal to exploit the low atomic weight of magnesium to develop a class of 
light-weight materials for a variety of structural applications including the automotive space. 
Hence, it was logical to explore some of these commercial alloys to demonstrate the use of 
magnesium as biodegradable implant material. Aluminum is known as the most effective 
alloying element in Mg alloys. Consequently, aluminum-containing alloys (Mg-Al) such as 
AZ31, AZ91, and etc. have been primarily developed and used for light-weight structural 
materials. Mg-Al based alloys exhibit suitable corrosion resistance and mechanical properties in 
both, in vitro and in vivo experiments. Similarly, alloying of Mg with various rare earth elements 
has demonstrated improvement in corrosion resistance and the associated mechanical properties. 
There are therefore rare-earth element containing (Mg-RE) alloys such as LAE224 and WE43. 
Thus, Mg-Al (49, 63-65) and Mg-RE (67-70) based alloys that have been intensely researched as 
degradable metallic biomaterials and have presented much promise for their use in medical 
devices. However, the various neurotoxic effects of aluminum (72-74) and the large knowledge 
gaps related to the known biological effects of rare earth element (82) in the human body make it 
questionable for these systems to be ubiquitously used for biological applications until much 
research is conducted to unequivocally demonstrate their biocompatibility and biosafety. 
On the other hand, the Mg-Zn alloys have been widely studied as degradable metallic 
biomaterials and exhibit much less toxicity concerns compared to Mg-Al or Mg-RE. Zinc is 
known to be biocompatible with the recommended daily allowance of 11 mg (83) and is an 
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effective alloying ingredient that improves room-temperature strength overcoming the 
unfavorable corrosive effect of impurities (84, 85). Zinc content up to 5% by weight is known to 
cause grain boundary, solid solution, and the secondary phase strengthening which results in 
improved corrosion resistance and desired enhanced mechanical properties (75). In a recent 
study, Mg-Zn alloys have exhibited considerable new bone formation after implantation in the 
femoral cavity of a rabbit model (59). Further, murine osteoblastic cells cultured on Mg-Zn 
alloys, in comparison to PLLA, have also exhibited an improvement in mRNA expressions of 
collagen type lαl and osteocalcin (59). 
1.6 STRONTIUM AND CERIUM: POTENTIAL MICRO-ALLOYING ELEMENTS 
FOR BONE REGENERATION 
As mentioned above different alloy systems have been researched and studied for a variety of 
biological applications. Similarly, different types of coatings have also been researched widely to 
improve the corrosion resistance of Mg alloys (48, 50, 52, 86-88). Drug eluting coating have 
been also proposed and studied to enhance the regeneration of wounded tissue. However, 
polymeric or ceramic coatings that can load drug molecules do not exhibit enough mechanical 
stability on the alloy surface. Use of different alloying elements in Mg alloys to control the 
mechanical and corrosion properties is a much more preferred approach. During the degradation 
of Mg alloys, the release of ions of alloying elements at the local wound site can significantly 
affect the wound healing and bone regeneration process.  Strontium (Sr) is widely studied for its 
effect on the differentiation of bone cells such as osteoclasts and osteoblasts. It is also known to 
promote the replication of pre-osteoblastic cells and activity of osteoblasts (89). Further, Sr also 
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reduces the differentiation of osteoclasts to enhance bone formation (90). Similarly, Cerium (Ce) 
has shown its ability to influence the osteogenic differentiation of hMSC (91, 92) while 
improving the stability of the corrosion protective layer following initial corrosion (87).  
Both Sr and Ce thus have significant merit as alloying elements if the release of these 
ions following the degradation of Mg alloys for medical devices can stimulate bone fracture 
repair. The ability to accelerate bone fracture repair and new bone formation using biodegradable 
fracture fixation devices will motivate further studies in device design, degradation control, 
biomechanics, etc.  
Accordingly four specific aims have been designed revolving around various alloy 
systems and study their materials characteristics combined with in vitro and in vivo response 
particularly for orthopedic related applications. Specific Aim 3 in particular, will be focused on 
systematically studying the in vitro characteristics of Sr and Ce containing Mg alloys. The bone 
regeneration effect will also be investigated using in vitro mineralization and alkaline 
phosphatase assays. 
 19 
2.0  THESIS GOALS 
2.1 SPECIFIC AIM I 
Processing and optimization of the Mg-Zn-Zr alloys 
Rationale:  Mg-Zn-Zr alloys have been studied and developed for corrosion resistant lightweight 
structural applications to replace some steel and aluminum materials. Its corrosion resistance and 
favorable mechanical properties are essential characteristics for biodegradable metal application 
and hence the system is clearly worthy of further investigation. Before characterizing the 
corrosion resistance, mechanical properties, and biocompatibility, it is crucial to investigate the 
optimal processing conditions to obtain a high quality Mg alloy with low impurities and desired 
microstructure. Low impurities and microstructure directly correlate with corrosion and 
mechanical properties. Impurities such as ion (Fe), nickel (Ni), and copper (Cu) as mentioned 
earlier, serve as a nucleation site for initiating corrosion and causing pitting corrosion which 
leads to heterogeneous degradation of the biodegradable Mg alloys. Micro structure also plays a 
key role in determining the mechanical properties of Mg alloys. Processing conditions such as 
melting temperature, settling time, heat treatment techniques, and impurity level of pure ingots 
essentially control the quality of Mg alloys in terms of impurities and microstructure. Therefore, 
processing conditions were investigated in detail essentially to have control on the impurity 
levels and on the microstructure to calibrate the integrity of Mg alloy assessment in terms of 
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achieving acceptable corrosion resistance, mechanical properties, combined with 
cytocompatibility as well as biocompatibility. 
Experimental Design: This involved the following various steps as outlined below. 
Conventional melting and casting: High-purity pure Mg (US Magnesium, 99.97%), Zn (Alfa 
aesar, 99.99%), and Zirmax (Mg-33Zr master alloy, Mg Elektron, Commercial grade) were used 
for producing Mg-4 wt.% Zn-0.5 wt.% Zr (ZK40) alloy to minimize the impurity level in the 
final alloy ingot. Pure Mg, Zn, and Zirmax were weighed and melted in a stainless steel crucible 
using an electrical resistant furnace at 700o C under protective atmosphere. The molten metal 
was stirred using a stainless steel rod, allowed to set for 30 minutes, and cast in a mild steel mold 
preheated at 500o C. Following melting and casting of the alloys, 1 cm from the top, bottom, and 
side of the cast ingots were correspondingly removed, and the remaining piece of ingots were 
used to minimize the probability of retention of voids and impurities resulting from the melting 
and casting processes.  
Post processing: Solution treatment was mainly investigated to solubilize the solutes into α-Mg 
matrix in the microstructure of ZK40 alloy. Based on the Mg-Zn binary phase diagram, a 
eutectic composition of Mg7Zn3 at 325 °C transforms into α-Mg and MgZn intermetallic during 
solidification. The Mg7Zn3 composition is known to undergo eutectic transformation below 
325oC forming α-Mg(Zn, Zr) solid solution and MgZn intermetallic which can exist as the 
second phase precipitates nucleating along the grain boundaries. As mentioned above, these 
second phase precipitates are undesired from the corrosion point of view contributing to galvanic 
corrosion albeit serving to improve the mechanical strength. The accelerated corrosion however 
outweighs the advantages of mechanical strengths and hence is undesired. Since the T4 treatment 
comprises heat treatment conducted above 325 °C, this can lead to unwanted second phase 
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precipitation which is undesirable as mentioned above and grain growth which is also not 
desirable since large grains can contribute to lower mechanical strengths. Thus the ZK40 alloy 
were correspondingly heat-treated at 300 °C for 1 hour followed by quenching in silicon oil to 
suppress the precipitation of these undesired secondary phases. 
Phase and microstructure characterization: X-ray diffraction (XRD) was performed to 
determine the phase(s) formation using Philips X’Pert Pro system employing the CuKα 
(λ=1.54056 Å) radiation operated at 45 kV and 40 mA at 2θ range of 10-80°. Alloy specimens 
were mounted in epoxy resin and polished using 9, 3, 1 µm diamond slurry, and 0.5 µm colloidal 
silica slurry to obtain mirror finish surface. Polished surface were imaged using back-scattered 
scanning electron microscopy (SEM) to observe the microstructure and precipitates. Energy-
dispersive spectrometry (EDS) probe was used along with SEM to analyze the elemental content 
of precipitates and grain matrices. Finally, polished surface were etched and observed using 
optical microscopy to obtain the optical microstructure images. 
Impurity characterization: Impurities in ZK40 alloys were analyzed using inductively coupled 
plasma-optical emission spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher, Waltham, 
MA) to confirm the real chemical composition of the as-cast ingots. Melting process can alter the 
final composition of the cast ingots due to evaporation and oxidation. Also, the presence of Fe, 
Ni, and Cu as mentioned earlier, can elevate the corrosion rates of Mg alloys. Therefore, ICP-
OES measurement of ZK40 was performed utilizing Mg, Zn, Zr, Fe, Ni, and Cu as standards. 
The content of precipitation along the grain boundary observed in back-scattered SEM 
microstructure analysis was assessed using EDS probe attached to SEM to check if unwanted 
impurities exist.  
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Statistical Considerations: Grain sizes of ZK40 alloy after different heat treatment condition 
will be analyzed using the t-test. The content of impurity levels from ICP analysis was saved for 
ANOVA analysis with corrosion rates as a dependent variable among the different batches, if 
batch to batch corrosion rates are observed to be very different. These statistical analyses were 
performed using Statistical Packages for Social Studies (SPSS) 17.0 (IBM). The results were 
correspondingly judged for significance at p < 0.05. 
Anticipated Results: Single phase form of Mg, α-Mg with restricted precipitation of the second 
phase is anticipated in the microstructure of the as-cast ingot. Correspondingly, low impurity 
levels (less than 20 ppm) for Fe, Ni, and Cu are also anticipated. Grain growth is also restricted 
to be in the size range lower than 100 µm to preserve the mechanical strength. Melting 
temperature, protective gas, heat treatment temperature and duration were thus investigated to 
optimize the impurity level and achieve the desired microstructure. Results of these studies are 
discussed in Chapter 3. Processing conditions were also correlated with corrosion resistance, 
mechanical properties, and biocompatibility in Specific Aim 2 and further optimized during the 
development of the biodegradable Mg-Zn based alloy which are discussed in Chapters 4 and 5. 
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2.2 SPECIFIC AIM II 
Identification of the potential of Mg-Zn based alloys as a biodegradable system using in 
vitro characterization methods  
Rationale: Corrosion resistance, mechanical properties, and biocompatibility are three primary 
criteria required to be assessed comprehensively to prove the safety and function of 
biodegradable Mg alloy for orthopedic application. In vitro assessment of biodegradable Mg 
alloys is designed to focus on mimicking the physiological environment and replicating the trend 
of in vivo degradation of the different Mg alloys. Pure Mg and various commercial Mg alloys 
such as AZ31 and WE43 have been reported to exhibit suitable corrosion resistance, mechanical 
properties, and biocompatibility in the initial stages of in vivo and in vitro experiments. Thus, 
pure Mg and AZ31 are good negative controls for assessing the in vitro characteristics of ZK40 
alloy and the result can determine the need for in vivo studies to understand the ZK40 alloy 
better. Understanding in vitro corrosion resistance, mechanical properties, and cell cytotoxicity 
of ZK40 will provide useful direction in developing Mg-Zn based alloys for orthopedic 
applications. 
Experimental Design: This will involve conducting several systematic studies as outlined below 
under various categories. 
Corrosion measurement: Corrosion measurement of biodegradable Mg alloys can be achieved 
using different methods such as mass loss immersion, hydrogen evolution, electrochemical 
impedance spectroscopy (EIS), and potentiodynamic polarization (PDP). In this study, mass loss 
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immersion and potentiodynamic polarization (PDP) were performed to assess the corrosion 
characteristics at different time points. Mass loss immersion has also exhibited similar trend of 
Mg alloy degradation compared to what is observed in in vivo subcutaneous implantation 
models. The specimens were immersed in cell culture media using a fishing line at 37.4 °C in a 
humidified atmosphere with 5% CO2. Media volume to surface area ratio was maintained at 20 
ml/cm2 according to the ASTMG31-72 standard. Samples were removed after 1, 2 and 3 weeks 
of immersion, rinsed with distilled water and dried at room temperature. Further, the corrosion 
product layer of samples were cleaned with a solution mixture of chromic acid and AgNO3. The 
difference in weight after immersion will be recorded, and the degradation rates (in units of 
mm/year) were obtained according to ASTMG31-72. 
Potentiostatic dynamic polarization (PDP): PDP was performed to measure the electrochemical 
stability of bare metal surface of Mg alloys. A three electrode cell setup was employed for the 
electrochemical corrosion test using platinum as the counter electrode, Ag/AgCl as the reference 
electrode, and the epoxy mounted sample as the working electrode. The tests were performed in 
the same culture media at pH 7.2 ± 0.2, held at 37.4 °C. Before each measurement, the sample 
was immersed in the media for 15 min at open circuit potential (OCP) to provide voltage 
stability. The cathodic and anodic branches of the generated Tafel plots were extrapolated 
linearly to calculate corrosion potential, Ecorr, and corrosion current density, icorr.  
Mechanical testing: Tension and compression tests were performed in accordance with ASTM 
standard practice for tensile testing ASTM-E8-04 and compressive testing ASTM-E9-09 at room 
temperature. For the tension tests, standard dog bone specimens of 12.7 mm in gauge length and 
3 × 3 mm in gauge cross-section were machined and pulled to failure employing a cross-head 
speed of 1.3 mm/min. Specimens for compression test corresponded to dimensions of 10 mm 
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diameter and 20 mm in length. The specimens were accordingly machined from the long axis of 
the ingots and loaded to failure at rate of 2mm/min. Tensile and compressive stress-strain curves 
were utilized to determine the yield strength (YS), ultimate tensile strength (UTS), Young’s 
modulus (E) during tension, total elongations (%), compressive yield strengths, and total 
compression (%) of each alloy specimens. 
Cell cytotoxicity: The mouse osteoblast-like cell line MC3T3 were cultured in Dulbecco’s 
modified eagle medium (α-MEM) with 10% fetal bovine serum (FBS) and 1% p/s at 37.4 °C in a 
humidified atmosphere of 5% CO2. Cells were seeded onto specimen surfaces and cultured for 
72h. The live/dead assay were performed subsequently with commercially available kit and 
fluorescence microscopy was used to determine the viability/cytotoxicity of cells. After 
fluorescence imaging, cells on the specimens were fixed by 2.5% glutaraldehyde and dehydrated 
by ethanol. Fixed cells were imaged by scanning electron microscopy after palladium sputtering. 
MTT(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to assess 
the cytotoxicity of degradation product after 72 h  immersion of specimens in culture medium. 
Extract media in dilution of 1x, 2x, 4x and 10x were added to the 24 h cultured MC3T3 cell and 
MTT assay will be performed after 72h. 
Statistical Considerations: One-way ANOVA with graphical and summary statistics was used 
to assess the degradation rates, mechanical properties, and cell cytotoxicity results. MTT cell 
cytotoxicity test were normalized by the negative control (cell culture plastic) to compare the 
cytotoxicity levels between the different alloy groups. Cell count of live/dead assay images were 
accordingly examined using the ImageJ software to add more justification to the analyses. 
Anticipated Results: In comparison to pure Mg and as-drawn AZ31, ZK40 alloy is expected to 
exhibit comparable characteristics to pure Mg and AZ31 with respect to degradation rates. Pure 
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Mg and AZ31 are reported to have good corrosion resistance and as-cast and heat-treated ZK40 
alloys are anticipated to perform similarly. In terms of mechanical properties, ZK40 alloys are 
expected to perform better than pure Mg. However, ZK 40 alloys are not expected to match the 
mechanical properties of commercial as-drawn AZ31 since the drawing technique will have a 
significantly higher level of grain refinement. Cell cytotoxicity result of ZK40 alloy on the other 
hand, is anticipated to perform better than AZ31 and as good as pure Mg following both MTT 
and live/dead assays. Results of these studies are discussed in Chapter 4. 
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2.3 SPECIFIC AIM III 
Effects of addition of Sr and Ce on the degradation, mechanical and biological properties 
of Mg-Zn-Zr alloys 
Rationale: As discussed above for the each alloy category, a new class of system considered 
here is alloys containing Sr and Ce. Both Sr and Ce as discussed earlier, naturally exist in bone 
and have been reported for their biological effect in terms of hMSC differentiation for bone. On 
the other hand, Sr is known to have grain refining effects while Ce is known to help form a 
stronger metallurgical corrosion protection layer on Mg alloy, thus significantly improving the 
quality and expected performance of the resultant alloy. Release of Sr and Ce during degradation 
of Mg alloys has potential to thus further enhance the regeneration of bone tissue. Therefore, 
small but nevertheless noticeable amounts of Sr and Ce as alloying elements have been added to 
the base Mg-Zn based alloy to study the effect of these elements. The amounts of Sr and Ce 
addition are thus fixed as 0.25 and 1 wt. %, to systematically investigate the correlation between 
the amount of the addition and the key three properties, as well as the bone forming ability. 
Experimental Design: Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr (Sr, Ce = 1, 0.25) alloys were melted 
and casted utilizing the same experimental setup as described in Specific Aim 1. Sr and Ce were 
accordingly added during melting, using Mg-Sr and Mg-Ce master alloy. Heat treatment 
conditions were optimized after microstructure and impurity analysis using SEM. After the 
processing parameters are determined, the in vitro corrosion, mechanical, and biological 
properties measurements were performed following the experimental design of Specific Aim 2 to 
understand the basic characteristics required for biodegradable Mg alloy. 
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In addition, bone forming ability of Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr alloys were assessed 
using alkaline phosphatase, and mineralization assay. hMSC were cultured with differentiation 
media supplemented with Mg, Sr, and Ce ions to test the effect of degradation product without 
engaging direct cell attachment. The alkaline phosphates assay was normalized by DNA 
quantification. After 1, 2, 3 weeks of culture, the hMSC lysates was mixed with p-nitrophenyl 
phosphate (pNPP) solution and substrate solution, incubated and observed at the absorbance of 
405nm. Mineralization of osteoblast cells was measured using alizarin red assay after 2 and 3 
weeks of culture. Quantitative analysis was performed after alizarin red staining and the stained 
cells was dissolved for quantitation using plate reader at the absorbance of 605nm. 
Statistical Considerations: The same statistical analyses from Specific Aim 1 and Specific 
Aim2 were employed for the repeated experiments performed on Mg-Zn-Sr-Zr and Mg-Zn-Ce-
Zr alloys. Two-way ANOVA was accordingly used for ALP and mineralization studies with 
independent variables of the group and time. The significance level was set at p < 0.5 to prove if 
Sr or Ce addition has an effect on bone forming ability. 
Anticipated Results: As outlined above, Ce and Sr addition to ZK40 alloy is not expected to 
deteriorate the corrosion resistance although even small amounts of these alloying elements are 
likely to form small precipitates along the grain boundary or inside of the parent Mg matrix 
phase. Mechanical properties would correspondingly change, but it is still expected to maintain 
80% of the ZK40 alloy in terms of tensile strength. Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr alloys are 
projected to exhibit significantly higher level of ALP activity and mineralization while the cell 
cytotoxicity of the alloys would not be significantly different from ZK40. These results are 
outlined in Chapter 5. 
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2.4 SPECIFIC AIM IV 
Rat femoral fracture repair using intramedullary pins of Mg-Zn-Sr-Zr alloy 
 
Rationale: Biodegradable Mg-Zn alloys are anticipated to exhibit suitable degradation, 
mechanical properties, and biocompatibility characteristics desired for various orthopedic 
applications. It is well-known that depending on the load experienced by the biodegradable Mg-
Zn implant device, the degradation rates will vary, and hence, the failure of the implanted device 
can induce a sudden inflammatory response. To demonstrate the influence of stress on the 
biodegradation and mineralization response of the Mg-Zn based alloy, a rat femoral fracture 
model is selected to investigate the biocompatibility and mineralization potential of the Mg-Zn 
alloy under load-bearing condition. Although the Mg-Zn alloy can be potentially used as 
intramedullary rod, the alloy will be implanted in the intramedullary region to support and fix a 
non-union resulting in healing of the fractured femur causing re-union. Correspondingly, 
biocompatibility of the Mg-Zn alloy and its degradation products will be assessed using blood 
test as well as the histology of liver and kidney. Bone healing and local toxicity will be assessed 
using bone histology and elemental analysis of the muscle.   
Experimental Design: To demonstrate the efficacy of the alloy in the above discussed rat 
femoral fracture model, a single composition of the Mg-Zn alloy was judiciously selected based 
on the in vitro corrosion resistance and mechanical properties. At the same time, Ti-alloy was 
used as a control group to mimic the level of toxicity observed in currently used state of the art 
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clinical biomaterial for bone fixation. Intramedullary pins were therefore machined 
corresponding to the same dimensions. Each pin was inserted in the intramedullary region of the 
right femur of each Sprague-Dawley rat after osteotomy. The animals with implant device were 
all sacrificed after 2, 8, and 14 weeks for assessing the biocompatibility of Mg and Ti pins.  
Blood test: Whole blood samples were accordingly analyzed for complete blood count panel. 
Serum samples were analyzed to obtain a comprehensive picture of the metabolic and chemistry 
profile. The chemistry profile was used to essentially assess the level of phosphorous and 
magnesium in the blood.  
Micro CT analysis: Micro CT imaging was also performed on the original implant and harvested 
bones. Degradation rates correspondingly have been calculated from the volume loss. Finally, 
bone healing response has been determined and assessed based on the the CT images. 
Histology: Liver and kidney tissues were also correspondingly fixed using neutral buffered 
formalin, embedded in paraffin, and sectioned using a microtome. Hematoxylin and eosin 
staining was performed to examine any tissue damage or abnormal response. Harvested femurs 
were then subsequently processed as undecalcified bone and embedded in plastic. Embedded 
tissue were correspondingly sectioned and subjected to various staining methods including 
Goldner’s Masson Trichrome and toluidine blue. 
Statistical Considerations: Two-way ANOVA statistical analysis was used to determine the 
mean comparison of degradation rates and blood test results with regards to independent 
variables, time and group. The significance level was set at p < 0.5 to prove that Sr or Ce 
addition indeed have an effect on bone forming ability. Histology results were also accordingly 
judiciously considered to justify only the subjective positive outcome. 
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Anticipated Results: After 14 weeks, more than 50% volume of the Mg pins is expected to 
remain following degradation. Callus formation on the fracture site will also be expected to 
occur while helping to maintain the stability of the fixation. No significant difference between 
groups and time will be expected from the blood test results and histology outcome. An elevated 
level of Mg could be likely expected following analysis of the chemistry panel analysis. 
However, it is anticipated that the level will be maintained within the normal range. Results of 
these studies are discussed in Chapter 6. 
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3.0  SPECIFIC AIM I: PROCESSING AND OPTIMIZATION OF MAGNESIUM-ZINC-
ZIRCONIUM ALLOYS 
3.1 INTRODUCTION 
For the present studies, Mg-4wt%Zn-0.5wt%Zr (ZK40) was selected based on the rationale 
discussed earlier in Chapter 2. Alloys were developed by permanent mold casting route and were 
further solution treated at elevated temperature. Elemental analysis was performed using an 
inductively coupled plasma (ICP) as explained in Chapter 2 to assess the final chemical contents 
including potential impurities. X-ray diffraction was also used to perform phase analysis. 
Microstructure analysis was accordingly performed using optical and back-scattered scanning 
electron microscopy. Energy dispersive spectroscopy technique using the equipment attached to 
the scanning electron microscope (SEM) was used along with back-scattered scanning electron 
microscopy to provide the chemical composition of the precipitates observed at the grain 
boundaries. Postentiodynamic polarization (PDP) measurements were also performed to identify 
the electrochemical corrosion properties of as-cast and solution-treated ZK40. 
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3.2 MATERIALS AND METHODS 
3.2.1 Mg alloy melting and casting 
Pure elemental ingots of Mg (US magnesium Inc. 99.97%), Zn shots (Alfa-Aesar 99.99%), were 
melted in a mild steel crucible inside an electrical resistance furnace (Wenesco Inc.). A typical 
melt size was 200 g. The melt was covered with (0.5% SF6 + balance Ar) protective gas 
atmosphere to prevent burning and loss of magnesium. Once the desired melting temperature 
(700 °C) was reached, equivalent amount of zirconium was added using Zirmax® (Mg-33.3 wt% 
Zr) master alloy (Magnesium Elektron Ltd.). The liquid melt after zirconium addition was stirred 
for 10 s after 1 min and 5 min intervals to dissolve and disperse the zirconium particles 
uniformly into the melt. Further, the melt was held for 30 min at 700 °C and then poured into a 
preheated mild steel mold (Ø 44.5 mm × 82.5 mm) at 500 °C. 
3.2.2 Heat treatment 
The as-cast ingots obtained were solution treated (T4) at 300 °C for 1 h inside a tubular furnace 
covered with magnesium powder as a getter under protective atmosphere of Ar and SF6 and then 
quenched into water. 
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3.2.3 X-ray diffraction 
The alloys were characterized for phase(s) formation using x-ray diffraction. Accordingly, x-ray 
diffraction (XRD) was performed using a Philips XPERT PRO system employing CuKα 
(λ=1.54056 Å) radiation operated at 45 kV and 40 mA in the 2θ range of 10-80°. 
3.2.4 Microstructure analysis 
The microstructure of as-cast and solution treated (T4) ZK40 alloys were observed using optical 
microscopy (Axiovert 40 MAT, Carl Zeiss, Jena, Germany). Square specimens were mounted in 
epoxy (EpoxiCure, Buehler), and mechanically polished using 9, 3, and 1 µm diamond slurry 
followed by 0.5 µm colloidal silica to obtain a mirror-like finish using semi-automatic polishing 
system (Tegramin-20, Struers, Ballerup, Denmark). Specimens following polishing were 
chemically etched in a solution of 5 mL acetic acid, 6 g picric acid, 10 mL water, and 100 mL 
ethanol and washed immediately using isopropanol to clearly reveal the grain boundaries. Grain 
size was calculated according to ASTM E112 (93) linear intercept method, and the ASTM grain 
number G was converted to average grain size. The alloys were further characterized to observe 
the presence of voids/impurities/oxide scales using computerized nano-tomography. 
Correspondingly, nano computed tomographic (nanoCT) images were captured using the 
Phoenix Nanotom-m 180 kV / 15 W X-ray nanoCT® system equipped with a tungsten filament. 
Disk samples of 1.5 mm dia × 3mm height was sectioned from the as-cast Mg-4%Zn-0.5%Zr 
alloy and nanoCT images were captured with a minimum voxel resolution ~ 300 nm to delineate 
the finer details of the microstructures.   
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3.2.5 Elemental analysis 
The alloy nominal compositions, determined by inductively coupled plasma optical emission 
spectroscopy (ICP-OES, iCAP duo 6500 Thermo Fisher, Waltham, MA), are listed in Table 3.1. 
 
Table 3.1 Chemical composition of Mg-4wt%Zn-0.5wt%Zr (ZK40) alloy. 
Alloy Chemical compositions (wt.%) 
Zn Zr Cu Fe Mn Ni Si  Mg 
Mg-4Zn—0.5Zr 4.28 ± 0.11 0.36 ± .008 0.014 0.002 0.003 0.018 0.007  Balance 
3.2.6 Potentiodynamic polarization (PDP) measurement 
Potentiodynamic polarization (PDP) test was carried out with an electrochemical workstation 
(CHI 604A, CH Instruments, Inc., Austin, TX) at a scanning rate of 1 mV/s and potential 
window of ~500 mV above and below the open circuit potential (OP). Square samples (surface 
area ~ 1cm2) were connected to a copper wire using silver epoxy, mounted in epoxy resin. The 
mounted samples were mechanically polished using 320, 600, and 1200 grits SiC papers, 
sonicated in isopropyl alcohol, and dried in air. A three electrode cell setup was employed for the 
electrochemical corrosion test with platinum being the counter electrode, Ag/AgCl as the 
reference electrode, and the epoxy mounted sample as the working electrode. The test was 
performed in Dulbecco’s Modified Eagle Medium (DMEM, with 4.5 g/l glucose, L-glutamine, 
and sodium pyruvate, Cellgro, Manassas, VA) supplemented with 10% fetal bovine serum (FBS), 
100 U/ml penicillin, and 100 μg/ml streptomycin at pH 7.2 ± 0.2 and temperature held at 37.4 °C. 
Before each measurement, the sample was immersed in DMEM for 15 min at open circuit 
potential to provide voltage stability. The cathodic and anodic branches of the generated Tafel 
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plots were extrapolated linearly to calculate the corrosion potential, Ecorr, and corrosion current 
density, icorr. Average and standard deviations of these 3 sample measurements are reported and 
one-way ANOVA was used to determine any significant mean differences with a p-value less 
than 0.05. Corroded samples following the test measurements were subsequently cleaned by 
immersion in 200 g/L of chromic acid and 10 g/L of AgNO3 solution for 10 min at ambient 
temperature to remove the corrosion products (94) and the corrosion surface was then 
characterized using scanning electron microscopy (SEM). 
3.3 RESULTS AND DISCUSSION 
3.3.1 Phase analysis 
 
Figure 3.1 X-ray diffraction patterns collected on pure Mg, ZK40 as-cast, and ZK40 T4-treated alloys. 
 
Figure 3.1 show the X-ray diffraction (XRD) patterns of the pure Mg, Mg-4%Zn-0.5%Zr 
(ZK40) as-cast and solution treated samples. All of the peaks were indexed to single phase α-Mg 
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matrix with the hexagonal close packed (hcp) crystal structure in case of Pure Mg.  Interestingly, 
in the case of Mg-4%Zn-0.5%Zr, both for the as-cast and solution treated samples, only α-Mg 
peaks were found. The XRD patterns thus clearly show that the α−Mg(Zn, Zr) solid solution 
single phase was formed during solidification which should be observed in the final 
microstructure. However, the highest diffraction peak intensity observed corresponded to the 
(101) pyramidal plane which suggests that the orientation of the α−Mg(Zn, Zr) solid solution 
single phase was altered during melting and solidification in comparison to pure α- Mg matrix 
suggesting the influence of either the alloying elements or the segregated elements within the 
crucible containing the melt acting as nucleating sites causing preferential aligning of the 
solidifying elements in the preferred (101) plane.  
 
 
Figure 3.2 Optical micrographs of Mg-4Zn-0.5Zr (ZK40) alloys (a) as-cast and (b) T4-treated at 300 °C for 1 h. 
 
Figure 3.2 correspondingly illustrates the optical micrographs of the as-cast and solution 
treated Mg-4%Zn-0.5%Zr alloys. It can be seen that the microstructures of both, the as-cast and 
solution treated alloys contain primary α-Mg matrix and minor secondary phase(s) precipitated 
along the grain boundaries. The average grain size for the as-cast and solution treated alloys were 
50±10 µm and 87±10 µm, respectively. The grains were uniform and equiaxed throughout the 
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microstructures, likely suggesting the excellent grain refinement ability of Zr inoculants added 
during solidification of the liquid melt (95, 96). It is well-known that Zr is an excellent grain 
refiner for magnesium and in the presence of solute (here zinc), the effective barrier for 
nucleation is likely much reduced leading to a large number of critical sized zirconium nuclei 
serving as active sites for nucleation, hence effectively refining the structure (97, 98). Zinc which 
is present as a solute also tends to segregate in the diffusion layer ahead of the solid/liquid 
interface of the growing grains during constitutional undercooling which helps to restrict α-Mg 
grains to grow further. Maxwell and Hellawell (99) and later Greer et al. (100) further showed 
that the grain refinement efficacy of a solute can be determined by the growth restriction factors 
(GRF). It has been determined that Zr and Zn have GRF values of 38.29 and 5.31 respectively, 
which thus together, impart a powerful grain refinement effect in the resultant alloy validating  
the observed microstructure(101). The slight increase in the average grain size of the T4-treated 
sample was likely due to coalescence of smaller grains along the triple junction grain boundary 
regions and eventually formation of supersaturated α−Mg(Zn, Zr) solid solution after the 
precipitates dissolve into the matrix.  The SEM of the as-cast and solution treated alloys were 
also captured using back-scattered electron (BSE) mode to reveal clearly the compositional 
contrast due to the large difference in the atomic number of Mg with Zn and Zr. Figure 3.3(a) 
shows the BSE mode SEM micrograph of as-cast ZK40 alloy. It can be observed that Zn/Zr rich 
second phase is continuously distributed along the grain boundary regions. Energy dispersive 
spectra (EDS) analysis of the Zn and Zr rich second phase shown in Figure 3.3(a) identified the 
elemental composition of the precipitates to be Mg7Zn3. According to the magnesium-zinc phase 
diagram there exist a eutectic composition of Mg7Zn3 ~ 325 °C which eventually transform in to 
α-Mg and MgZn intermetallic during solidification (102). It is believed that Mg7Zn3 undergoes 
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eutectic transformation and formed σ-Mg(Zn, Zr) solid solution and MgZn intermetallic which is 







Figure 3.3 Back-scattered mode (BSE) SEM micrographs and EDS analysis of (a) as-cast ZK40 and (b) T4-treated 




alloys the MgZn intermetallic was observed along the grain boundaries (see Figure 3.3b). 
However, the reduction in the volume percent of second phase was evident due to rapid 
dissolution of MgZn intermetallic in to α-Mg grain during solution treatment. 
 
 
Figure 3.4 NanoCT images of as-cast Mg-4%Zn-0.5%Zr alloy, (a) top view, (b) spatially high resolution image 
showing distances between the interior of grains to grain boundary regions. 
 
Figure 3.4(a) shows the nanoCT scan image of the as-cast Mg-Zn-Zr alloys. It clearly 
reveals the absence of any casting defects/inclusion suggesting the excellent castability of the 
Mg-Zn-Zr alloy composition and the cleanliness of the melting and casting approach adopted in 
this study. The high resolution nanoCT scan shown in Figure 3.4(b) illustrates the average 
distance between grain interiors to the grain boundaries. Table 3.1 also illustrates the ICP data of 
the alloy composition which further validates that the impurity levels of the liquid melt was very 
low (combined impurity levels including Fe, Ni, Mn, Cu, and Si was ~ 440 ppm) ensuring the 
better biocompatibility and degradation properties of this alloy in the physiological environment.  
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3.3.2 Tafel analysis of the potentiodynamic polarization measurement on Mg-Zn-Zr alloy 
Table 3.2 Chemical composition of DMEM + FBS (mM/L) + P/S (mg/L) used for the present biocorrosion study. 









Amino acid 1605.36 
Fetal bovine serum 10% 
Penicillin/streptomycin 1% 
 
The potentiodynamic polarization (PDP) behavior of the ZK40  in both, the as-cast and solution 
treated conditions along with pure Mg and as-drawn AZ31 alloys have been studied extensively 
under DMEM + 10%FBS+1% P/S physiological condition. The composition of the DMEM + 
10%FBS+1% P/S is listed in Table 3.2. The potentiodynamic polarization curves (Tafel plot) of 
the various samples and pure Mg, recorded at a scan rate of ~1 mV/s are plotted in Figure 3.5. In 
general, the cathodic branch of the tafel plot shows the hydrogen evolution through a reduction 
process whereas the anodic branch represents the magnesium dissolution by oxidation.  
The cathodic plateaus of pure Mg suggest that the corrosion potential, Ecorr for hydrogen 
evolution occurs at −1.62 V versus Ag/AgCl reference electrode. The calculated corrosion 
current density, icorr (tabulated in Table 3.3) for pure Mg is ~29.26 µAcm-2 equivalent to 













(103). On the other hand, the as-cast ZK40 and as expected, the as-drawn AZ31 samples showed 
improved corrosion potential and Ecorr values displaced toward the more noble direction 
compared to pure Mg. It is already known that zinc contributes to elevation of the corrosion 
potential and thus improve the corrosion rate (104). Corrosion potentials for as-cast ZK40 and 
AZ31 alloys were determined to be -1.49 V and -1.48 V, respectively. 
The calculated corrosion rate, icorr (determined by Tafel extrapolation) values for the as-
cast ZK40 and AZ31 was ~ 0.90 mm/year and 0.43 mm/year, respectively. Although the 
corrosion potential of solution treated ZK40 alloy is -1.55 V, which shifted slightly towards the 
cathodic direction, there was an improvement in the corrosion rate over the as-cast sample. The 
corrosion rate, icorr of the solution treated ZK40 sample is 0.87 mm/year. Improvement in the 
corrosion current density (~39.32 µAcm-2) and corrosion rate of solution treated ZK40 alloy 
compared to the as-cast state is primarily due to reduction in the second phase (Mg7Zn3) 
intermetallic which was observed to be discontinuously precipitated along the grain boundaries 
in the as-cast sample as discussed earlier.  Solution treatment of the as-cast sample at 300 ○C for 
1 h reduces the volume fraction of the second phase [Mg7Zn3 → σ-Mg(Zn,Zr) + MgZn] 
occurring as a consequence of the eutectic transformation causing an increase in the amount of 
σ-Mg(Zn, Zr) primary phase resulting hence in the sudden drop in the corrosion potential.  
Figure 3.5 also illustrates the formation of a passivation layer in the anodic branch of the 
polarization plot. The breakdown potential, Eb of pure Mg, AZ31, as-cast and solution treated 
ZK40 samples were correspondingly -1.41, -1.35, -1.41, and -1.33 V, respectively. It can be seen 
that the Eb for AZ31 and solution treated ZK40 samples were both higher and thus better than 
pure Mg which suggests that pure Mg was more prone to localized corrosion by disruption of the 
protective oxide layers. On the other hand, both AZ31 and solution treated ZK40 exhibit  
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Table 3.3 Corrosion rates (mm/year) determined by potentiodynamic polarization and immersion techniques of pure 
Mg, as-drawn AZ31, as-cast and solution treated ZK40 alloys (n=3, *p<0.05 with all other groups).  
 
 
resistance to localized corrosion by the well-known passivation phenomena. Interestingly, the as-
cast ZK40 alloys exhibited a low breakdown potential (-1.41 V). In general, the anodic branch of 
polarization curve is characterized by a sudden drop in the anodic current representing a change 
in the slope, known as the breakdown Potential (Eb). During anodic polarization, a passive film 
formed on the surface provides a protective barrier that keeps the corrosion current at a low value 
so that the extent of corrosion damage is minimized. An effective protective layer is obviously 
characterized by one that provides a strong resistance to breakdown of the passivation layer. As 
the potential is increased, corrosion via surface breakdown will begin at a certain voltage value 
termed as the breakdown potential (Eb), the lowest potential at which corrosion occurs. Since 
corrosion relates to an increase in the oxidation rate, the Eb is determined by the corresponding 
increase in measured anodic current. An increase in Eb is associated with higher resistance to 
corrosion. Breakdown potentials cause the disruption of the passive film and thus expose bare 
sites of the surface to an aggressive physiological environment wherein the tendency for attack is 













Pure Mg -1.62 29.26±3.18 -.141 0.70±0.07* 
As-drawn AZ31 -1.48 19.20±2.08 -1.35 0.43±0.05* 
As-cast ZK40 -1.49 39.69±1.08 -1.41 0.90±0.02 








Figure 3.6 SEM micrographs of (a) pure Mg (b) AZ31 (c) as-cast ZK40 (d) T4-treated ZK40 surfaces after 
potentiodynamic polarization measurements. Samples were cleaned with CrO3/AgNO3 solutions for 10 min. 
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Figure 3.6 shows the corrosion morphology evolved during potentiodynamic polarization 
test of the samples, after the corrosion products were correspondingly cleaned by CrO3 and 
AgNO3 treatment. Previous scientific studies have shown that in a multi-phase alloy, the 
corrosion rate is primarily controlled by the following factors: a) purity, b) the composition of 
matrix, c) composition of second phase(s) and its distribution in the microstructure (105, 106). 
Since, in the case of pure Mg, there is no second phase present, the corrosion mechanism was 
primarily governed by the total impurity present and the presence of weak grain boundary 
regions. Figure 3.6(a) shows that, mainly irregular localized corrosion pits was evident which 
was laterally spread over the whole surface. The presences of small, discrete pits in the 
microstructure suggest that the presence of impurities do play a role for localized corrosion in 
case of pure magnesium. On the contrary, in the case of AZ31 sample, Mg17Al12 (β-phase) is the 
predominant second phase present along the grain boundaries. The presence of second phase will 
accelerates the corrosion of adjacent α-Mg matrix. Figure 3.6(b) shows the corroded surface of 
AZ31 where pitting was the predominant corrosion mechanism evident by the presence of small 
interconnected pits throughout the corroded surface. Figure 3.6(c) shows the corroded surface of 
ZK40 sample in the as-cast condition wherein the presence of irregular pits on the surface clearly 
suggests that pitting was indeed the dominant corrosion mechanism. Microstructural 
investigation of ZK40 as-cast sample outlined in section 3.3.1 shows that secondary phase(s) of 
Mg7Zn3 and MgZn are present along the grain boundaries likely causing the accelerated 
corrosion of the α-Mg matrix. However, in the case of solution treated ZK40 sample, the 
percentage of second phase(s) decreases with solution treatment having a direct consequence on 
the corrosion rate and morphology as clearly, no surface pits are observed on the corroded 




Microstructural analysis of the as-cast and solution treated Mg-4wt%Zn-0.5wt% Zr or ZK40 
alloys by optical and SEM suggest the formation of uniform equiaxed grains throughout the 
microstructures with average grain size of  50±10 µm and 87±10µm, respectively. SEM 
performed in the back-scattered mode and execution of the EDS analysis of the as-cast ZK40 
alloy clearly shows the presence of Mg7Zn3 intermetallic phase along the grain boundaries which 
undergoes eutectic transformation during solution treatment at 300 ○C for 1 h resulting in the 






4.0  SPECIFIC AIM II: IDENTIFICATION OF THE POTENTIAL OF MAGNESIUM-ZINC 
BASED ALLOYS AS A BIODEGRADABLE SYSTEM USING IN VITRO 
CHARACTERIZATION METHODS 
4.1 INTRODUCTION 
Following the synthesis and materials characterization studies reported in Chapter3, both as-cast 
and solution-treated Mg-4wt%Zn-0.5wt%Zr (ZK40) were further investigated for their 
biocorrosion resistance, mechanical properties, and cytocompatibility. Corrosion resistance of 
ZK40 alloy was further assessed using immersion corrosion test methods. Accordingly, tensile 
and compressive mechanical properties were investigated using Instron universal test machine. 
Preliminary cytocompatibility experiments such as a direct (live/dead) and indirect (MTT) assay 
were performed using a mouse osteoblast-like cell line. Finally, an in vivo murine subcutaneous 
model was used to explore the acute host response after 40 and 70 days of implantation. Results 
of these studies are described in this chapter. 
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4.2 MATERIALS AND METHODS 
4.2.1 Tensile and compression test 
Tension tests were performed for both, the as-cast and T4 treated ZK40 alloys as well as AZ31, 
and pure Mg in accordance with ASTM standard practice for tensile testing ASTM-E8-04 (107) 
at room temperature using an MTS11 frame with 50kN load cells and LX500 laser extensometer 
(MTS Systems Corporation, Eden Prairie, MN, USA) by OrthoKinetic® Testing Technologies. 
Standard dog bone specimens of 12.7 mm in gauge length and 3 × 3 mm in gauge cross-section 
were machined and used for the tension tests. Samples were accordingly pulled to failure at the 
cross-head speed of 1.3 mm/min. Tensile stress-strain curves were utilized to determine the yield 
strength (YS), ultimate tensile strength (UTS), Young’s modulus (E) during tension, and total 
elongations (%) of each alloy specimens. Averages of 3 sample measurements were reported. 
4.2.2 Immersion corrosion measurement 
Immersion corrosion measurements were performed in conformation with ASTM G31-72 (108). 
Pure Mg, ZK40 as-cast and ZK40 T4-treated specimens were prepared in dimension of 10 × 10 × 
1 mm and polished up to 1200 grit using SiC paper. Surface area and the weight of each 
specimen was carefully recorded before the immersion test. The specimens were thoroughly 
cleaned in acetone using a sonicated bath followed by UV sterilization for 30 min for each side. 
After sterilization, the specimens were immersed in DMEM + 10% FBS + 100 U/ml penicillin, 
and 100 μg/ml streptomycin using a fishing line at 37.4 °C in a humidified atmosphere with 5% 
CO2. DMEM + 10% FBS media volume to surface area ratio was 20 ml/cm2 according to the 
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ASTMG31-72 standard (108). Specimens were removed after 1, 2 and 3 weeks of immersion, 
rinsed with distilled water and dried at room temperature. Further, the specimens were cleaned 
with 200 g/L of chromic acid and 10 g/L of AgNO3 solution for 10 min to remove the corrosion 
products similar to the procedure described in Chapter 3 (94). The difference in weight before 
and after immersion was recorded and the degradation rates (in units of mm/year) were obtained 
according to ASTMG31-72 (108). The corrosion rate is thus given by: 
Corrosion rate = (K × W)/(A × T × D) ….. Eq. (1) 
where the time conversion coefficient K = 8.76 x 104, W is the weight difference before and after 
immersion (g), A is the sample area exposed to solution (cm2), T is the exposure time (h) and D 
is the density of the material (g cm–3). The pH value of the solution was also recorded during the 
immersion tests. Averages and standard deviations of 3 sample measurements were reported and 
one-way ANOVA was used to determine any significant mean differences with a p-value less 
than 0.05 for each time point. 
4.2.3 Indirect MTT cell viability assay 
Pure Mg, ZK40 as-cast, and ZK40 T4-treated specimens were sectioned to exhibit dimensions of 
10 x 10 x 1 mm, polished up to 1200 grit SiC paper, sonicated in isopropanol, and sterilized 
under ultraviolet radiation for 30 min before extract preparation. The specimens were incubated 
with modified Eagle’s medium alpha (α-MEM) supplemented with 10% fetal bovine serum 
(FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a humidified atmosphere 
with 5% CO2 for 72 h. The specimen weight to extraction medium ratio was maintained at 0.2 
g/mL in accordance with EN ISO standard 10993:12 (109). This extraction ratio was designated 
as 100% extract, with less concentrated extracts prepared by diluting the 100% extract into 50%, 
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25%, and 10% extract solutions, respectively. Extracts were then sterile filtered using 0.2 μm 
syringe filter before being added to cells. 
Further, the murine osteoblastic cell line (MC3T3-E1, American Type Culture Collection, 
Rockville, MD) was used in in vitro cell cytotoxicity experiments, cultured in modified Eagle’s 
medium alpha (αMEM), 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml 
streptomycin at 37.4 °C in a humidified atmosphere with 5% CO2. The cells were seeded in a 96-
well plate at cell density of 6000 cells/well and incubated for 24h to attach before adding the 
extraction medium. The controls used as culture medium without extract as the negative control 
and 10% DMSO culture medium as the positive control Cell culture media with pre-cultured cell 
was replaced with the 200 μl extract media at 1x, 2x, 4x, and 10x extract dilution and incubated 
for 72 h under cell culture condition. The cytotoxicity of the extracts was tested using the MTT 
assay. Media and extracts were replaced with fresh cell culture medium to prevent interference 
of the magnesium ions in the extract from interacting with the tetrazolium salt (110). The MTT 
assay was performed according to the Vybrant MTT Cell Proliferation Kit (Invitrogen 
Corporation, Karlsruhe, Germany) by first adding 10 μl of 12mM 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) dissolved in phosphate buffer solution (PBS, pH = 7.4) 
to each well. MTT salt was dissolved in PBS at the ratio of 5 mg/mL and diluted in phenol red 
free media in a1:11 ratio to replace the magnesium ion containing media from interfering with 
the blue formazan measurement. The mixture of MTT solution and phenol red free media 
replaced the extract media after 72 h culture and was incubated for another 4 h under cell culture 
condition. Formazan crystals were solubilized using sodium dodecyl sulfide dissolved in 0.01M 
hydrochloric acid at the ratio of 1mg/10 mL (SDS-HCl). 100ul of SDS-HCl was added to each 
well and incubated for 12 h under cell culture condition. The well plate was then analyzed by a 
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ELISA microplate reader at a wavelength of 570 nm with a reference wavelength of 635nm. 
Averages and standard deviations of 3 sample measurements were reported and one-way 
ANOVA was used to determine any significant mean differences with a p-value less than 0.05 
for each dilution factors of the extract media. 
4.2.4 Live/dead cell viability assay 
The murine osteoblast-like cell line MC3T3 was cultured in Dulbecco’s modified eagle medium 
(α-MEM) with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin 
at 37.4 °C in a humidified atmosphere of 5% CO2. Cells were seeded onto specimen surfaces at 
cell density of 4 × 104 cells/mL and each well contained 2mL of media to completely cover the 
specimen. After 72 h of incubation, the live/dead assay was performed using commercially 
available LIVE/DEAD viability/cytotoxicity kit (Invitrogen Inc. Karlsruhe, Germany) to stain 
the live and dead cells to glow in green (ethidium homodimer-1) and red (calcein-AM) 
respectively, under fluorescence microscopy at the excitation wavelength of 495 nm. After 
fluorescence imaging, cells on the specimens were fixed by 2.5% glutaraldehyde for 15 min and 
dehydrated by immersing the specimens in 70, 80, 90, 95, and 100% diluted ethanol for 15 min 
per dilution factor subsequently. Specimens with fixed cells were air dried and captured by SEM. 
 
4.2.5 In vivo murine subcutaneous study 
In vivo murine subcutaneous study was conducted to explore any acute host response of pure 
Mg, as-drawn AZ31, and as-cast ZK40 samples. Mice implantation was performed at 
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University of Cincinnati with an approval of its Animal Care and Use Committee (IACUC) 
in collaboration with Dr. Zhonghyun Dong. For this study, discs of 5 mm diameter and 1.4 
mm thickness were sectioned from as-cast ZK40, pure Mg, and AZ31 alloy specimens. The 
disc samples were than sonicated in acetone, air-dried, and further sterilized by UV radiation. 
Healthy nude mice were housed under controlled conditions and maintained with a standard 
diet and water. Mice were anesthetized by isoflurane and a small skin incision was made for 
implantation of the disc in the subcutaneous regions. Surgical staples were used to close the 
incisions. After 40 and 70 days, the animals were sacrificed using a CO2 gas chamber and 
disc samples were removed followed by the cervical dislocation. The disc implants with 
surrounding tissue were recovered, carefully separated from the tissue, cleaned, air-dried, 
and weighed. The surrounding subcutaneous tissue was harvested and fixed using 10% 
formalin in PBS, paraffin-embedded, and sectioned (4 µm/section) for hematoxylin-eosin 








4.3 RESULTS AND DISCUSSION 
4.3.1 Mechanical properties of Mg-Zn-Zr alloy 
Table 4.1 summarizes the mechanical properties of both, the as-cast and solution treated Mg-
4%Zn-0.5%Zr (ZK40) alloys as well as pure Mg, and commercial as-drawn AZ31 studied for the 
present work along with a direct comparison made with natural bone (111). It is worthy to 
mention here as discussed earlier for the corrosion response as well, that compared to pure Mg, 
the addition of zinc and small amount of zirconium has a dramatic effect on the values of tensile 
strength. Yield strength and ultimate tensile strength (UTS) for the as-cast Mg-4%Zn-0.5%Zr 
was 96 MPa, and 176 MPa respectively. However, there was a little drop in the yield strength 
and UTS values of solution treated Mg-4%Zn-0.5%Zr alloy compared to as-cast alloys likely due 
to increase in the average grain size which invariably reduces the yield strength as is well-known 
in the physical metallurgy literature (112, 113). As-drawn AZ31 showed the highest yield 
strength of 55 MPa and UTS of 202 MPa among all the alloys studied here. Elastic Modulus of 
the pure magnesium was low ~5 GPa, however, Mg-4%Zn-0.5%Zr alloys demonstrated 
excellent modulus (~ 64 GPa) suggesting that the alloy possesses high strength under tensile 
testing. Similarly, the as-drawn AZ31 also display a high stiffness value. It should be noted that 
all the alloys studied here possess a high modulus values compared to natural bone except pure 
magnesium. The total elongation to failure (%) for pure magnesium and as-drawn AZ31 samples 







Table 4.1. Mechanical properties of the as-drawn AZ31, pure Mg, ZK40, and ZK60 alloys (n=3, *buckling noticed 
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In contrast, total elongation to failure under tension of Mg-4%Zn-0.5&Zr alloys in the as-
cast and solution treated conditions was observed to be 4 and 3%, respectively.  The low value of 
elongation to failure for both the as-cast and solution treated Mg-4%Zn-0.5%Zr alloy is likely 
due to the presence of second phase (Mg7Zn3) which increases the hardness and strength of the 
alloy while undermining the total elongation to failure. Similar observation was reported by Cai 
et al. (75) who observed that addition of more than 5 wt% zinc has a negative effect on the 
mechanical properties of the alloy due to the presence of number of MgZn intermetallic phase(s) 
which precipitate along the grain boundary during solidification. Commercial as-drawn AZ31 
alloy displayed a higher yield and tensile strengths compared to all the alloys studied here. 
Increase in yield value and tensile strength with the addition of 4% zinc and 0.5% zirconium to 
the pure magnesium mainly originates from the strong grain refinement efficacy of zirconium on 
the alloy microstructure which is based on Hall-Petch relationship (112, 113). According to the 
Mg-Zn establish phase diagram (114), the maximum solubility of zinc is 1.6 wt% in magnesium 
at room temperature. Thus zinc mainly dissolve in primary α-Mg and imparts solid solution 
strengthening improving the castability of the alloy (111, 115).  It is also important to note that 
the presence of Mg7Zn3 intermetallic along the grain boundary regions in Mg-4%Zn-0.5%Zr 
alloys hinders the dislocation movements during plastic deformation causing an increase in the 
strength of the alloys at the expense of desired plasticity. However, the discontinuous 
precipitates formed along the grain boundaries may sometimes act as stress concentrators leading 
to brittle fracture of the alloy under tensile loading.  
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Figure 4.1 Fractographs of (a) as-drawn AZ31, (b) as-cast ZK40, and (c) Solution treated ZK40 alloys. 
 
Figure 4.1 provides the fractographs of the cross-sectional surfaces after tensile testing. 
The fracture surface of the as-drawn AZ31 alloy specimen (see Figure 4.1a) shows a ductile 
mode fracture with the presence of dimples throughout the fracture surface. On the other hand, 
the as-cast ZK40 tensile specimen in Figure 4.1b illustrates a mixed fracture mode including 
inter-granular cracks and cleavage patterns. The presence of cleavage and quasi cleavage 
patterns are common for Mg-4%Zn alloy which have been verified by others (116-118). The 
presence of intermetallic phase along the grain boundaries leads to crack propagation under 
tensile loading which may result brittle failure. However, solution treated ZK40 alloys exhibited 
both brittle-ductile fracture mode together supported by the presence of cleavage planes and 
dimples. The number of dimples observed on the fracture surface (Figure 4.1c) was minimal and 
possibly appeared when the second phase was dissolved back in to the α−Mg matrix during 
solution treatment, causing grain softening leading to possible ductile mode failure.  
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4.3.2 Immersion corrosion properties of Mg-Zn-Zr alloy 
 
Figure 4.2 Corrosion rate of pure Mg, as-cast ZK40, and T4-treated ZK40 by mass loss after 7, 14, and 21 days 
immersion in DMEM + 10%FBS (n = 3, §p<0.05 denotes a significant difference with all other groups).  
 
  The average weight loss of pure Mg, as-drawn AZ31, as-cast and solution treated 
ZK40 alloys are displayed in Figure 4.2. The average corrosion rate for pure Mg and AZ31 
was determined to be 0.69±0.13 and 0.66±0.05 mm/year, respectively, after 7 days of static 
immersion in DMEM + 10%FBS. The corrosion rate was decreased further during 14 days 
and 21 days immersion test which is in agreement with the reported values in literature (119). 
The decrease in the average weight loss rate was likely due to the formation of a passivation 
layer on the surface which retarded further corrosion. However, in the case of as-cast and 
solution treated ZK40 samples opposite trends were observed. The corrosion rates were 
increased in the order of 7, 14, and 21 days static immersion in DMEM + 10%FBS. The 
average weight loss of the as-cast and T4 treated ZK40 alloys after 7 days of immersion were 
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0.39 ± 0.05 and 0.53 ± 0.12 mm/year, respectively. The corrosion rate was dramatically 
increased to 1.07 ± 0.26 and 1.53 ± 0.25 mm/year for the as-cast ZK40 sample during 14 
days and 21 days immersion, respectively.  
The increase in corrosion rate suggests that the protective layer [Mg(OH)2] which forms on 
the surface during static immersion was not stable and contributed to further corrosion. The 
above finding was in agreement with electrochemical corrosion study where it was 
determined that the breakdown potential, Eb (-1.41 V) of as-cast ZK40 alloy was close the 
corrosion potential, Ecorr (-1.49 V) which resulted in rapid corrosion and dissolution of the 
corroded product simultaneously. The average corrosion rate for solution treated ZK40 alloy 
was slightly reduced from 0.53 ± 0.12 mm/year, to 0.46 ± 0.03 mm/year from 7 days to 14 
days but again increased to 0.89 ± 0.09 mm/year after 21 days static immersion. The exact 
reasons for this anomalous corrosion rate are still unknown and subject of further 
investigation. A possible explanation could be the nature of the hydroxide formed due to the 
solution treatment causing dissolution of Zinc into the α-phase of Mg and formation of 
MgZn intermetallic. It is possible that the stability of the Mg-hydroxide due to incorporation 
of Zn is altered at the 21 day time period probably leading to fine precipitates forming likely 
increasing the solubility causing an inrease in the corrosion rate observed. These are however, 
largely speculatory at present warranting further study. 
  Surface morphology of the corroded surfaces as-cast and solution treated ZK40 alloys 
after 21 days static immersion was shown in Figure 4.3. It appears that both as-cast and 
solution treated ZK40 alloys were uniformly corroded. However, the presence of large holes 
was likely due to severe pitting corrosion along the grain boundary regions which were weak 
spots due to presence of second phase(s) precipitates that was more prone to attack locally by 
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Cl-, HCO3-, SO42, ions etc. present in the cell culture media (75, 120).  
 
Figure 4.3 SEM micrographs of as-cast ZK40 alloy after exposure of (a) 7 days, (b) 14 days, (c) 21 days, and 
T4-treated ZK40 after (d) 7 days, (e) 14 days, (f) 21 days of immersion in DMEM+10% FBS+1% P/S 
physiological environemnt at 37.4 °C 5% CO2 atmosphere. 
4.3.3 Cytocompatibility of Mg-Zn-Zr alloy 
4.3.3.1 Direct MC3T3 cytocompatibility using Live/dead assay 
 
 
Figure 4.4 Fluorescent images of live (green) and dead (red) MC3T3-E1cells attached on the polished surfaces 




Cell viability was studied for the pure Mg, AZ31, as-cast and solution treated ZK40 samples 
with the 3 day cell culture time with extracts. Figure 4.4 shows the osteoblastic MC3T3-E1 
cells cultured in direct αMEM + 10% FBS for 3 days and then stained with calcein-AM and 
EthD-1. Live cells convert calcein AM to the green fluorescent calcein through intracellular 
esterase activity, while EthD-1 enters cells with compromised membranes where it binds 
with nucleic acids and produces a bright red fluorescence. As-cast as well as solution treated 
ZK40 sample show improved cell viability when compared with AZ31 and pure magnesium 
as the cell density is clearly seen to be more and evenly distributed. There was no significant 
difference in the shape of the live cells (green) between the control and the studied samples 
groups. Only a few apoptotic cells (red fluorescence in the nuclei) were seen in each group.  
 
 
Figure 4.5 SEM micrographs of MC3T3 cells fixed on (a) AZ31 (b) pure Mg (c) as-cast ZK40 (d) T4-treated 
ZK40 after 3 days culture followed by live/dead cell viability assay. 
 
  Figure 4.5 shows the morphology of the fixed MC3T3-E1 cells in 2.5% 
glutaraldehyde solution for 15 min after 3 days incubation in the α-MEM. The cells can be 
seen to attach to the surface of the sample and it is also evident that the cells start to 
proliferte on the surface. The cell spreading can be seen to be uniform with filopodia 
formations suggesting that the Mg-Zn-Zr sample are stable in the physiological environment 
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and likely forming a protective layer which retards the released ion cocentrations (Mg2+, 
Zn2+) facilitating cell growth and proliferation.  
4.3.3.2 Indirect MC3T3 cytocompatibility using MTT assay 
 
Figure 4.6 Indirect cytotoxicity of MC3T3 cells cultured for 3 days in extract media from pure Mg, as-cast 
ZK40, and T4-treated ZK40 alloys. Viability is taken as percent of negative control (n =3). 
 
Figure 4.6 shows the indirect cytotoxicity results performed using MC3T3-E1 cells and the MTT 
assay for 3 days extract. For 3 days culture periods, cell viability was almost non-existent with 
undiluted extract (100%) concentration compared to negative control. However, cell viability 
was increased as the extract of the corrosion media was diluted to 50%, 25% and 10% and fresh 
media was added to the cell. The cell viability level was recorded as ~ 80% for as-cast and pure 
Magnesium level at the 50% dilution level suggesting the good cell compatibility of ZK40 alloy. 
The cell compatibility level was further improved with 25% extract dilution. All the three 
samples of as-cast and solution treated ZK40 and pure Mg showed greater than 75% cell 
viability level at 50% and 25% extract dilution with respect to the negative control. The above 
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finding are in good agreement with the recent findings reported in the literature which show 
higher extract concentrations are highly cytotoxic in nature leading to osmotic shock due to the 
released ion concentration, suggesting that a 10-fold extract dilution will be more suitable and 
likely sufficient to determine the cytotoxicity level among various magnesium alloys (121). The 
ISO protocol of cytotoxicity test also identified 75% or higher cell viability as indicator for non-
cytotoxicity (122) and thus the results here suggests the biocompatibility of the studied ZK40 
alloy material. 
4.3.4 In vivo biocompatibility of Mg-Zn-Zr  
Figure 4.7 exhibits the histological image of local sites of implants harvested in murine 
subcutaneous tissue surrounding as-cast ZK40, pure Mg, and AZ31 after 40 and 70 days. Some 
visible amount of gas pocket was observed around as-cast ZK40 implantation after 40 days and a 
significant mass loss of as-cast ZK40, compared to pure Mg and AZ31, was measured after 
sacrificing the animals and explanting the alloy specimen. Moderate inflammatory response was 
observed in the H&E histology results (see Figure 4.7). Abundant population of fibroblasts was 
observed around the Mg alloy samples. Degradation of as-cast ZK40 was observed to be more 
progressively pronounced than pure Mg and as-drawn AZ31 (see Figure 4.8). An acute 
inflammatory response was however, not apparent in the specimens though analysis of long term 
responses along with degradation analysis is required to provide a more detailed, accurate and 












Figure 4.7 H&E staining of murine subcutaneous tissue in contact with pure Mg, as-drawn AZ31, and as-cast 
ZK40. 
 
Figure 4.8 Corrosion rate of pure Mg, AZ31, and as-cast ZK40 by mass loss after 40 and 70 days of pellet 
implantation in murine subcutaneous tissue (n =1). 
 
4.4 CONCLUSIONS 
In the present studies, as-cast and solution treated ZK40 alloys were investigated as a 
potential biodegradable alloys for possible orthopedic and craniofacial applications. 
Potentiodymamic polarization test in DMEM + 10% FBS discussed in Chapter 3 shows that 
the ZK40 alloy has a comparable corrosion rate with pure Mg and as drawn AZ31. Long term 
corrosion by static immersion technique however, shows that the corrosion trends for as-cast 
and solution treated ZK40 alloys are in fact, opposite than pure Mg and AZ31. The average 
weight loss rate for pure Mg and AZ31 was observed to be stabilized after 7 days immersion 
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and decreased gradually following 14 days and 21 days static immersion, whereas the 
average weight loss rate for as-cast ZK40 alloy shows an increse in average weight loss rate 
likely due to formation and dissolution of protective layers simultaneously on the corroded 
surface. In vitro analysis by direct live-dead assay and indirect MTT assay using murine 
osteoblast MC3T3 cells show good cell viabiltity compared to pure Mg and AZ31. Direct 
implanatation of as-cast ZK40 samples in mice subcutaneous model also shows no acute 
inflammatory response and healthy fibroblast formation along the implantation site after 40 
and 70 days, suggesting that ZK40 alloy could be a potential biodegradable implant. 
Preliminary in vitro and in vivo results suggest that long term testing and animal experiments 
are however, necessary to understand the degradation behavior, loss of mechanical strength, 
and immune response under in vivo environment. Further, extrusion/rolling, and equal 
channel angular pressing at elevated temperature have been reported to be capable of 
removing the voids, solidification shrinkage, etc. present in the as-cast ingots and improve 
the mechanical strength and corrosion characteritics (123-125). Thus, hot extrusion or hot 
rolling will be explored as a potential steps for the use of Mg-Zn-Zr alloy as a potential 
biodegradable implant material in the near future. Extrusion in fact, has been attempted and 
the results have been discussed as part of an in vivo fixation device study explained in more 




5.0  SPECIFIC AIM III: EFFECTS OF ADDITION OF STRONTIUM AND CERIUM ON 
THE DEGRADATION, MECHANICAL AND BIOLOGICAL PROPERTIES OF 
MAGNESIUM-ZINC-ZIRCONIUM ALLOYS 
5.1 INTRODUCTION 
As discussed all along in the previous chapters, Mg and Mg-based (Mg) alloys have been widely 
researched as a potential degradable metallic biomaterial with suitable mechanical properties and 
biocompatibility (126). Corrosion however, is the major degradation mechanism of 
biodegradable Mg alloys which need to be controlled or monitored to achieve the optimal device 
resorption rates desired by devices for different applications (38). Corrosion of Mg alloys as 
outlined in the earlier chapters is controlled by modifying various alloying elements and also 
adjusting the melting-casting as well as post processing conditions to alter the microstructure of 
the alloyed systems. Controlled degradation is indeed the major cornerstone ultimately desired 
requiring proper design of the alloy composition as well as the processing conditions and 
parameters to maintain the optimal metal ion release rates to be within the accepted tolerable 
ranges. These ranges are very much needed for fabricating the particular medical devices which 
will result in elimination of hydrogen gas pockets once implanted in the animal models (127).  
Advanced clinical synergy is also anticipated when biodegradable Mg alloys is used as 
bone fixation devices. Mg alloys are attractive as outlined earlier primarily due to the excellent 
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match of density and mechanical properties of Mg alloys to natural human bone. Bone fixation 
devices while being very essential are also not preferred to remain in the body once bone healing 
and desired remodeling has been achieved. Permanent metallic devices are often removed from 
patients in case of corrosion and wear of the devices. However, such a removal is more forced 
due to complications or rejection of the implanted hardware leaving the patient very much 
compromised without a proper remedial treatment of the original medical problem. In most 
cases, once a solution has been provided and there is healing of the bone with the implanted inert 
and biocompatible hardware, the hardware is in general kept inside the patient due to the 
stiffness mismatch with normal bone causing residual stress and stress shielding problems. 
Removal surgery is more common in pediatric patients to avoid any interference or conflict with 
growing inherent pediatric bone plates with the implanted hardware causing major complications 
that run the risk of creating permanent damage. However, such removal surgeries as outlined 
earlier have their own share of associated risks of recurring fracture, inflammation and other 
complications. Hence the option of having a degradable metal with mechanical properties 
matching natural bone renders the concept very attractive and highly lucrative. 
Biodegradable Mg-based bone fixation screws have therefore recently received 
considerable attention and also been recently approved by regulatory agencies in South Korea 
and Europe (128). These screws are made of Mg-Ca-Zn (129) and Mg-Y-Re-Zr (58) alloys that 
have exhibited the desired slow corrosion rates. In addition to these alloys, Mg-Zn-Zr alloys also 
exhibited favorable corrosion resistance, mechanical properties, and cytocompatibility (62, 130, 
131). Zn is known for its grain boundary strengthening effect when used up to 5 wt. % as an 
alloying element in magnesium alloys. Zirconium up to 0.48 wt. % acts as a grain refiner that 
serves as initial grain forming cite and reduces grain sizes (132, 133).  
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Mg-Zn-Zr alloys have been available commercially as ZK series alloys. Microstructure of 
Mg-Zn-Zr can also be suitably monitored to control the corrosion and mechanical properties. 
Effects of various micro-alloying elements have been researched to achieve higher mechanical 
properties and corrosion resistance by altering the phase and content of the precipitates. Rare 
earth elements such as Y, Nd , RE, and Gd are also investigated as additional alloying element to 
improve the mechanical properties of Mg-Zn-Zr alloys (134-136). 
In this regard, Ce is known for providing stable oxide layer coating on Mg alloy when 
used as an alloying element.  Mischmetal is widely used in Mg alloys for improving corrosion 
resistance and 50% of the Mischmetal content is normally comprised of Ce. Ce is known to 
affect osteogenic differentiation of hMSC and thus, it is of high interest as an alloying element 
for biodegradable Mg alloys (91, 92). Sr also promotes osteogenic differentiation of hMSC 
(137). Mg-Sr, Mg-Zn-Sr and Mg-Sr-Zr has thus been reported as biodegradable Mg alloys 
exhibiting good cytocompatibility and corrosion resistance (41, 138, 139). Both Ce and Sr 
however, tend to form secondary phases along the grain boundary. These T-phase precipitates 
along the grain boundary as any other grain boundary phases are not desirable since they are 
deleterious as they are notorious for enhancing corrosion and lowering the corrosion resistance. 
The present study is thus exploring the use of Sr and Ce as additional micro alloying 
element in the parent Mg-Zn-Zr alloy discussed earlier in Chapter 3 and 4. Accordingly, as-
extruded Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr alloys have been synthesized to examine the corrosion 
and mechanical properties. In addition, the effect of Ce and Sr ions along with Mg ions has been 
investigated in terms of osteogenic differentiation of human mesenchymal stem cells which are 
new in the field of biodegradable magnesium alloys. Results of these studies are presented and 
discussed in this chapter. It is reported that 10 mM MgSO4 supplementation in differentiation 
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media enhanced the osteogenic differentiation of hMSC. Hence, in the present study, 0.1 and 1 
mM SrCl2 and CeCl3 salts were supplemented in addition to 10 mM MgSO4 to explore the 
osteogenic ability of the relevant concentration of Sr and Ce ions based on the alloy 
compositions of the Mg-Zn alloys. 
5.2 MATERIALS AND METHODS 
5.2.1 Design and synthesis of alloys 
Table 5.1 Abbreviated notation and chemical composition of the Mg-Zn alloys. 
Alloys Mg Zn Sr Ce Zr 
Mg-Zn-Zr Bal 4 - - 0.5 
Mg-Zn-0.25Sr-Zr Bal 4 0.25 - 0.5 
Mg-Zn-1Sr-Zr Bal 4 1 - 0.5 
Mg-Zn-0.25Ce-Zr Bal 4 - 0.25 0.5 
Mg-Zn-1Ce-Zr Bal 4 - 1 0.5 
 
Table 5.1 tabulates the abbreviated notation and chemical composition of the Mg-Zn alloys that 
are studied in the current chapter. Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr (Sr, Ce = 1, 0.25) alloys were 
melted in a mild steel crucible using an electrical resistance furnace and casted in a mild steel 
mold preheated at 500 °C. Pure elemental ingots of Mg (US magnesium Inc. 99.97%), Zn shots 
(Alfa-Aesar 99.99%), and Mg-30Sr/Mg-30Ce master alloys were weighed accordingly and 
homogenized at 700 °C to synthesize Mg-Zn-Sr-Zr and Mg-Zn-Ce-Zr alloy in 250g batch size. 
At equilibrium, Zirmax® Mg-33.3 wt% Zr (Magnesium Elektron, UK) was added to the molten 
mixture. Stirring for 10 s after 1 min and 5 min was performed to achieve uniform dispersion and 
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dissolution of zirconium particles in the melt. Finally, the temperature was maintained at 700 °C 
for 30 minutes and then casted. Following the solution treatment at 300 °C for 1 hour, hot 
extrusion was performed using an extrusion ratio of 30:1 at North Carolina A&T University 
(Greensboro, NC). 
5.2.2 X-ray diffraction 
X-ray diffraction (XRD) phase analysis was performed using Philips XPERT PRO system 
employing the Cu Kα (λ=1.54056 Å) radiation source with a Si-detector. X-ray generator was 
operated at 45 kV and 40 mA at a 2θ range of 10-80°. X’Pert HighScore Plus version 3.5 
software was used to identify the XRD patterns comparing to ICSD database.  
5.2.3 ICP analysis 
Elemental analysis on the alloy compositions of was performed using inductively coupled 
plasma optical emission spectrometry (ICP-OES, iCAP duo 6500, Thermo Scientific). ZK40, 
ZJ40/41, and ZY40/41 alloy specimens were dissolved in 1% nitric acid. The solutions were then 
analyzed for the concentration of Mg, Zn, Zr, Ce, Sr, Fe, Mn, Ni, Al, and Cu using known 
standards. 
5.2.4 Microstructure analysis 
The microstructure of heat-treated (T6) and extruded ZK40, ZJ40/41, and ZY40/41 alloys were 
mounted in epoxy (EpoxiCure, Buehler), and mechanically polished with 9, 3, and 1 µm 
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diamond slurry followed by 0.5 µm colloidal silica to obtain a mirror-like finish using semi-
automatic polishing system (Vector, Buehler). Specimens were then subjected to chemical 
etching in a solution of 5 mL acetic acid, 6 g picric acid, 10 mL water, and 100 mL ethanol 
followed by washing immediately using isopropanol to clean the surface. The microstructure of 
the heat-treated (T6) and extruded ZK40, ZJ40/41, and ZY40/41 alloys were observed using 
optical microscopy (Nikon, Japan). The polished and etched microstructure of ZK40, ZJ40/41, 
and ZY40/41 alloy specimens were also analyzed using a scanning electron microscop (JSM 
6610LV, JEOL, Japan) equipped with an energy dispersion spectrometer (INCA, Oxford 
Instruments) to identify the secondary precipitates within the grain boundaries. Computer 
tomographic (Phoenix Nanotom-m 180 kV / 15 W X-ray nanoCT® system, GE) images were 
also captured with a minimum voxel resolution ~ 80 um to analyze presence of any inclusions, 
voids, and secondary precipitates in the as cast, annealed ingots.  
5.2.5 Immersion corrosion measurement 
Immersion corrosion properties of heat-treated (T6) and extruded ZK40, ZJ40/41, and ZY40/41 
alloys were assessed in conformation with ASTM G31-72 (71). Heat-treated (T6) and extruded 
ZK40, ZJ40/41, and ZY40/41 alloys were prepared in disks, 5 mm in diameter and 1.5 mm in 
thickness. These disks were polished up to 1200 grit using SiC paper. Surface area and the 
weight of each specimen were measured prior to the immersion tests. The specimens were then 
cleaned in acetone using a sonicator bath and sterilized under UV for 30 min each side. After 
sterilization, the specimens were immersed for 1, 3, and 5 weeks in Hank’s Balanced Salt 
Solution (HBSS) at 37.4 °C. The HBSS media volume to surface area ratio was maintained at 20 
ml/cm2. The immersed specimens were subsequently removed from HBSS media at each time 
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point, rinsed with distilled water, and dried at room temperature. Further, the degradation 
product of each specimen was cleaned with 200 g/L of chromic acid and 10 g/L of AgNO3 
solution for 10 min to assess the mass loss (56) similar to the procedure described in Chapter 3 
and 4. The difference in mass before and after immersion was recorded, and the degradation rate 
were calculated using the mass loss, density and surface area according to ASTMG31-72 (71). 
Averages and standard deviations of 3 sample measurements were reported and one-way 
ANOVA with Tukey’s post-hoc test was used to determine any significant mean differences with 
a p-value less than 0.05 for each time point. 
5.2.6 Tensile testing 
Tensile testing was conducted in accordance with ASTM-E8-04. ZK40, ZJ40/41, and ZY40/41 
alloys were machined into a standard dog-bone shape with a gauge length of 13.5mm, width of 
3mm, and thickness of 3mm. Uniaxial tensile testing was performed using an Instron machine 
employing a 5kN load cell at room temperature at a cross-head speed of 1.3mm/min. Yield 
strength (YS), ultimate tensile strength (UTS), Young’s modulus (E), and percent elongation 
(%) were obtained from the stress-strain curve obtained for each specimen. Young’s modulus 
was also determined from the initial linear portion of the curves. Average and standard 
deviations of these 3 sample measurements are reported in the results sections to follow. 
Averages and standard deviations of 3 sample measurements were reported and one-way 
ANOVA with Tukey’s post-hoc test was used to determine any significant mean differences with 
a p-value less than 0.05 for each time point. 
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5.2.7 MTT cell viability test 
In order to study the cytocompatibility of extruded ZK40, ZJ40/41, and ZY40/41 alloys, murine 
osteoblast-like cell line, MC3T3 (ATCC, Rockville, MD), was cultured with the extract media 
prepared by immersing the alloy specimens in culture medium and incubating them for 72h. 
Modified Eagle’s medium alpha (αMEM) with 10% FBS and 100 U ml−1 penicillin–streptomycin 
was used as cell culture media. The alloy specimens were machined into disks,10 mm diameter 
and 5 mm thickness, and polished up to 1200 grit using SiC paper. The ratio of culture media 
volume to specimen weight was maintained at 1 mL to 0.2 g in conformation with EN ISO 
10993:12. The extract media was filtered using 0.2 µm membrane with this original extract being 
considered as 100% extract. The chemical concentration of Mg, Zn, Zr, Sr, and Ce in the 100% 
extract was then measured using an inductively coupled plasma – optical emission spectroscopy 
(ICP-OES) similar to the procedure described earlier in Chapters 3 and 4. The 100% extract was 
further diluted to 50%, 25%, and 10% extract solutions. MC3T3 cells were seeded in a 96-well 
plate with a cell density of 6,000 cells per well and incubated for 24 h. The MC3T3 cells were 
further incubated with the 100%, 50%, 25%, and 10% extract media. After 72 h of incubation, 
Vybrant MTT Cell Proliferation Kit (Invitrogen Corporation, Karlsruhe, Germany) was used to 
assess the cell viability. Prior to the MTT assay, the extract media was replaced with fresh 
culture media to prevent any interaction between Mg ions and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). 110 µL of 1.2 mM MTT in phosphate buffered saline 
(PBS) was then added to each well and incubated for 4 h of incubation.  Sodium dodecylsulfate–
hydrochloric acid solution solution was then added and incubated for 12 h to solubilize the 
formazan crystal. The absorbance of formazan dye was then measured at a wavelength of 570 
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nm using Synergy 2 microplate reader (BioTek Instruments, Winooski, VT) similar to the 
procedure described earlier. Averages and standard deviations of 3 sample measurements were 
reported and one-way ANOVA was used to determine any significant mean differences with a p-
value less than 0.05 for each dilution factors of the extract media. 
5.2.8 Human mesenchymal stem cell culture with salt solution 
Human mesenchymal stem cells (Lonza, Allendale NJ) were used to assess the effect of Mg, Sr, 
and Ce ions on the osteogenic differentiation of hMSCs. The third passage cells were cultured 
with both growth and differentiation media that contain Mg, Ce, and Sr ions. Modified Eagle’s 
medium alpha (αMEM) with 20% FBS and 100 U ml−1 penicillin–streptomycin was used as the 
growth media. 100 nM dexamethasone, 50 μM ascorbic acid, and 10 mM β-glycerophosphate 
were further added to the growth media to generate the osteogenic media. Additionally, 10 mM 
MgSO4, 0.1/1 mM SrCl2, or 0.1/1 mM CeCl3 were added to the differentiation media as 
tabulated in Table 5.2. hMSCs were seeded at the cell density of 6000 cells per cm2, and cultured 
with the growth media for 7 days. Following this, the growth media was replaced with the 
sample media and cultured for another 7 and 14 days to investigate the alkaline phosphatase 
activity and osteogenic gene expression. Averages and standard deviations of 3 sample 
measurements were reported and one-way ANOVA with Tukey’s post-hoc test was used to 







Table 5.2 Abbreviated notation and chemical formulation of sample media. 
Abbreviated notation for 
sample media 
Sample media formulation 
GM Growth media 
DM Differentiation media 
DM-Mg 10 mM MgSO4 in the differentiation media 
DM-Mg-0.1Sr 10 mM MgSO4 and 0.1 mM SrCl2 in the differentiation media 
DM-Mg-1Sr 10 mM MgSO4 and 1 mM SrCl2 in the differentiation media 
DM-Mg-0.1Ce 10 mM MgSO4 and 0.1 mM CeCl2 in the differentiation media 
DM-Mg-1Ce 10 mM MgSO4 and 1 mM CeCl2 in the differentiation media 
  
5.2.8.1 Alkaline phosphatase measurement 
Alkaline phosphatase (ALP) activity was assessed using an enzymatic assay measuring the 
conversion of p-nitrophenyl phosphate (pNPP) as a phosphatase substrate. hMSC cells were 
washed with PBS and lysed using a lysis buffer (CelLytic M, Sigma Aldrich) to prepare the cell 
lysate containing ALP. pNPP substrate solution was added to the cell lysate to assess the 
enzymatic reaction. After 30 m incubation, 0.3N NaOH solution was then supplemented to stop 
the enzymatic reaction, and measure the absorbance at 405 nm. pNPP standard solutions with 
different concentrations were prepared by diluting the pNPP substrate solution with 0.02N 
NaOH solution. The ALP activity was determined by comparing the absorbance to the standard 






5.2.8.2 Gene expression study using qRT-PCR 
 
Table 5.3 Primer sequences of GAPDH, ALPL and OPN of hMSC. 
 Forward Primer (5’-3’) Reverse Primer (5’-3’) 
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC 
Alkaline phosphatase (ALPL) GACCCTTGACCCCCACAAT GCTCGTACTGCATGTCCCCT 
Osteopontin (OPN) CTCAGGCCAGTTGCAGCC CAAAAGCAAATCACTGCAATTCTC 
 
 
hMSCs were cultured with growth media and differentiation media with the different alloying 
element salts mentioned above in the section 5.2.8. RNA isolation was performed on these 
hMSCs using a commercially available RNA extraction kit (Nucleospin RNA Extraction Kit, 
Macherey Nagel). RNA concentration was measured using a microplate reader (Synergy 2, 
BioTek Instruments) at the wavelength of 260 and 280 nm. Approximately 50 ng of RNA was 
used for each reverse transcription reaction. Reverse transcription was performed using a 
commercially available kit (Improm-II Reverse Transcription Kit, Promega). After that, 
complementary DNAs were subjected to qPCR reactions using SYBR green mastermix (Brilliant 
II, Agilent) and the primers as listed in Table 5.3.  
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5.3 RESULTS 
5.3.1 Phase and elemental analysis 





































































Figure 5.1 X-ray diffraction patterns of as-extruded.Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr. 
 
Figure 5.1 shows x-ray diffraction (XRD) patterns of the base alloy Mg-Zn-Zr (ZK 40), Mg-Zn-
Sr-Zr, and Mg-Zn-Ce-Zr alloys after extrusion. The patterns were identified as a single phase α-
Mg matrix with hcp crystal structure of pure Mg.  Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr 
alloys exhibited presence of no distinct intermetallic phases in combination with Mg, Zn, Ce, Sr, 
or Zr. The XRD patterns clearly exhibits that α−Mg solid solution single phase was formed in all 
of the different alloy systems and no detectable amount of any intermetallic content was 
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observed. However, unlike pure Mg, the highest peak intensity for Mg-Zn-Zr, Mg-Zn-Sr-Zr, and 
Mg-Zn-Ce-Zr alloys was observed for the (101) pyramidal plane. This observation suggests that 
the orientation of the α−Mg solid solution single phase was altered during alloy synthesis and 
processing. 
Back-scattered electron (BSE) microscopy was employed to observe the microstructure 
of the extruded Mg alloys to show the influence of the various alloying elements and perform 
elemental analysis on the alloy matrix and precipitates. In Figure 5.2, the BSE images of the Mg 
alloys analyzed in the matrix indicated as M and in the precipitates indicated as P revealed the 
presence of intermetallic precipitates as high contrast areas along the grain boundaries. Increase 
in precipitate amounts were observed with an increase in Sr and Ce amount (Figure 5.2a vs. 
5.2b-e). Mg-Zn-Zr showed the formation of solid solution close to its nominal composition and 
Zn-rich Mg7Zn3 precipitates similar to the case described in Chapter 3 for the ZK40 alloy. 0.25 
wt.% Sr addition to Mg-Zn-Zr had no effect on the alloy matrix but caused the presence of Sr 
and less Zn contents in the precipitate (Figure 5.2b). Further increasing the Sr content to 1 wt.% 
Sr addition did not seem to alter the composition of the solid solution or precipitates much 
showing similar composition range. However, an increased number of precipitate sites were 
observed (Figure 5.2d). Cerium addition also exhibited similar effect on the precipitate indicating 
presence of Ce and decreased amounts of Zn compared to Mg-Zn-Zr (Figure 5.2c,e). Mg-Zn-Ce-
Zr exhibited more precipitates compared to Mg-Zn-Sr-Zr (Figure 5.2b,d vs. 5.2c,e). Thus, Ce 
addition was observed to cause more precipitates compared to Sr addition due to the higher solid 










Figure 5.2 Back-scattered electron microscopy of (a) Mg-Zn-Zr, (b) Mg-Zn-0.25Sr-Zr, (c) Mg-Zn-0.25Ce-Zr, (d) 





5.3.2 Immersion corrosion measurement 
 
Figure 5.3 Immersion corrosion rates of Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr (n = 3, §p<0.05 denotes a 
significant difference with all other groups). 
 
An effect of adding Ce and Sr as micro alloying elements on the corrosion resistance of Mg-Zn-
Zr alloy was investigated using immersion corrosion measurement in HBSS for 7 and 35 days. In 
Figure 5.3, mass loss of the Mg alloys were converted to immersion corrosion rates in millimeter 
per year (mmpy) as described in earlier chapter 4. Mg-Zn-Sr-Zr alloys does not exhibit any 
significant difference in the corrosion rate compared to Mg-Zn-Zr. On the other hand, Mg-Zn-
1Ce-Zr exhibits a significant increase in corrosion rate after 35 days of immersion whereas Mg-
Zn-0.25Ce-Zr still maintained comparable corrosion resistance with other Mg alloys. As 
observed and discussed in section 5.3.1 in the BSE images, more secondary phase contents in the 
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case of Mg-Zn-1Ce-Zr results in a catastrophic corrosion initiated from the Mg-Zn-Ce mixtures 
along the grain boundaries. Overall, the addition of 0.25 and 1 wt.% of Sr as well as 0.25 wt.% 
of Ce did not deteriorate the corrosion resistance significantly compared to commercial AZ31. 
5.3.3 Tensile mechanical properties 
Mechanical properties of the different alloys was determined using tensile tests, the results of 
which as tabulated in Table 5.4. Mg-Zn-Zr alloy (ZK 40) exhibited an elastic modulus of 45.8 
GPa, yield strength of 286.6 MPa (YS), and an ultimate tensile strength of 327.2 MPa (UTS), 
and 9.3% elongation. Addition of 0.25 wt. % and 1 wt. % Sr to the Mg-Zn-Zr only resulted in a 
slight decrease in UTS to 317.3 MPa and 320.9 MPa. There were no significant difference in 
modulus, YS, and elongation. On the other hand, addition of 0.25 wt. % and 1 wt. % Ce to Mg-
Zn-Zr exhibited a significant increase in UTS to 335.2 MPa and 341 MPa, respectively. A 
significant decrease in elongation from 9.3% to 7.6% was also observed in the case of Mg-Zn-
1Ce-Zr. 
 
Table 5.4 Tensile properties of Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr alloys (n=3, §p<0.05 denotes a 
significant difference with all other groups). 







Mg-Zn-Zr 45.8±5.2 286.6±8.0 327.2±6.2 9.3±3.5 
Mg-Zn-0.25Sr-Zr 42.4±3.6 292.8±6.2 317.3±2.4 12.6±2.1 
Mg-Zn-1Sr-Zr 41.0±2.5 292.7±9.5 320.9±1.9 9.5±1.0 
Mg-Zn-0.25Ce-Zr 39.7±4.0 271.9±7.1 335.2±0.4 § 10.2±1.0 
Mg-Zn-1Ce-Zr 45.9±4.3 282.5±3.3 341.7±2.9 § 7.6±1.1 § 
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Figure 5.4 MC3T3 cell viability of Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr after (a) 1 day and (b) 3 days (n=3). 
 
MC3T3 cell viability was assessed using MTT assay after culturing the cells for 1 and 3 days 
with extract media containing the degradation products of Mg-based alloys. Compared to the 
growth media as negative control, the MTT assay result was plotted as shown in Figure 5.4. 
100% extract media of Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr alloys, as expected in 
contrast to commercially available AZ31B or pure Mg, exhibited less than 10% cell viability 
immediately even after 1 day culture (Figure 5.4a). The cell viability of these alloys was 
however restored to ~50% with 50% extract media and increased to ~90% with 25% and 10% 
extract media. Figure 5.4b showed similar cell viability pattern for the MTT assay after 3 days of 
culturing the MC3T3 with the extract media. Fischer et al. (121) suggested 10% extract media is 
suitable to determine the cytotoxicity of biodegradable Mg alloys due to the nature of the static 
culture causing cell necrosis induced by osmotic shock of total metal salt concentration as 
discussed in Chapter 4. ISO 10993:5 protocol determines that achieving 75% or higher cell 
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viability is generally considered non-cytotoxic. Hence, the cell viability of 10% extract media 
suggests that these alloys are indeed cytocompatible with the MC3T3 cell line. 
5.3.5 ALP activity measurement 
 
Figure 5.5 ALP activity of hMSCs cultured for 7 and 14 days with osteogenic media supplemented with Mg, Sr, 
and Ce ions (n=3, §p<0.05 denotes a significant difference with differentiation media control). 
 
Human mesenchymal stem cells were (hMSC) cultured with growth media for 7 days. ALP 
expression levels were measured after 7 and 14 days of culturing the hMSCs with osteogenic 
differentiation media containing alloying elements (Figure 5.5). Although higher ALP level was 
observed compared to growth media for all the salt concentrations, there was no significant 
improvement in ALP expressions in the differentiation media groups with the addition of the 
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alloying element salts. Lower level of ALP activity was observed in differentiation media 
containing CeCl3 after 7 days but the ALP level was restored compared to differentiation media 
after 14 days. No other significant difference in ALP expressions was caused by the addition of 
Mg and Sr ions  
5.3.6 Gene expression 
Alkaline phosphatase (ALPL) and osteopontin (OPN) gene expression are shown in Figure 5.6. 
Fold changes of ALPL and OPN was obtained by subtracting GAPDH housekeeping gene 
expression and subtracting the average of the growth media groups. ALPL expression exhibited a 
significant increase in DM-Mg-1Sr group. In the case of OPN, Mg, 0.1/1 mM Sr, and 0.1 mM Ce 
supplemented media exhibited significantly enhanced expression level whereas Ce supplemented 
media exhibited no significant improvement. 
 
Figure 5.6 (a) ALPL and (b) OPN gene expression of hMSC cultured for 7 and 14 days with osteogenic media 





5.4.1 Effect of Sr and Ce on corrosion resistance and mechanical properties 
The present study has been conducted with one of the primary goals being to explore the effect 
of Sr and Ce additions to Mg based alloys particularly, the Mg-Zn-Zr system.  Additionally, the 
goal is to study the corrosion resistance, mechanical properties, cytocompatibility and more 
importantly, also investigate the osteogenic response of incorporation of gradually adding Sr and 
Ce to biodegradable Mg-Zn-Zr alloys. As discussed in the earlier Chapters 3 and 4, Mg-Zn-Zr is 
a commercially available Mg alloy system that was developed and used for structural 
applications. Its potential use as a biodegradable metal was identified as discussed in Chapters 
and 3 and 4 primarily owing to its suitable corrosion resistance, mechanical properties and 
cytocompatibility. As discussed in Chapter 3 and 4, Mg-Zn (Mg7Zn3) secondary phase 
precipitates are observed to form in the grain boundary area. These precipitates are vulnerable to 
galvanic corrosion and serve as initiators for pitting corrosion. Hence, as discussed in Chapter 2 
in the specific aims section, Sr and Ce have been selected as microalloying elements to alter the 
composition of these precipitates. Strontium (Sr) refines the grain sizes of Mg alloys and Ce can 
form stable oxides due to the higher bond energies and bond strengths and affinity of Ce to form 
cerium oxides thus serving to protect the Mg-Zn-Zr alloy from corrosion. In addition, Sr and Ce 
have been reported to have a positive effect on the proliferation and osteogenic differentiation of 
human mesenchymal stem cells. 
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Strontium (Sr) and Cerium (Ce) were both used as micro alloying elements in the amount 
of 0.25 wt.%  and 1 wt.%. Only small amount of Sr and Ce were used due to the low solubility 
limit of these alloying elements exceeding which can form more secondary phase precipitates 
which can deteriorate corrosion resistance leading to galvanic corrosion. Phase analysis was 
performed on the Mg-Zn-Sr/Ce alloy system using an x-ray diffraction. As shown in Figure 5.1, 
no distinct second phase or unalloyed single elements or multiphase alloys or compounds were 
observed in the Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-Ce-Zr alloy systems. However, presence of 
second phase precipitates along the grain boundaries of the Mg alloys were still revealed under 
back-scattered scanning electron (BSE) microscopy as shown in Figure 5.2 possibly due to the 
processing conditions of melting and casting not allowing enough time for complete 
homogenization of the melt or possibly during extrusion of the alloy, the time, temperature and 
reduction ratios selected exacerbated causing instabilities to the precipitates leading to further 
break down and distribution of the precipitate particles within and around the grain boundaries. 
The composition of the precipitates in the Mg-Zn-Zr alloy system thus transformed the 
precipitate compositions to ternary mixtures of Mg, Zn, and Sr/Ce in Mg-Zn-Sr/Ce-Zr alloy 
systems thus leading to precipitates of Mg-Zn-Sr in the case of Mg-Zn-Sr-Zr system and Mg-Zn-
Ce in the Mg-Zn-Zr-Ce system. Although the chemical composition of the precipitates were 
more similar to the composition of the base alloy (Mg-Zn-Zr (ZK 40) system) in each alloy, 
more number of precipitates were observed in the BSE images. Ce addition was more prone to 
form grain boundary precipitates compared to Sr addition (See Figure 5.2b, d vs. 5.2c, d). As a 
result of these precipitates from Sr and Ce addition, the immersion corrosion measurements 
exhibited no significant improvements in corrosion resistance. Except for Mg-Zn-1Ce-Zr alloy 
composition, the corrosion rates in general for all the other compositions and additions of Sr and 
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Ce were comparable to commercially available AZ31 without displaying any significant 
difference. Mg-Zn-1Ce-Zr in fact, demonstrated increase in corrosion rates after 35 days of 
immersion due to the higher volume of precipitates formed as seen in the BSE images. 
Precipitates at the grain boundary can also serve to impede dislocation movement as is 
well-known in the literature leading to improvement in the mechanical strength of Mg alloys. It 
is well-known from physical metallurgical principles, precipitation hardening is routinely used to 
increase precipitation of second phase precipitates from alloying elements or inclusions or 
impurity phases by performing heat treatment above the melting point of a specific alloying 
element via the time-temperature-transformation (TTT) diagrams.  Although such optimizations 
were not performed in this study, the initial results presented here clearly show that such 
optimizations can be conducted to indeed reap the potential of these optimization studies of the 
addition of Sr and Ce. Nevertheless, it can be seen that the addition of Sr to Mg-Zn-Zr exhibited 
no significant difference in tensile properties. On the other hand, the ultimate tensile strength was 
significantly improved to 335 MPa and 342 MPa with Ce – 0.25 wt% and 1 wt% additions, 
respectively. However, as is usually the case with the 1 wt.% of Ce addition, a decrease in 
elongation was obtained to offset the grain boundary strengthening.  
5.4.2 Cytocompatibility and osteogenic potential of Sr and Ce additions to Mg-Zn-Zr 
alloys 
Toxicity of biomaterials are often examined using in vitro experiments prior to initiation of in 
vivo experiments. In this regard, ISO 10993 protocols have been developed and used for 
screening polymeric and metallic biomaterials based on the cell viability shown using the MTT 
assay (140). Fischer et al. initially reported that MTT assay followed by direct cell culture with 
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Mg alloy materials can result in a false positive due to Formazan salt conversion by actively 
corroding Mg ions serving to interfere with the assay results (110). Fischer et al. also addressed 
that osmolality issue of Mg ions causing osmotic shock to the cells although Mg alloys 
implanted in the animal exhibits no significant tissue damage (121). Hence, in this study the 
work has focused on the indirect MTT assay results indicating cell viability with 10% extract 
media serving as a better acceptable indicator to rank the toxicity of Mg alloys. It has been 
widely accepted that in vitro degradation and cytocompatibility exhibited by Mg during the static 
immersion tests do not really represent the in vivo implantation response of biodegradable Mg 
alloys (110, 141). Mg alloys on the other hand, tend to degrade in a much slower rate during in 
vivo implantation and hence, exhibit minimal inflammatory response.  
Cytocompatibility of the Mg alloys have been examined using MC3T3 cell line in 
compliance with the ISO standard with modifications. MTT assay after 3 days of culturing 
MC3T3 cells with the 10% extract media exhibited good cytocompatibility in all the Mg alloys 
studied compared to pure Mg. Pure Mg and commercial AZ31 were used as experimental control 
groups and exhibited the cell viability higher than 75% when using 100% extract media.  
In addition to cytocompability, osteogenic effect of the alloying elements such as Mg, Sr, 
and Ce was investigated by culturing the human mesenchymal stem cells (hMSC) with 
osteogenic media supplemented with MgSO4, SrCl2, and CeCl3. However, Zr or Zn ions were not 
considered for this study since there are no reports on their influence on osteogenic 
differentiation of hMSCs. Concentration of MgSO4 was maintained at 10mM as reported to be 
optimal for hMSC proliferation (142). SrCl2 and CeCl3 are dissolved in the osteogenic media 
with 10mM MgSO4 to reach concentrations of 1 or 0.1 mM since Sr and Ce content in Mg-Zn-
Sr/Ce-Zr alloys is limited to 1 wt.% in the present study. Further, hMSC is used instead of 
 90 
MC3T3 since hMSC has the ability to differentiate into multiple lineage whereas MC3T3 is 
already in the early stage of osteoblast. Confluent hMSCs were cultured with the supplemental 
media for 7 and 14 days as mature osteoblast can be obtained after 14 days of culturing hMSC in 
osteogenic media (143). 
Alkaline phosphatase was measured after culturing hMSC for 7 and 14 days since it is an 
early marker for osteogenic diffentiation of hMSC (144). Compared to growth medium, 
osteogenic media and supplemented media exhibited higher ALP activity. However, no 
significant improvement in ALP activity was observed with osteogenic media supplemented with 
Mg, Sr, or Ce (see Figure 5.5). Hence, the gene expression was quantified using qRT-PCR to 
investigate any osteogenic effect of these elements. ALPL expressions normalized by GAPDH 
housekeeping gene seemed to be significantly upregulated with 1mM Sr containing media as 
shown in Figure 5.6. Overall, osteogenic media supplemented with Mg, Sr, and Ce ions however, 
exhibited no additional improvement in ALP activity and mRNA expression.  
5.5 CONCLUSIONS 
 
The effect of adding Sr and Ce as micro alloying element to biodegradable Mg-Zn-Zr alloy has 
been studied in terms of corrosion and mechanical properties as well as biological influence of 
these alloying elements contributing to mineralization and exhibiting any osteogenic potential. 
Using these micro alloying elements, it was observed that second phase precipitates were 
formed. The precipitates appeared to be successfully formed owing to the solubility of Sr and Ce 
in the binary Mg-Zn phase system to correspondingly form Mg-Zn-Sr/Ce ternary phase 
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precipitates in the presence of Zr as well. Unfortunately, it appears that the introduction of 
additional alloying elements induced formation of more precipitates along the grain boundaries. 
Thus, a significant improvement in corrosion resistance was not observed though anticipated. On 
the other hand, the mechanical properties were improved due to the large volume of precipitates 
formed confirmed by the back scattered SEM analysis showing formation of Mg-Zn-Sr and Mg-
Zn-Ce precipitates for Sr and Ce addition. Cytocompatibility of Mg-Zn-Zr was found to be not 
affected by adding Sr or Ce. Zn however, exhibited low tolerance in the cell viability after 
culturing MC3T3 cells with different alloying element in the form of chloride salts dissolved in 
the culture media. Thus, similar cell viability in MTT assay was obtained due to the constant Zn 
content in Mg-Zn-(Sr/Ce)-Zr alloys. ALP activity and ALPL gene expression exhibited no 
significant improvement whereas OPN gene exhibited some improvement after culturing hMSCs 
with osteogenic media supplemented with Mg, Sr, and Ce salts signifying that the alloying 
elements do not have any potential adverse contribution to the mineralization potency of the 
alloy system. However, in vivo studies would be required to ascertain the true osteogenic 
potential of these alloy systems containing Sr and Ce in addition to Zn and Zr.  
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6.0  SPECIFIC AIM IV: RAT FEMORAL FRACTURE REPAIR USING 
INTRAMEDULLARY PINS OF MAGNESIUM-ZINC-STRONTIUM-ZIRCONIUM ALLOY  
6.1 INTRODUCTION 
Magnesium alloys have been developed for their potential use as biodegradable fracture fixation 
devices (FFD) (145).  Thus far to date, permanent metals such as titanium (Ti), cobalt-chromium 
(Co-Cr), and stainless steel (SS) have been widely used for fracture fixation in the clinical 
settings. Although high mechanical strength of these materials is beneficial for load-bearing 
application, a mismatch in mechanical properties compared to the cortical bone often cause stress 
shielding effects that tend to damage the surrounding tissues (13, 14). In addition, debris 
formation from corrosion and wear due to constant use can initiate inflammatory response and 
foreign body reaction (FBR) that is now synonymous with these bioinert systems (16-18). On the 
other hand, biodegradable Mg alloys appear to be a paradigm shift in the arena of degradable 
materials, a term that was more commonplace with polymeric systems. These materials are 
designed to degrade with degradation products that are also biocompatible and exhibit 
mechanical properties much closer to the natural bone (38). Furthermore, Mg ions exist in bone 
naturally and contribute to osteoblast proliferation (142). In order to bringing these benefits of 
using Mg alloys for orthopedic applications, research and development that has burgeoned 
significantly over the past decade has focused on identifying and development of biodegradable 
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Mg alloys that exhibit controlled corrosion and more importantly, demonstrating the true 
biosafety aspects of Mg and the various alloying elements added to Mg to improve its corrosion 
and mechanical properties. 
Corrosion is the degradation mechanism common to biodegradable Mg alloys. During the 
reaction of magnesium with water, magnesium hydroxide and hydrogen gas are produced. Rapid 
corrosion of Mg alloys can develop gas pockets near the implantation site which leads to 
considerable patient level discomfort and pain due to the consequent pH change and the 
imminent hydrogen gas evolution state (146). Also, rapid corrosion can cause immature 
mechanical failure of the devices during the initial fracture healing process, loosening of the 
device and hardware a ubiquitous problem (147). In order to overcome rapid corrosion of 
magnesium, altering alloy compositions and the microstructure by choice of the alloy system and 
the processing conditions have typically been employed (76, 129). Mg-Zn (59-62), Mg-Al (49, 
63-65), Mg-Y(66, 67), and Mg-Y (67-70) based alloys have demonstrated their suitable 
corrosion resistance, mechanical properties, and biocompatibility demonstrating their potential 
use as a biodegradable metal.  
Biosafety of biodegradable Mg alloys have been examined using in vitro and in vivo 
experiments. However, a discrepancy between in vivo and in vitro degradation characteristics of 
Mg alloys have typically caused a mismatch in the cell viability results and the expected versus 
actually observed in vivo biocompatibility (148). Static culture is limited to mimic physiological 
conditions for testing Mg alloys. Cell viability is highly dependent on the osmolality of Mg ions 
in the culture medium (110). Osmotic shock of Mg ions can cause cell necrosis during in vitro 
studies. Also, Mg ions in Mg alloys conflict with Formazaan salt-based assays for in-vitro cell 
viability tests (149). Therefore, in vivo studies have been preferred to in vitro studies. Toxicity 
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and degradation of biodegradable Mg alloys have been reported using various animal models 
(57, 131, 150). A few clinical trials of biodegradable Mg-based fixation screws have been also 
been reported to date. Syntellix AG and U&I corporation have also conducted clinical trials and 
earned regulatory approvals in Europe and South Korea, respectively (58). Although there are 
approved non-load bearing fixation devices of biodegradable Mg alloys, more research is 
critically needed to develop Mg devices for use under load-bearing conditions.  
The objective of this study was therefore to investigate the degradation effects, local 
tissue response, and systemic toxicity of Mg-4Zn-0.25Sr-0.5Zr pins that are implanted in the 
intramedullary region of the fractured rat femurs. Mg alloys are not intended for use as femoral 
rods. However, rat femoral fracture model has been selected for this study to primarily 
understand the degradation profile of Mg-Zn pins and examine the toxicity of Mg-Zn pins under 
load-bearing conditions. Corrosion of metal is known to be accelerated when mechanical stress is 
applied commonly termed as stress-corrosion cracking (SCC). In the present study, ZK40 alloy 
was modified by adding 0.25 wt. % of Sr to improve corrosion resistance as discussed in the 
earlier Chapter 5. Mg-4Zn-0.5Zr (ZK40) exhibited comparable corrosion resistance and 
mechanical properties as other biodegradable Mg alloys such as Mg-Y or Mg-Al alloys. Sr also 
has been reported to stimulate osteoblast proliferation and osteogenic differentiation of human 
mesenchymal stem cells although the present work was focused primarily on in vivo 
biocompatibility. 
 95 
6.2 MATERIALS AND METHODS 
6.2.1 Alloy processing and fabrication of femoral pins 
Mg-4Zn-0.1Sr-0.5Zr (Mg-Zn) alloy was synthesized using an electrical resistance furnace 
(Wenesco Inc.). Pure Mg (US magnesium Inc. 99.97%), Zn shots (Alfa-Aesar 99.99%), Mg-30Sr 
master alloy were melted in a mild steel crucible. The total melt amount was 250 g. Melting 
process was performed using 0.5% SF6 + balance Ar protective gas atmosphere to protect the 
molten magnesium alloy from oxygen as outlined in Chapters 2-4. The molten mixture of Mg, 
Zn, and Sr were homogenized at 700 °C and zirconium content was added using Zirmax® (Mg-
33.3 wt% Zr) master alloy (Magnesium Elektron Ltd.). After 1 and 5 minutes, the liquid melt 
was further homogenized by stirring for 10 seconds to dissolve and disperse the zirconium 
particles uniformly. The melt was maintained at 700 °C for 30 min, following which the molten 
liquid was poured into a mild steel mold (Ø 44.5 mm × 82.5 mm) preheated at 500 °C. 
 The middle part of the as-cast Mg-Zn-Sr-Zr (Mg-Zn) alloy following removal of the top, 
sides and the bottom as outlined in Chapter 2 was machined to a dimension of 37.6 mm diameter 
and 60 mm height by using a lathe. The as-cast Mg-Zn-Sr-Zr (Mg-Zn) alloy was then heat-
treated at 300 °C for 1 hour, quenched in oil, and annealed at 205 °C for 12 hours. Following 
heat treatment, hot extrusion was performed using an extrusion ratio of 30:1 at North Carolina 
A&T University (Greensboro, NC). 
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6.2.2 Animal study design 
 
Figure 6.1 Pin and cuff implantation in rat femurs. 
 
The animal study was conducted in accordance with a protocol approved by Animal Care and 
Use Committee (IACUC) at the University of Pittsburgh. A schematic of the surgical procedure 
executed is displayed in Figure 6.1. Groups, time points, and number of animals involved in the 
current chapter are explained in Table 6.1. 30 Sprague-Dawley rats of approximately 250 g of 
body weight were used. 15 rats were randomly selected for Ti alloy implantation and the other 
rats were implanted with Mg alloy pins. For each implant material, 10 rats were implanted with 
pins for 2 and 14 weeks and 5 rats were implanted with the cuff for 14 weeks. For each pin 
implanted, the right femur of each rat was approached laterally and an osteotomy was performed 
in the middle of the femur using a dremel drill with a diamond wheel blade. A pin of Ti or Mg 
alloy was inserted into the intramedullary region to achieve a stable reunion of the fractured 
femur. 5 rats from both Ti and Mg groups were sacrificed for fracture healing and toxicity 
analysis after 2 or 14 weeks of implantation. For each cuff implantations, a cuff of Ti or Mg-Zn 
alloy was implanted around the unfractured femur for toxicity analysis after 14 weeks.  
 97 
 
Table 6.1 Groups, time points, and number of animals used for Ti and Mg-Zn device implantation 
Group Time point N / time point 
Ti alloy pins 2 and 14 weeks 5 
Mg-Zn pins 2 and 14 weeks 5 
Ti alloy cuffs 14 weeks 5 
Mg-Zn cuffs 14 weeks 5 
6.2.3 Radiographic imaging and computer tomography analysis 
X-ray images of all animals were obtained after 7 days to observe implant location and 
alignment of fractured femurs. The Mg-Zn alloy pins before implantation were scanned using 
micro-computed tomography (microCT) (VivaCT40; Scanco Medical, Switzerland). The 
harvested femurs were also scanned using microCT after embedding in plastic. Analysis of the 
microCT images were performed using Mimics (Materialise, Belgium) to calculate the 
degradation rate of the Mg alloy pins and assess fracture healing. Averages and standard 
deviations of 5 sample measurements were reported and t-test was used to determine any 
significant mean differences with a p-value less than 0.05 for Mg-Zn pin groups at different time 
points. 
6.2.4 Blood test 
Blood samples were obtained before operation and after euthanasia at 2 and 14 weeks. The 
samples collected in K2-EDTA were sent to Marchfield Labs (Cleveland, OH) for hematologic 
analysis. Red blood cell count, hemoglobin, hematocrit, platelet count, and white blood cell 
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count were analyzed using a Sysmex XT2000i Automated Hematology Analyzer (Sysmex 
Corporation, Japan). For biochemical analysis, the blood samples were maintained at room 
temperature to clot for 30 minutes and centrifuged at 2,000 rpm for 10 minutes. The supernatant 
serum samples were analyzed using an Olympus AU chemistry analyzer (Olympus Corporation, 
Japan). Alanine aminotransferase (ALT), alkaline phosphatase (ALP), total protein, albumin, 
total and direct bilirubin, cholesterol, glucose, urea, creatinine, phosphorus, chloride, potassium, 
sodium, and magnesium were accordingly measured. Averages of 3 sample measurements were 
reported and compared to the reference ranges for each parameter. 
6.2.5 ICP analysis 
Harvested liver and kidney tissues were dried in an oven at 70 °C overnight. Dried tissue 
samples were then ground using a mortar and pestle. 0.5 g of ground tissues were dissolved in 5 
mL of concentrated nitric acid that was kept heated at 130 °C for 14 hours, and supplemented 
with 1 mL of 30% hydrogen peroxide (151, 152). Sample solutions were then diluted 10 times 
and measured using an inductively coupled plasma optical emission spectroscopy (ICP-OES, 
iCAP duo 6500 Thermo Fisher, Waltham, MA) with standard solutions of the various elements 
being analyzed. Averages and standard deviations of 3 sample measurements were reported and 
one-way ANOVA was used to determine any significant mean differences with a p-value less 
than 0.05 for all other groups. 
 99 
6.2.6 Soft tissue histology 
Harvested liver and kidney tissues were fixed in 10% neutral buffered formalin for 48 hours. The 
fixed tissues were sectioned in small pieces, dehydrated in ethyl alcohol series from 70% to 
100%, cleaned using xylene substitute and embedded in paraffin. Paraffin tissue blocks were 
then sectioned using a rotary microtome. Tissue slices were accordingly dewrinkled on a warm 
water bath, and transferred to glass slides. After drying, tissue slides were imaged using an 
optical microscope after staining with hematoxylin and eosin (dyes) and mounted using a 
mounting solution.  
6.2.7 Bone tissue histology 
Undecalcified embedding was used to perform histology analysis of the harvested femurs with 
implants. Harvested femurs were fixed in 70% ethyl alcohol for 72 hours. The fixed femurs were 
then dehydrated in diluted ethyl alcohol from 70% dilution to 100% consecutively. The femurs 
were cleaned in xylene and embedded in poly methyl methacrylate (PMMA) (OsteoBed, Life 
Technology). 7 to 10 um tissue sections were obtained from the embedded femurs using a rotary 
microtome with a tungsten carbide blade. Sections were adhered to tape to prevent shattering 
during sectioning. Sections were subjected to Goldner’s Masson Trichrome and alkaline 
phosphatase staining. The stained sections were mounted on a glass slide using a glycerol 






6.3.1 In vivo degradation of the magnesium-zinc-zirconium-strontium (Mg-Zn-Zr-Sr) 
alloy pins 
 
Figure 6.2 X-ray radiograph image of (a) Ti pin, (b) Mg-Zn pin, and (c) Mg-Zn cuff pin implanted rats after 1 week 
(GP: gas pocket). 
 
Figure 6.2 exhibits representative x-ray radiograph images of Ti and Mg-Zn pin implanted rats 
after 1 week of osteotomy surgery. The images were used to determine the time point for 
euthanizing each animal based on the quality of fractured femur fixation. In the x-ray image, 
some visible hydrogen gas evolution was observed around the Mg-Zn implants as shown in 
Figure 6.2b and 6.2c. Rats implanted with both Ti and Mg-Zn pins exhibited normal movement 
and ambulatory behavior.  
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Harvested femurs exhibited normal fracture healing response with intramedullary pins. 
Callus formation was observed around the wound. Callus formed on the femurs with both Ti and 
Mg-Zn pins exhibited no visible difference. However, the callus formed on the femurs after 8 
and 12 weeks of implantation was more hardened compared to the callus after 2 weeks of 
implantation. The fracture femurs with Mg-Zn pins was not aligned as straight as the femurs with 
Ti pins. 
 
Figure 6.3 Micro CT analysis image of (a) Ti pin at 14 weeks and Mg pins at (b) 2 weeks, and (c) 14 weeks. 
 
Figure 6.3 shows the representative micro-computed tomography (micro-CT) images of 
rat femurs with Ti or-Mg-Zn pins after plastic embedding. Femur with a broken Mg-Zn pin 
resulted in a misalignment of fractured bones. At 2 weeks, 3 out of 5 Mg-Zn pins were fractured 
into 2 pieces. Ti pins on the other hand, exhibited no fracture or damage due to the load. Mal-
union of the femurs with broken Mg-Zn pins can lead to a significant difference in the fracture 
healing. However, the micro-Ct images for 14 months for both Ti and Mg-Zn pins implanted 
shown in Figure 6.3 indicated that the fracture healing process was not completed. More 
hydrogen gas bubbles were evolved around Mg-Zn pins following 2 weeks of implantation not 
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distinguishable in micro CT but was noticeable in the histology as discussed later. After 14 
weeks, the gas bubbles were however, not distinguishable in the micro-CT images. 
 
 
Figure 6.4 (a) Corrosion rate and (b) volume remaining of Mg-Zn pins implanted after 2 and 14 weeks (n=5, 
§p<0.05 denotes a significant difference between groups). 
 
The remaining volume of Mg-Zn pins in the intramedullary region was analyzed from the 
micro-CT images (see Figure 6.4b). The remaining volume of Mg-Zn pins after 2 weeks of 
implantation was 87.7%. After 14 weeks, the remaining volume was significantly decreased to 
42.0%. Corrosion rates of Mg-Zn pins were calculated from the volume loss and original surface 
area as shown in Figure 6.4a. Mg-Zn pins for 2 weeks of implantation exhibited the corrosion 
rate of 0.91±0.65 mmpy. The corrosion rate at 2 weeks was anticipated to be higher than the 
other time points since the Mg-Zn pins was exposed to the largest mechanical stress at the 2 
week time point. The Mg-Zn pins for 14 weeks of implantation continued to degrade with larger 
surface area being exposed which resulted in the corrosion rate of 0.77±0.30 mmpy.  
§ 
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6.3.2 Blood test results 
Table 6.2 summarizes blood test results of rats before and after osteotomy surgeries for 2 and 14 
weeks of Ti and Mg-Zn pins/cuffs implantation. Red blood cell, hemoglobin, and platelet count 
exhibited no significant difference in the groups for the different implants and the different time 
durations. White blood cell count after 2 weeks of Ti pin implantation was significantly higher 
compared to the Mg-Zn group. However, it still remained within the reference range. 
Biochemical analysis results rats before and after osteotomy surgeries for 2 and 14 weeks 
of Ti and Mg-Zn pins/cuffs implantation are listed in Table 6.3. ALT after 2 weeks of 
implantation for both Ti and Mg-Zn pins exhibited significantly higher level compared to the 
implants for the other time points. However, these ALT values still remain within the reference 
range. For ALP, TBIL, TP, ALB, UA, CR, and GLB, all groups exhibited no significant 
difference between implants and implantation duration suggesting no signs of liver or kidney 
damage due to degradation of Mg-Zn pins. 
Calcium, sodium, chloride, phosphorous, and magnesium ion levels in the serum before 
and after implantation are listed in Table 6.4. No significant difference in these ion levels were 
found between implants or implantation duration. All values remained within the reference range 
suggesting that there were no changes to the systemic ion concentration due to implantation and 












Table 6.2 Hematologic analysis results from blood panel test after Ti pin (2 and 14 weeks), Mg-Zn pin (2 and 14 





































(7.00-9.00) (13.7-16.8) (680-1280) (1.1-7.5) 
Pre-operation 
 
7.4 14.1 618.3 6.8 
Ti pin 2 weeks 7.8 14.9 656.0 9.0 
Mg-Zn pin 2 weeks 7.4 14.1 547.0 3.7 
Ti pin 14 weeks 7.5 14.0 563.0 5.9 
Mg-Zn pin 14 weeks 7.3 13.7 598.0 4.5 
Ti cuff 14 weeks 7.6 13.8 637.0 5.8 






Table 6.3 Biochemical analysis on blood serum after Ti pin (2 and 14 weeks), Mg-Zn pin (2 and 14 weeks), and 



























mg/dL U/L U/L mg/dL g/dL g/dL mg/dL mg/dL g/Dl 
 


















181.2 55.8 175.2 0.17 5.7 3.3 20.7 0.37 2.4 1.4 
Ti pin  2 weeks 322.0 132.6 151.2 0.14 6.2 3.3 17.6 0.42 2.9 1.1 
Mg-Zn pin  2 weeks 293.0 123.0 140.0 0.18 6.7 3.5 20.5 0.53 3.2 1.1 
Ti pin  14 weeks 229.5 56.8 187.0 0.18 6.3 3.7 21.8 0.52 2.6 1.4 
Mg-Zn pin  14 weeks 124.2 57.8 181.8 0.20 6.3 3.6 22.2 0.56 2.7 1.3 
Ti cuff  14 weeks 154.4 50.2 163.6 0.18 6.2 3.6 19.6 0.52 2.6 1.4 








Table 6.4 Electrolyte levels of blood serum after Ti pin (2 and 14 weeks), Mg-Zn pin (2 and 14 weeks), and Mg-Zn 
cuff (2 weeks) implantations. 
 
 
Name Implantation time Calcium Sodium Chloride Phosphorous Magnesium 
Units 
 
mg/dL mmol/L mmol/L mg/dL mg/dL 
Ref. ranges 
 
(9.5-13.9) (146-151) (98-104) (5.6-16.8) (3.8-5.5) 
Unoperated 
 
9.8 138.2 100.5 5.5 2.0 
Ti pin 2 weeks 11.5 143.8 100.2 9.7 3.4 
Mg-Zn pin 2 weeks 12.1 141.3 100.3 12.0 3.7 
Ti pin 14 weeks 12.2 145.2 99.0 9.6 3.6 
Mg-Zn pin 14 weeks 11.3 146.8 100.6 9.4 3.3 
Ti cuff 14 weeks 11.6 147.6 99.6 9.2 3.3 
Mg-Zn cuff 14 weeks 12.2 148.0 99.8 8.7 3.5 
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6.3.3 ICP analysis on liver and kidney 
 
Figure 6.5 Mg concentration of (a) liver and (b) kidney using ICP analysis (n=5). 
 
ICP analysis of the liver or kidney was performed to examine any form of Mg accumulation in 
the organs after implantation of the Mg-Zn alloy pins and cuffs in comparison to the Ti control. 
In Figure 6.5a, Mg concentration determined in the kidney harvested from the experimental 
groups containing Mg-Zn implants exhibited no accumulation of Mg when compared to the 
concentration of kidney from the non-operated groups. Figure 6.5b shows Mg concentration 
observed in the liver tissue from the non-operated controls to be in the range of 521 µg of Mg per 
gram of dried tissue. Regardless of implantation time, Mg-Zn alloy groups implanted with pin 
did not show any significant difference with the control level in Mg concentration of liver 
samples. The observation was consistent with blood test results indicating that implantation of 













6.3.4 H&E staining of liver and kidney 
Hematoxylin and eosin staining of liver and kidney tissue sections were performed to visualize 
any histological differences in tissue morphology due to Ti and Mg-Zn pins implantation. Liver 
sections of both Ti and Mg-Zn groups after 2 and 14 weeks of implantation shown in Figure 6.6 
exhibited a normal distribution of hepatocytes with clearly visible nuclei and central vein. In the 
kidney histology, no visible difference in glomeruli morphology, Bowman’s space, capillaries, 
and convoluted tubules was observed between Ti control and Mg-Zn groups following 14 weeks 
of implantation. Histological morphology of liver and kidney tissues of all experimental groups 
displayed similar morphology as the non-operated control, and no difference was observed in 
between the groups or at different time points although data is not shown. In addition to ICP and 
blood test results, the H&E staining confirmed no damage to vital kidney and liver organs due to 
degradation following implantation of the biodegradable Mg-Zn pins. Although the H&E 
staining cannot be used to determine any accumulation of Mg, the fact that the histology shows 
normal and functional tissue serves to indicate that it is likely that there is no accumulation 
related damage of the kidney and liver tissue and it is possible that with time, there will be 
certainly removal of Mg following the normal excretory process prevalent in the body. More 
advanced techniques will however be needed to ascertain the definitive accumulation of Mg, Zn, 












Figure 6.7 Goldner’s Masson Trichrome staining of rat femurs after implantation of Ti and Mg-Zn pins for 2 and 14 







6.3.5 Bone tissue histology 
Goldner’s Masson Trichrome staining of rat femoral sections after plastic embedding 
revealed a typical fracture healing response as shown in Figure 6.7. After 2 weeks of 
implantation, the femurs with Ti and Mg-Zn alloy pins exhibited endochondral bone 
development and fibrous tissue formation around the fracture. Bone tissue section of the femur 
with Mg-Zn alloy pins after 2 week of implantation exhibited a gas pocket due to the degradation 
of Mg-Zn pins. After 14 weeks of implantation however, femurs with both Ti and Mg-Zn alloy 
pins exhibited bone remodeling and intramembraneous bone formation. In addition, the gas 
pocket of femurs with Mg-Zn pins was filled with fibrous tissues. In any event, fracture repair of 
either Ti or Mg-Zn groups was not completed after 14 weeks of implantation. 
 
6.4 DISCUSSION 
Biodegradable Mg alloys have gained considerable attention as discussed earlier for its potential 
to provide comparable or even improved benefits in fracture repair and for bone fixation 
compared to biodegradable polymer and permanent bioinert metallic devices. Mg is 
characterized by mechanical properties being matched to natural human bone. Hence alloys are 
designed to exhibit mechanical properties with better match to natural bone while exhibiting the 
desired timely corrosion rates with more biocompatible degradation products as compared to 
biodegradable polymers that tend to provide acidic by-products while also additionally lacking 
the desired osteogenic potential to function as an acceptable bone scaffold system. The rapid 
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corrosion of biodegradable Mg alloys can cause hydrogen gas evolution and immature 
mechanical failure warranting the need for improved alloy design and other surface engineered 
strategies to control the corrosion rates while preserving the mechanical strenghths. Hence, in 
vivo degradation and toxicity of Mg alloys have been widely studied to demonstrate the much 
desired biosafety and efficacy as candidate biomaterials for implantable devices. Orthopedic 
devices are often used in load-bearing conditions and metals often tend to corrode more rapidly 
when stress is applied via the well-known stress corrosion mechanisms. This is a common fixture 
and often the mode of much observed problems to date in permanent metal devices which also 
reveal stress induced corrosion, wear, and debris formation. 
The current study is aimed to test degradation properties and biocompatibility of Mg-Zn-
Sr-Zr alloys under load-bearing condition. Mg alloys are not intended for use as a femoral rod 
since they are known to degrade in the body. However, a femoral fracture model using 
intramedullary pins can exert a significant load on the implant material to cause a stress-induced 
corrosion for examining relevant physiological response such as bone healing, inflammatory 
response, and systemic toxicity thus serving as an ideal model system to study healing under the 
presence of stress. Thus using this fracture model, a group of rats were implanted with femoral 
cuffs for 14 weeks to compare any difference in systemic toxicity due to implantation site. 
In vivo degradation of Mg-Zn pins and cuffs was assessed using x-ray radiographs after 1 
week of surgery. It is widely accepted that hydrogen gas bubble evolves in the earlier time points 
and tend to kinetically slowdown in 2~3 weeks (127). Mg alloys implanted in bone without a 
significant load also are reported to show slow degradation exhibiting no gas bubbles while Mg 
alloys in subcutaneous region exhibit significant gas bubbles due to the surrounding 
vascularization and presence of blood flow  (153). Both Mg-Zn alloy pins and cuffs were 
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observed to be surrounded with hydrogen gas in the surrounding tissue. Bone histology results 
were also consistent with the x-ray images showing gas pockets near the fracture site in the 
image following 2 weeks of Mg-Zn pin implantation (see Figure 6.2). Both x-ray radiograph and 
bone histology results indicate that the corrosion of Mg-Zn alloy implants in rat femurs were 
rapid enough to create gas bubbles. However, the gas bubbles appear to be eliminated after 14 
weeks of implantation as shown in the bone tissue histology image. 
 Computed tomography was used to perform fracture healing and determine 
quantitatively the degradation rate. Failure of the Mg-Zn alloy pins were observed in fractured 
femurs after 2 weeks of implantation. After 14 weeks however, callus formation and bone 
remodeling around the fracture site were exhibited. Femurs with both Ti and Mg-Zn alloy pins 
revealed similar bone repair response. Rat femoral fracture model typically require up to 5 
months to complete the fracture healing process (154). 3 out 5 rat femurs with implantation of 
Mg-Zn pins for 14 weeks were observed with a malunion that might have resulted from the 
breakage of the pins due to the excessive stress experienced by the animals following immediate 
surgery and allowing the rats to ambulate subjecting the area to significant load serving as a 
classic stress corrosion fracture model. Despite this, it should be noted that the implants showed 
acceptable and favorable bone healing response as indicated by the other femurs in union 
exhibiting better bone healing with more bone remodeling and united callus formation over the 
cortical bones. This result serves to demonstrate the potential safety and efficacy of the alloy 
system for potential orthopedic applications. Accelerated corrosion rates of Mg-Zn alloy pins 
obviously as explained earlier result from stress corrosion. Mg-Zn alloy alloys are in fact, known 
to degrade with higher corrosion rates compared to Mg alloys under non-load bearing condition 
according to the literature (155). Based on the analysis reported here and discussed above, rapid 
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corrosion of Mg-Zn alloy pins under load-bearing condition did not significantly affect the 
fracture repair in terms of adverse local tissue response. However, mechanical strength of Mg 
alloys decreases with corrosion (156, 157) and the Mg-Zn alloy pins therefore underwent failure 
which could have affected the fracture healing outcome negatively although not necessarily 
serving to negate the potential applicability of the system for orthopedic application with further 
optimization of the alloy and the processing parameters. 
Systemic toxicity of rats with Mg-Zn alloy pins were assessed after 2 and 14 weeks of 
implantation when 15% and 55% of total volume of the implants were resorbed (see Figure 6.4). 
In addition, a group of the Mg-Zn alloy cuffs were assessed to evaluate the toxicity of Mg-Zn 
alloy in contact with both bone and muscle. After 14 weeks, the cuffs were fully resorbed. Blood 
and serum examination was focused on hematologic and biochemical analysis to detect any 
disruption in blood, liver and kidney tissue state. Blood cell count and biochemical parameters 
were maintained within the reference ranges and there were no significant difference among Ti, 
Mg-Zn, and control groups. Recent publications also reported no significant abnormality in 
blood test results following in vivo degradation of Mg alloys (153, 158). BUN, CR, and UA from 
serum analysis also indicates no significant changes in the renal function. No accumulation of 
Mg in liver and kidney were also found following the inductively couple plasma analysis 
conducted on the digested tissues. Histology of liver and kidney also displayed histomorphology 
pattern mirroring healthy tissue. Excess Mg in body is known to excrete in urine after renal 
filtration (159). Bodily Mg concentration beyond the tolerance limit can however, cause renal 
failure (122). Based on the published literature to date, the toxicity test methods described herein 
are effective since high Mg dose in body does not cause local accumulation in a specific organ 
other than liver or kidney. In order to track localized Mg accumulation in other organs, 
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biosensors or quantum dot staining methods can be considered to locate the exact location as 
well as the amount of accumulation. Overall, the observations from blood test, Mg concentration, 
and histology results consistently indicate that the Mg-Zn alloy implant considered here and their 
degradation products are indeed biocompatible for potential use as possible orthopedic implants 
under load-bearing conditions.  
6.5 CONCLUSIONS 
Mg-Zn alloy, in comparison to Ti alloy as a control, was examined as femoral pins under 
load-bearing condition using a rat femoral fracture model. Accelerated degradation of the Mg-Zn 
alloy pins occurred due to stress corrosion. Hence, hydrogen gas pockets were observed initially 
and some pins tend to lose their mechanical stability in the early stages of 2 week implantation. 
However, normal bone healing was displayed following bone histological analysis. No fibrous 
capsule formation or adverse immune response was observed in local tissues around the Mg-Zn 
alloy implant devices as well. Furthermore, degradation of Mg-Zn implants caused no significant 
changes in hematologic or biochemical markers assessed using blood panel tests. Magnesium 
concentration of liver and kidney demonstrated no accumulation of Mg in these organs as well 
following elemental analysis of the tissue for the specific alloying elements. Histology of liver 
and kidney also displayed no organ damages due to the Mg-Zn alloy implants. Overall, the 
results suggest that Mg-Zn alloy demonstrates favorable biocompatibility under load-bearing 
conditions. Further improvement of the alloy design and experimentation is required to improve 
the alloy mechanical stability particularly, during degradation of the hardware devices to achieve 
even more desirable bone healing and fracture repair. 
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7.0  GENERAL CONCLUSIONS AND FUTURE WORK 
The four chapters discussed herein have shown by virtue of the four relevant specific aims the 
efficacy of two primary Mg based alloys, Mg-Zn-Zr and Mg-Zn-Sr-Zr alloys for potential 
orthopedic applications. Accordingly, Mg-Zn-Zr alloy was initially studied to explore the 
potential of its use as a biodegradable metal for orthopedic applications. Both as-cast and 
solution treated Mg-Zn-Zr was synthesized by melting in an electric resistant furnace, casting in a 
mild steel mold, and post-processing of heat treatment in a box furnace. X-ray diffraction patterns of 
as-cast and solution-treated Mg-Zn-Zr exhibited α-Mg phase without any distinct intermetallic peaks. 
However, back-scattered electron microscopy revealed Mg/Zn intermetallic precipitates along the 
grain boundaries. Solution treatment of Mg-Zn-Zr was performed to cause phase transformation of 
these precipitates to reduce the galvanic corrosion between Mg-Zn precipitates and α-Mg matrices. 
Mg-Zn precipitates were successfully transformed to Mg-Zn-Zr phase mixture which is more close to 
the nominal composition of the alloy. However, no significant improvement in the corrosion 
potential or current density was exhibited in the potentiodynamic polarization measurement. 
 As-cast and solution-treated Mg-Zn-Zr were then subjected to in vitro assessments in terms 
of corrosion resistance, mechanical properties, and cytocompatibility. Corrosion of Mg-Zn-Zr was 
improved after solution treatment due to the phase transformation of precipitates. Immersion 
corrosion rates of solution-treated Mg-Zn-Zr was observed to be lower than that of as-cast Mg-Zn-Zr. 
Tensile and compressive strengths of both as-cast and solution-treated Mg-Zn-Zr were observed to be 
higher than pure Mg but not comparable to commercial as-drawn AZ31. Cytocompatibility of Mg-
 117 
Zn-Zr alloys was assessed using ISO 10993 standards with modifications for biodegradable metals. 
Good cell viability of MC3T3 murine pre-osteoblast cells was exhibited by both as-cast and solution-
treated Mg-Zn-Zr alloys. Promising preliminary in vivo degradation and tissues compatibility results 
were also exhibited by these alloys when as-cast Mg-Zn-Zr pellets were subcutaneously implanted in 
nude mice models. 
 Addition of Sr and Ce as micro alloying element to Mg-Zn-Zr alloys were investigated to 
further improve corrosion resistance by reducing Zn-rich intermetallic phase in grain boundary 
precipitates. Microstructure analysis using back-scattered electron microscopy clearly exhibited the 
phase transformation of precipitates. Unfortunately, an introduction of micro alloying element 
created more precipitates although only 0.25% and 1% addition were introduced into the Mg-Zn-Zr 
system due to the inherent low solubility of Sr and Ce in Mg. Ce was more prone to form precipitates 
along the grain boundaries compared to Sr due to the higher melting point of Ce required for 
homogenization of alloy melts before casting and extrusion. Overall, the corrosion resistance of Mg-
Zn-0.25Sr-Zr, Mg-Zn-1Sr-Zr and Mg-Zn-0.25Ce-Zr did not exhibit a significant difference compared 
to Mg-Zn-Zr. However, Mg-Zn-1Ce-Zr exhibited higher corrosion rate after immersed in Hank’s 
buffered solution for 35 days. In tensile testing, as-extruded Mg-Zn-Zr, Mg-Zn-Sr-Zr, and Mg-Zn-
Ce-Zr outperformed commercial AZ31. Ultimate tensile strength increased with Ce addition since 
more precipitates contributed to dislocation impediment leading to increased strengths. Mg-Zn alloys 
also exhibited good cytocompatibility with MC3T3. Tolerance of Mg, Zn, Sr, and Ce ion levels were 
studied using MC3T3 and low Zn tolerance up to 0.1 mM was observed. Osteogenic differentiation 
ability of Mg, Sr, and Ce were further studied with human mesenchymal stem cells. ALP activity and 
ALPL gene expression did not exhibit any significant change compared to the differentiation media 
control. However, OPN gene expression exhibited some improvements with addition of Mg, Sr, and 
Ce ions in the differentiation media.  
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 In order to demonstrate biocompatibility of Mg-Zn alloys, Mg-Zn-0.25Sr-Zr (Mg-Zn) alloy 
was selected for rat femoral fracture model intended to create stress corrosion environment. 
Intramedullary pins of Mg-Zn and Ti alloy control were implanted after osteotomy to assess the 
degradation and toxicity under load-bearing condition. Accelerated corrosion of Mg-Zn alloy due to 
stress corrosion was anticipated due to the model selected to test the toxicity of Mg-Zn alloy and its 
degradation products in an extreme stress corrosion environment. X-ray images after 1 week of Mg-
Zn pin implantation exhibited hydrogen gas pockets around the implantation site due to rapid 
corrosion. Micro computed tomography analysis exhibited higher corrosion rate of Mg-Zn pin 
compared to in vitro corrosion rate of the Mg-Zn alloy. However, bone histology and CT analysis 
after 14 weeks of implantation revealed that the gas pockets around Mg-Zn pins were filled with 
fibrous tissue and normal fracture healing was observed compared to Ti alloy control. Cuffs of Mg-
Zn-0.25Sr-Zr and Ti alloy were implanted on rat femurs to investigate any difference in local tissues 
response or systemic toxicity when these implants are in contact with both bone and soft tissue. In 
both scenarios, no adverse toxic response was observed in blood panel tests as well as hematoxylin & 
Eosin staining of liver and kidney after 2 and 14 weeks of Mg-Zn and Ti device implantation. No 
accumulation of Mg in liver and kidney was confirmed by using inductively coupled plasma analysis 
on digested organs. Thus by virtue of all the four specific aims, the study essentially shows that the 
Mg-Zn alloy system is indeed quite promising and when effectively processed could exhibit 
improved corrosion, tailored mechanical strengths and also likely expected osteogenic potential with 
the addition of controlled amounts of Sr and Ce. 
 Based on the studies conducted in this thesis, it can be construed that the Mg-Zn alloy has 
been developed quite effectively and the desired biosafety of Mg-Zn alloys has also been clearly 
demonstrated under both in vitro and in vivo conditions. Despite the promising results, further 
development is clearly warranted to evaluate the efficacy of a specific Mg-Zn device for technology 
transition and regulatory approval. More specific animal studies with appropriate models selected 
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and suitably designed with proper processing conditions are needed to clearly understand the 
correlation between the expected and desired biomechanical tissue and materials response matching 
the ultimate healed tissue and the desired degradation. These optimal design considerations can be 
brought to fruition by matching theoretical first principles density functional theory studies 
implemented along with finite elements and continuum mechanics modeling studies combined with 
robotic assisted evaluation. Such modeling studies conducted in combination with proper processing 
conditions of the alloys will help in clearly delivering theoretically predicted alloying elements 
combined with simulation results to experimentally generate as predicted alloys with the expected 
physical, chemical and biological response. Also, various coating techniques such as micro artic 
oxidation (MAO), layer by layer (LbL) polyelectrolyte coatings, use of synthetic and natural 
polymers, and a variety of metallic coatings can explored as coating strategies that can be applied to 
the biodegradable Mg-Zn devices. These strategies can help to prevent rapid corrosion and premature 
mechanical failure while also augmenting delivery of growth factors and signaling molecules to 
generate a ‘smart’ scaffold and implant system serving as a scaffold as well as drug and biological 
molecule delivery system. These studies can be hopefully conducted in the near future. 
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APPENDIX A 
BIODEGRADABLE IRON-MANGANESE-CALCIUM/MAGNESIUM ALLOY 
DEVELOPMENT FOR BINDER-JETTING 3D PRINTING OF PATIENT-SPECIFIC 
CRANIO-MAXILLOFACIAL SCAFFOLDS 
A.1 INTRODUCTION 
Fixation screws, plates, and meshes have been widely used to reconstruct skull or facial fractures 
(160). In most cases, these treatments result in a successful reunion of the remaining bone 
fragments. However, the treatments tend to fall short when there are civilians who have 
succumbed to severe automotive accidents, traumatic battlefield injuries, and bone cancer 
conditions. Injuries such as these often involve a critical-sized bone defect (CSBD) that has a 
large region or gap of missing bone that the body’s own homeostatic healing prowess alone is 
incapable of providing the healing. As a result, the defect needs to be either filled with a 
synthetic bond void filler or a synthetic or naturally derived bone graft taken from the patient 
alone or from another donor, all of the approaches suffering from limitations (161, 162). Newer 
approaches particularly, based on additive manufacturing technologies appear very promising. 
The technology is particularly novel since it involves matching the geometry of the bone graft to 
that of the affected area which is indeed necessary in order to obtain satisfactory results.  
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Intraoperative adjustments have been widely used to prepare an autograft or allograft for 
reconstructive surgery (11). These surgical procedures although innovative on its own accord 
boasting of much desirable success are very much depended on existing materials which do not 
really match or fit the patient’s specific bone or defect configuration, shape or size. As a result, 
many times complicated machining methods are needed to fit the defect size or in many cases, 
the materials or implants that are available in certain specific sizes would need to be force fit into 
the defect site. As a result, additional materials may be needed to put the device in place or in 
some cases, the implant would need to be force fit into place. In either case, the degree to which 
the geometry is accurately replicated is referred to as the geometrical fit of the device. Efforts 
have been made to improve the geometrical fit of the device by utilizing CAD/CAM 
technologies and stereolithography techniques (163, 164). Recently, 3-dimensional printing 
(3DP) has been explored as a fabrication method for patient-specific devices utilizing existing 
biomaterials such as PEEK (165), titanium (166), Co-Cr (167), and hydroxyapatite (168) which 
have been discussed in Chapter 1 as well. These synthetic scaffolds have been widely used as 
they eliminate the need for a donor site; thus reducing the risk of complications  and lowering the 
chance of patient infection or device rejection compared to traditional bone grafting (169). 
However, conventional synthetic biomaterials have some limitations. Ceramic or polymeric 
scaffolds for example, exhibit insufficient mechanical properties or tend to undergo slow in vivo 
degradation (170). Non-degradable metallic biomaterials such as Ti6V4Al, Co-Cr, and stainless 
steel on the other hand, as outlined in Chapter 1 possess the desired sufficient strength, but often 
cause stress shielding and undergo corrosion, wear, and debris formation when used for long-
term (171, 172). As a result, other complications eventually surface such as metallosis, as well as 
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delayed type hypersensitivity which can lead to rejection of the implant causing the need to 
remove the implant or other related complications which can have untoward irreversible 
complications and risks that can be harmful to the patient. 
Biodegradable metals such as Mg-based or Fe-based alloys have gained significant 
attention in recent years due to their degradation characteristics and higher mechanical strength 
compared to biodegradable polymers and ceramics (38) while also providing the flexibility to 
match the mechanical properties to natural human bone. 3D printing of biodegradable metals has 
the potential to deliver patient-specific biodegradable scaffolds to individuals with traumatic 
injuries as well as providing customized patient specific geometries eliminating the problems of 
machining and other mismatch of the hardware to the patient desired geometry and configuration 
of the defect. Further, depending on the required properties of the scaffold at different 
implantation sites, a porous structure of the scaffold can be designed and fabricated by 3-D 
printing. At the same time, the design can engineered to specifically load any bone grafting 
materials, engineered tissues, or drugs. Hence, bone regeneration is often desired to replace the 
biodegradable scaffold with newly mineralized tissue obviating the need for removal of the 
implanted hardware at any later point in time putting the patient at risk. Generating and 
fabricating such degradable materials that also have osteogenic potential by 3-D printing to 
manufacture customized patient specific implants would offer a novel pathway to bone tissue 
engineering and regenerative medicine of mineralized tissue. 
In this regards, Mg-based alloys have been widely studied for orthopedic and 
cardiovascular applications. Improving the purity of cast ingots and refining the grain sizes of the 
alloy as discussed in the earlier Chapters allows for controlled corrosion of these Mg-based 
alloys (173). Homogeneous ingots with low levels of impurities have exhibited gradual 
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degradation rates. Additionally, the use of post-processing methods such as hot extrusion, 
rolling, and equal channel angular pressing (ECAP) have been proven to improve corrosion 
resistance and mechanical strength by refining the microstructure (79, 80). Compression screws 
made of the magnesium-based alloy WE43 have obtained the CE conformity marking in Europe, 
and 26 patients have already been recruited and have participated in a clinical trial (58). Human 
clinical trial of cardiovascular stents is also ongoing in Europe. The potential synergy between 
biodegradable metals and 3D printing has also initiated much needed research in selective laser 
melting (SLM) to achieve 3D printing of magnesium powder (174). The high vapor pressure and 
low melting points of magnesium tend to be major barriers to fabrication of quality parts of 
accurate dimensions, although lasers can break the oxide layer of magnesium particles 
effectively leading to fusion and sintering. Indeed, post-processing methods such as hot 
extrusion, ECAP, or rolling are not applicable for 3D-printed magnesium parts with complex 
shapes, whereas the microstructure refinement is a key to overcoming the rapid pitting corrosion 
of magnesium. 
Fe-based alloys, on the other hand, tend to degrade too slowly, and thus, research had 
been focused on increasing the degradation rates. An iron-manganese binary composition was 
introduced as a biodegradable Fe-based alloy with enhanced corrosion rate and reduced 
ferromagnetic properties (175). Various alterations of the Fe-Mn system have been studied. 
Addition of 6 wt. % Si in Fe-30 wt. % Mn induced a shape memory effect (176).  Addition of 1 
wt.% of Pd to Fe-10 wt.% Mn resulted in a 10-fold faster corrosion compared to low carbon steel 
(177). Fe-Pd and Fe-Pt have also exhibited faster degradation rates compared to pure iron, and 
also exhibited minimal cytotoxicity in an indirect MTT cytocompatibility test with L-929 and 
ECV304 cells after 4 days of culture (178). Fe-W and Fe-CNT composites have also exhibited 
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no toxicity with L929 and ECV304 cells as well as good hemocompatibility (179). Fe-Mn-C (-
Pd) alloy was developed and evaluated in both in vitro and in vivo conditions (180, 181). Unlike 
in vitro degradation, in vivo degradation of Fe-Mn-C (-Pd) however resulted in little degradation 
although no sign of inflammation or local toxicity was reported. Recent literature reports thus 
suggest that higher degradation rate still remains a major challenge and a primary limitation 
preventing the development of biodegradable Fe alloys for medical device applications. 
 
Researchers in the current group studied the feasibility of binder-jet 3D printing of a Fe-
30 wt.% Mn binary mixture to fabricate biodegradable scaffolds (182). Binder-jet 3D printing of 
the Fe-Mn mixture exhibited micropores with favorable effects on in vitro degradation and cell 
attachment. A porous structure with an open porosity of 36% was obtained after sintering of 3D-
printed (3DP) specimens. 3DP Fe-Mn specimens exhibited a significantly higher corrosion rate 
when compared to pure Fe using potentiodynamic polarization tests due to the perceived porosity 
induced by 3DP. Cell infiltration was also observed in the open pores of the 3DP Fe-Mn 
specimens during cytocompatibility tests using the MC3T3-E1 pre-osteoblast cell line.  
In the present study, the research was focused on developing Fe – (35 - y)  wt.% Mn – y 
wt.% X (X = Ca, Mg, and y = 0, 1, 2) employing a CALPHAD theoretical model to predict the 
alloy composition with enhanced degradation properties. In order to test the hypothesis, Fe-Mn-
X alloy powders were synthesized using high energy mechanical alloying (HEMA), and assessed 
in terms of degradation properties and cytocompability. Furthermore, Fe–35 wt.% Mn and Fe–34 
wt.% Mn–1 wt.% Ca were selected for 3D printing study based on their cytocompatibility and 
degradation characteristics. The 3DP specimens of Fe–35 wt.% Mn and Fe–34 wt.% Mn–1 wt.% 
Ca alloys were evaluated to confirm if the enhanced degradation and cytocompatibility 
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characteristics observed following milling and conventional sintering are indeed maintained after 
the 3D printing approach. 
A.2 MATERIALS AND METHODS 
A.2.1 Methodology for CALPHAD studies 
To evaluate the effect of different alloying elements on the corrosion stability of the alloys a 
prior study was conducted that focused on evaluating of the thermodynamic driving force of the 
overall hydrolysis reaction of magnesium and its alloys in pure water (183). Using the Density 
Functional Theory (DFT) approach, the heats of the aqueous chemical reactions calculated for 
Mg alloys have been compared with that corresponding to the reaction of pure Mg with water. 
The heats of reactions are dependent upon the chemical compositions of the alloys, for this study 
the role of Ca, Zn, Y, Al, and Fe on the aqueous chemical stability and reactivity of these Mg-
alloys has been discussed.  
The first-principles calculations require substantial computational resources, making their 
applications to multi-component and multiphase systems a formidable task. In addition, the 
calculations were carried out at 0 K, a temperature at which the relevant phase stabilities may 
deviate from those at the body temperature of 310 K.  
To overcome difficulties of the first-principles study of the thermodynamic parameters of 
the hydrolytic reactions the less physically-grounded but yet much more efficient CALPHAD 
technique (184) could be used. This technique can be used to investigate the thermodynamic 
stability of various metals and alloys in various aqueous environments. With the help of several 
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well-developed thermodynamic databases, this approach provides the flexibility to investigate 
the corrosion behavior of alloys with arbitrary compositions in aqueous phases with 
environmental conditions (temperature and pressure, etc.) matching the authentic human blood 
media, thus compensating the limitations of the first-principles approaches.  
In a previous paper (183), researchers involved in this study suggested focusing on a 
change in enthalpy δ∆HRdop in their actual first-principles calculations in order to assess 
whether the alloying element retard (δ∆HRdop > 0) or promote (δ∆HRdop < 0) the corrosion 
process. Accordingly, in the current study, the same criterion was employed for evaluation of the 
corrosion stability of Fe–35 wt.% Mn alloys doped with small amounts of Ca and Mg. In 
essence, the following two aqueous reactions were considered; the Gibbs free energy ∆GR was 
calculated for each reaction and the difference between them (δ∆GR) was plotted as a function of 
the chemical composition of the materials. 
 
Fe(s) + 2H2O(l) => Fe(OH)2(s) + H2(g)                                                                      (1) 
[Fe-Mn-Ca/Mg](s) + 2H2O(l) => [Fe-Mn-Ca/Mg](OH)2(s) + H2(g)                          (2) 
Reaction (1) is the hydrolytic reaction for pure Fe in water, while the reaction (2) 
represents the same process for various considered Fe-based alloys.  
 
In the present study the thermodynamic software Thermo-Calc (185) has been employed 
to conduct the calculations using SSUB4 database for chemical substances such as oxides, 
hydroxides and gas phases (186), and TCFE7 for solid Fe-Mn-Ca/Mg alloy phases (72). All the 
calculations have thus been conducted at temperature T = 370 °C and pressure P = 1 atm. 
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A.2.2 Powder preparation 
Pure iron powder, pure manganese powder, and pure calcium granules were used to synthesize 
Fe – (1 - y)  wt.% Mn – y wt.% X (X= Ca, Mg, and y = 0, 1, 2) alloy powder. Milling balls and 
pure elemental powder mixtures were weighed at a mass ratio of 10:1 and subjected to high 
energy mechanical alloying (HEMA). The milling vial was sealed under ultra-high purity (UHP) 
argon atmosphere within a glove box in order to prevent any oxide formation. A P5 planetary 
mill (Fritsche, Idar-Oberstein, Germany) was used to perform up to 16 h of dry milling followed 
by 8 h of wet milling cycles with toluene. The Fe-based alloy powder was collected and sieved 
using -325 mesh. The alloyed powders were imaged using scanning electron microscopy (SEM; 
JSM-6610, JEOL, Tokyo, Japan) for particle morphology. Phase analysis was performed using 
X-ray diffraction employing X’pert Pro system (Philips, Netherlands) with CuKα radiation (λ = 
1.5418 Å) and Si-detector (X’celerator) operated at 45 kV and 40 mA. 
A.2.3 3D parts fabrication 
3D parts were fabricated using two methods: cold isostatic pressing (CIP) followed by sintering 
and binder-jet 3D printing followed by also binder burn out and subsequent sintering in order to 
study the effect of Ca and Mg addition on the degradation properties of the Fe-Mn system. The 
mechanically alloyed powders were consolidated using cold isostatic pressing (CIP) followed by 
sintering at 1200 °C under a gettered ultra-high purity (UHP) argon atmosphere. For further 
studies, Fe-Mn and Fe-Mn-1Ca were selected to fabricate 3D printed specimens using an Ex-Lab 
machine (The ExOne Company, LLC, North Huntingdon, PA) with a water-based organic 
binder. The 3D-printed parts were cured at 200 °C for 2 h under air. The cured parts were then 
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heat-treated at, 430 °C for 0.5 h, 620 °C for 0.5 h, and 1200 °C for 3 h to achieve binder burn-out 
and subsequent sintering of the Fe-Mn and Fe-Mn-1Ca alloys. 
A.2.4 Physical properties 
Absolute density of the 3D-printed parts corresponding to dimension of 10 x 10 x 4 mm, was 
measured using an AccuPyc II 1340 helium pycnometer (Micromeritics, Norcross, GA). The 
envelope density of the 3D-printed parts was then measured using a GeoPyc 1360 
(Micromeritics). Using these density values, percent open porosity was calculated using the 
following equation: 
Open porosity (%) = ((absolute density – envelope density)/absolute density) x 100  Eq. 1 
Percentage shrinkage of 3D-printed parts before and after sintering was calculated from the 
volume as measured by the GeoPyc 1360 of the sintered parts and the measured volumes of the 
parts before sintering. 
A.2.5 Mechanical properties 
Tensile test analyses was conducted in accordance with ASTM-E8-04. Bar specimens were 
printed, cured, sintered, and finally machined into a standard dog-bone shape with a gauge length 
of 13.5 mm, width of 3 mm, and thickness of 3 mm. Uniaxial tensile testing was performed at 
room temperature with an Instron machine, using a cross-head speed of 1.3 mm/min and a 5 kN 
load cell. Yield strength (YS), ultimate tensile strength (UTS), Young’s modulus (E), and 
percent elongation (%) were determined from the stress-strain curves generated from each 
specimen. Young’s modulus was obtained by considering the linear portion of the curves. 
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Average and standard deviations of these 3 sample measurements are reported. Averages and 
standard deviations of 3 sample measurements were reported and t-test was used to determine 
any significant mean differences with a p-value less than 0.05. 
A.2.6 Electrochemical corrosion test 
Potentiodynamic polarization testing was conducted to assess the degradation rates of the 3D 
specimens. The specimens, with a surface area of ~0.5 cm2, were connected to a copper wire 
using a silver epoxy and finally mounted in epoxy resin. The mounted samples were 
mechanically polished with an increasingly small abrasive size up to 1 µm, sonicated in 
isopropyl alcohol, and air dried. An electrochemical workstation (CHI 604A, CH Instruments, 
Inc., Austin, TX) was employed to conduct the test with three-electrode cell setup utilizing 
platinum as the counter-electrode, Ag/AgCl as the reference electrode and the epoxy-mounted 
sample as the working electrode. The test was performed using Hank’s Balanced Salts Solution 
(HBSS H1387, Sigma-Aldrich, Canada) with 0.35 g l−1 sodium bicarbonate warmed to 37.4  oC 
to mimic the physiological conditions. Tafel analysis was used to determine the equilibrium 
corrosion current, Icorr, and the corrosion potential, Ecorr, obtained as the intersection of the 
linearly fitted cathodic and anodic branches of the generated Tafel plot similar to the studies 
conducted in Chapter 3 and 4. Averages and standard deviations of 3 sample measurements were 
reported. 
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A.2.7 Live/dead direct cell viability assay 
To access the direct cell cytotoxicity, the murine osteoblast-like cell line, MC3T3 (ATCC, 
Rockville, MD), was cultured on the surface of 3D-printed plate specimens. The 3D-printed 
specimens with dimensions of 10 x 10 x 1 mm were polished up to 1200 grit using SiC paper, 
sonicated in isopropyl alcohol, and sterilized using UV radiation for 30 min. Modified Eagle’s 
medium alpha (αMEM) supplemented with 10% FBS, 100 U ml−1 penicillin and 100 μg ml−1 
streptomycin was used as culture medium. MC3T3 cells were seeded onto specimen surfaces at 
cell density of 4 × 104 cells ml−1 and incubated at 37.4 °C in a humidified atmosphere with 5% 
CO2. After 72 h of incubation, cell cytotoxicity was assessed by performing live/dead cell 
viability assay using commercially available kit (Invitrogen Corporation, Karlsruhe, Germany) 
and following the manufacturer’s protocol. During the assay, the live and dead cells were stained 
using ethidium homodimer-1 and calcein-AM respectively, which exhibits live cells as green and 
dead cells as red under fluorescence imaging at the excitation wavelength of 495 and 528 nm 
similar to studies reported in Chapter 3 and 4. After the assay, the cells were fixed by immersing 
the specimens with cells in 2.5% glutaraldehyde for 15 min followed by dehydration steps 
subsequently in 70, 80, 90, 95 and 100% diluted ethanol for 15 min each. Specimens with fixed 
cells were then air-dried and imaged using scanning electron microscopy. 
A.2.8 Indirect MTT cell cytotoxicity assay 
MC3T3 cells were also used to assess in vitro cytotoxicity of the extract media prepared by 
immersing 3D-printed specimens in culture medium. Modified Eagle’s medium alpha (αMEM) 
with 10% FBS, 100 U ml−1 penicillin and 100 μg ml−1 streptomycin was used as this cell 
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culture media. Prior to the extract media preparation, the 3D-printed specimens were fabricated 
to have dimensions of 10 x 10 x 4 mm and polished up to 1200 grit to match the surface finish 
used in live/dead direct cell viability testing. The ratio of culture media volume to specimen 
weight was maintained at 1 mL to 0.2 g, according to EN ISO 10993:12. After 72 h incubation, 
the extract media was filtered using 0.2 µm membrane, this filtered extract was designated as 
100% extract. The 100% extract was subjected to inductively coupled plasma – optical emission 
spectroscopy (ICP-OES) to measure chemical concentration of Fe, Mn, and Ca. For this, 100% 
extract was then diluted to 50%, 25%, and 10% extract solutions. MC3T3 cells were seeded in a 
96-well plate with a cell density of 6,000 cells per well. After 24 h of incubation, the culture 
media was replaced with the 100%, 50%, 25%, and 10% extract media and cells were further 
incubated for 72 h. Vybrant MTT Cell Proliferation Kit (Invitrogen Corporation, Karlsruhe, 
Germany) was used to assess the cytotoxity of the extract media. After 72 h culture, the extract 
media was replaced with fresh culture media to prevent any interaction between the metal ions 
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). 12 mM MTT in 
phosphate buffered saline (PBS) was diluted 10x using culture media and 110 µL of diluted 
MTT solution was added to each well for 4 h of incubation.  Formazan crystal was solubilized 
using sodium dodecylsulfate–hydrochloric acid solution solution, incubated for 12 h, and 
analyzed at a wavelength of 570 nm using Synergy 2 microplate reader (BioTek Instruments, 
Winooski, VT). Furthermore, in order to check the tolerance of metal ion contents from the Fe 
alloys’ degradation products, 0.1, 1, and 10 mM of Fe, Mn, and Ca were prepared by dissolving 
their chlorides in culture media, applied to MC3T3-E1 cells for 7 days, and followed by MTT 
assay. Averages and standard deviations of 3 sample measurements were reported and two-way 
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ANOVA with Tukey’s post-hoc test was used to determine any significant mean differences with 
a p-value less than 0.05. 
A.3 RESULTS 
A.3.1 Theoretical and experimental approaches to develop degradable Fe-based powder 
alloys  
CALPHAD results 
For evaluation of the effect of Ca and Mg on the corrosion behavior of Fe-Mn alloy, the 
following compositions have been chosen in the present computational study: Fe65Mn(35-
x)(Ca/Mg)x, where x represents the percent composition by weight 0<x<5 wt.%. Hydrolysis of 
pure Fe has been considered as a reference point.  
The resulting dependence of δ∆GR on chemical composition of the Fe-Mn alloys is 
shown in Figure A.1. On this graph, the hydrolysis of pure Fe is set at zero energy and all ∆GR 
for the alloys was calculated in comparison with ∆GRFe for pure Fe. A horizontal dashed line at 
-42.0 kJ/mol denotes δ∆GR for the Fe65Mn35 alloy composition as the reference.  
One can see that all lines representing changes of the free energy for all the Fe-based 
alloys are located at the negative area of the graph, implying that the effects of all 
thermodynamic stimuli for the hydrolytic reactions are larger (more negative) than that for 
hydrolysis of pure Fe. Increased negativity is a result of higher stability of Mn, Ca, and Mg 
oxides and hydroxides (the hydrolytic products) in comparison with analogous substances of Fe. 
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This may therefore indicate a lower stability of the Fe-Mn based alloys in the aqueous 
environment compared to pure Fe suggesting faster corrosion.  
Two sloped lines represent δ∆GR for Fe-Mn alloys doped with Ca and Mg. One can see 
that both doping elements increase the overall thermodynamic stimulus of the hydrolysis, 
although to different extents. Oxides and hydroxides of both Ca and Mg are more stable than that 
of Mn and thus, partial substitution of Ca and Mg for Mn in Fe-Mn alloy should lead to more 
negative δ∆GR, in turn leading to lower stability of the Fe-Mn-Ca/Mg alloys compared to 
undoped Fe-Mn suggesting faster corrosion for these Ca and Mg containing Fe-Mn alloys. 
Thus, according to the results shown on Figure A.1, the corrosion rate of Fe-Mn doped 
with Ca and Mg is expected to be higher than the corrosion rate of undoped Fe-Mn alloy. Doping 
with Mg has a stronger effect on the corrosion rate than doping with Ca, as seen by the higher 
corrosion rate of the Mg doped alloy compared to the same weight fraction of Ca. Although this 
computational study considers only thermodynamic aspects of the hydrolysis without taking into 
account any kinetic parameters of the process. Nevertheless, these qualitative results are in 
excellent agreement with experimental measurements of the corrosion rates of the materials as 









Figure A.2 exhibits the X-ray diffraction patterns of as-milled Fe-Mn-Ca and Fe-Mn-Mg alloy 
powders. Binary Fe-Mn alloys are known to consist of ɤ-phase austenite and ɛ-phase martensite 
phases (187). Mechanically alloyed Fe-Mn also exhibited ɤ- and ɛ- phase in the diffraction 
pattern. No undesired phase transformation was observed as an effect of introducing Ca and Mg 
in the solid solution. Distinct peaks of pure Ca or Mg were also not still observed in Fe-Mn-2Ca 
or Fe-Mn-2Mg alloy composition prepared by HEMA. Homogeneous solid solutions of Fe-Mn-
Ca and Fe-Mn-Mg alloy powders were thus obtained and subjected to further in vitro assessment 


















































Electrochemical corrosion of compacted samples 
 
 
Figure A.3 Tafel curves from potentiodynamic polarization measurements of Fe-Mn, Fe-Mn-Ca, and Fe-Mn-Mg 
compacted pellets. 
 
The potentiodynamic polarization behavior of sintered Fe-Mn, Fe-Mn-Ca, and Fe-Mn-Mg 
compacted pellet was recorded at a scan rate of 1 mVs-1 and plotted in a Tafel plot shown in 
Figure A.3.  The representative curve for each group of alloy was based on the average corrosion 
potential and current density after testing multiple samples (N = 6). Tafel plots were used to 
determine the corrosion current density, corrosion potential, and corrosion rate. Average values 
of these calculations are tabulated in Table A.1. Addition of Ca or Mg to the Fe-Mn alloys 
increased both the corrosion potential and the current density to shift toward the positive side. 
Although the corrosion potential was increased suggesting that the alloy containing Ca and Mg is 
likely more stable than the pure Fe-Mn alloy, the corrosion current densities indeed reflected 
higher values suggesting the true corrosion propensity of introducing Ca and Mg into the Fe-Mn 
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alloy system. Thus corrosion current density of the alloys increased from 1.00 µA cm-2 to 2.12 
µA cm-2 and 6.36 µA cm-2 after replacing 1 and 2 wt. % of Mn with Ca respectively. Similarly, 
by introducing Mg into the solid solution, the corrosion current density was increased from 1.00 
µA cm-2 to 5.89 µA cm-2 and 9.16 µA cm-2 after replacing 1 and 2 wt. % of Mn. Corrosion 
current density is linearly correlated with a corrosion rate, and an increase in corrosion current 
density implies higher corrosion rate. Hence as mentioned above, the present electrochemical test 
results exhibit enhanced degradation properties of Fe-Mn alloys alloyed with Ca or Mg content. 
 
Table A.1 Corrosion potential and corrosion current density of Fe-Mn, Fe-Mn-Ca, and Fe-Mn-Mg compacted 
pellets (n=3). 
Material 
Corrosion potential, Ecorr 
[V) 
Corrosion current density, icorr 
[µA cm-2] 
Fe-Mn -0.72±0.04 1.00±0.06 
Fe-Mn-1Ca -0.71±0.02 2.12±0.92 
Fe-Mn-2Ca -0.66±0.02 6.36±1.75 
Fe-Mn-1Mg -0.65±0.02 5.89±0.80 
Fe-Mn-2Mg -0.64±0.03 9.16±1.25 
 
 
Live/dead cell viability of compacted samples 
Fluorescent images of the live/dead assay are obtained, as shown in Figure A.4, after 1 and 3 
days of culturing osteoblastic MC3T3-E1 cells on the sintered pellets of Fe-Mn, Fe-Mn-Ca, and 
Fe-Mn-Mg alloy powders. Live cells are represented by a fluorescent green, a result of 
intracellular conversion of calcein-AM to calcein. Dead cells glow in red fluorescent due to the 
 138 
compromised cell membrane that permits binding of nucleic acid with ethidium D-1. More live 
cells were observed in the fluorescent images after 3 days compared to the images after 1 days. 
Both Fe-Mn-1Ca and Fe-Mn-2Ca exhibited more live cells compared to Fe-Mn or Fe-Mn-Mg 
specimens suggesting the likely better cytocompatibility of incorporating Ca into the Fe-Mn 
alloy system in comparison to introduction of Mg.   
 
 
Figure A.4 Fluorescent images of live dead cell viability of MC3T3-E1 cells seeded on the compacted pellets of (a) 
Fe-Mn, (b) Fe-Mn-1Ca, (c) Fe-Mn-2Ca, (d) Fe-Mn-1Mg, (e) Fe-Mn-2Mg, and (f) cell culture plastic control after 1 
day culture. Respective results of the 3 day culture are seen in fluorescence images (g)-(l). 
A.3.2 3D printing of Fe-based powder and in vitro assessment 
Fabrication of 3D printed specimens 
 














Fe-Mn 7.73 4.69 39.3 31.6 
Fe-Mn-1Ca 7.48 3.53 52.9 11.7 
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In order to validate the effect of adding Ca on 3D printing, Fe-Mn and Fe-Mn-1Ca alloy powders 
were chosen for comparison. This selection was based on good cytocompatibility of sintered Fe-
Mn-Ca pellets compared to the Fe-Mn-Mg pellets as discussed above. Hence, 3D printing of Fe-
Mn and Fe-Mn-1Ca alloy powder was performed using the binder-jet 3D printing approach. 
SEM images of both initial alloy powder and sintered 3D printed specimens were obtained as 
seen in Figure A.5.  Fe-Mn and Fe-Mn-1Ca alloy powders are observed in various sizes with 
diameters between 5-30µm. Micro pores in the diameter of ~ 5µm are shown on the surface of 
sintered Fe-Mn and Fe-Mn-Ca specimens. Absolute and envelop density measurement results are 
tabulated in Table A.2. Higher shrinkage and lower open porosity after sintering was observed 
for Fe-Mn compared to Fe-Mn-1Ca. SEM images confirmed the powder-powder diffusion after 
sintering the 3D-printed specimens for both Fe-Mn and Fe-Mn-Ca, although some differences in  
 
 




densification occurred during the sintering process. Thus, the 3D-printed specimens were further 
tested in terms of degradation, cytotoxicity, and mechanical properties. 
 
Electrochemical corrosion of 3D printed specimens 
 
 
Figure A.6 Representative tafel curves from potentiodynamic polarization measurement of 3DP Fe-Mn, and Fe-Mn-
1Ca. 
 
Tafel plots of 3D-printed Fe-Mn, and Fe-Mn-1Ca specimens was obtained through scanning at 
the rate of 1mV s-1, as shown in Figure A.6.  A representative curve is shown for each group 
based on the average corrosion potential and current density after testing multiple samples 
(N=4). Tafel plots were used to determine the corrosion current density, corrosion potential, and 
corrosion rate and the average values are tabulated in Table A.3. Porous morphology of 3D-
printed specimens was not considered for these calculations, nominal surface area was instead 
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used to calculate corrosion current density. Corrosion potential of Fe-Mn, and Fe-Mn-1Ca was -
0.64 V, and -0.63 V, respectively indicating higher corrosion propensity of Fe-Mn alloy similar 
to the CIP derived systems discussed earlier. After normalization using surface area, the 
corrosion current density of 3D-printed Fe-Mn-1Ca was 2.88 µA/cm2 (Table A.3), slightly 
improved from the corrosion current density of compacted Fe-Mn-1Ca, 2.12 µA/cm2 (Table 
A.1) and that of the 3D printed Fe-Mn corrosion current density of 2.21 µA/cm2 (Table A.3). 
 
Table A.3 Corrosion potential and corrosion current density of 3DP Fe-Mn and Fe-Mn-1Ca (n=4). 
 
Corrosion potential,  
E corr [V] 




Fe-Mn -0.64±0.02 2.21±0.35 
Fe-Mn-1Ca -0.63±0.02 2.88±0.54 
 
Figure A.7 presents the surface morphology after the potentiodynamic polarization test of 3DP 
Fe-Mn and Fe-Mn-1Ca. Exposed surface areas of both samples exhibited different pore sizes. 
Although nominal surface area is used to calculate the corrosion current density tabulated in 
Table A.3, the actual surface area exposed for the testing can be larger due to the porosity of 3DP 
Fe-Mn and Fe-Mn-1Ca. Corrosion pits were observed on the surface of both samples. The 
insoluble degradation products correspondingly mainly to iron and manganese oxides that are 





Figure A.7 Surface morphology of 3DP Fe-Mn at (a) 100x (b) 500x and 3DP Fe-Mn-1Ca at (c) 100x (d) 500x after 
potentiodynamic polarization measurement. 
 
In vitro cytoxicity test of 3D printed specimens 
 
Figure A.8 Fluorescence images of live dead cell viability of MC3T3-E1 cells on (a) 3DP Fe-Mn, (b,) 3DP Fe-Mn-
1Ca, and (c) cell culture plastic control after 1 day culture. Respective results after 3 days culture are seen in the 
fluorescence images (d)-(f). 
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Figure A.9 Scanning electron microscopy (SEM) images of fixed MC3T3-E1 cells after live dead cell viability 
assay on (a) 3DP Fe-Mn and (b) 3DP Fe-Mn-1Ca for 1 day culture. Respective SEM images of fixed cells for 3 day 
culture are shown in images (c)-(d). 
 
Fluorescent images of live/dead cell viability assay are presented in Figure A.8 to assess the 
cytotoxicity of 3D-printed Fe-Mn and Fe-Mn-1Ca. After 1 and 3 day cultures, 3D-printed Fe-Mn 
and Fe-Mn-1Ca specimens exhibited live cell viability comparable to the tissue culture plastic 
control. Figure A.9 exhibits the cell morphology after fluorescent imaging of the live/dead cell 
viability assay. Substantial cell-cell junctions and cytoplasmic extension of MC3T3 cells was 
observed on 3D-printed Fe-Mn and Fe-Mn-1Ca specimens as shown in Figure A.9.  
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Figure A.10 Indirect MTT cell viability of MC3T3-E1 cells cultured for 3 days with the extract media of 3DP Fe-
Mn and Fe-Mn-1Ca (n=3). 
 
The indirect cytotoxicity test result was plotted in Figure A.10 to represent the corrosion 
extracts derived from 3D-printed Fe-Mn, and Fe-Mn-1Ca samples. After 3 days of culturing 
MC3T3-E1 in 100% extract, the cell viability assessed using MTT cytoxicity test exhibited in 
excess of 80% of cell viability, with respect to negative control of cell culture plastic. Cell 
viability of 50, 25, and 10% extract media diluted with fresh media exhibited ~100% cell 
viability for both alloy systems. In contrast to the live/dead assay result, no significant difference 
in cell viability was observed among the different groups. According to ISO protocol for 
cytotoxicity testing, a 75% or higher cell viability is generally considered a good representation 
of non-toxicity (123). Thus, good cell viability of 3D-printed Fe-based samples is demonstrated 
using indirect MTT cytotoxicity test. Similar Fe and Mn compositions were observed in the 
extract media for both, Fe-Mn compared to Fe-Mn-Ca, while a relatively high Ca concentration 
compared to its nominal composition in the Fe-Mn-Ca alloy was observed as shown in Table A.4 
indicating the higher corrosion propensity of the Fe-Mn-Ca system. 
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Table A.4 Fe, Mn, and Ca concentration in the extract media of 3DP Fe-Mn and Fe-Mn-1Ca. 
 
Fe (ppm) Mn (ppm) Ca (ppm) 
Fe-Mn 3.01 4.53 - 
Fe-Mn-1Ca 4.43 4.40 29.12 
 
Figure A.11 illustrates the cell viability of 0.1, 1, and 10 m mol of FeCl2, MnCl2, and CaCl2 
dissolved in the culture media after 7 days culture. Cell viability higher than 75% was 
maintained for Fe and Mn at concentrations up to 1 mM. On the other hand, as expected, Ca and 
Mg exhibited no cytotoxicity at 10 mM, although higher concentrations of Ca and Mg were not 
tested for this study.  
 
Figure A.11 MC3T3-E1 cytocompatibility of Fe, Mn, Ca, and Mg salt in culture medium at 0.1, 1, and 10 mM 








Figure A.12 Representative stress vs. strain curves from tensile testing of 3DP Fe-Mn and Fe-Mn-1Ca. 
 
Stress-strain curves, shown in Figure A.12, represents tensile properties of 3D-printed Fe-Mn, 
and Fe-Mn-1Ca after sintering. Ultimate tensile strength (UTS), yield strength (YS), elongation 
(E) and Young’s modulus of 3D-printed specimens are tabulated in Table A.5. 3D printed Fe-Mn 
exhibited an UTS of 228.1 MPa, YS of 189.7 MPa, and modulus of 0.39 GPa. Addition of Ca to 
Fe-Mn alloy resulted in higher stiffness which increased UTS from 228.1 to 296.6 MPa, and 
modulus from 0.39 to 1.63 GPa. However, brittle fracture without any yield point was observed 






Table A.5 Tensile properties of 3DP Fe-Mn and Fe-Mn-1Ca (n=5, §p<0.05 denotes a significant difference 
between two groups. 
Materials Ultimate Tensile Strength (MPa) Modulus (GPa) 
Yield Tensile Strength 
(MPa) 
Fe-Mn 228.1±10.6 § 0.39±0.05 § 189.7±25.6 
Fe-Mn-1Ca 296.6±45.8 § 1.63±0.2 § - 
A.4 DISCUSSION 
A.4.1 Strategy for alloying 
Various alloying elements or composite materials have been attempted to improve the 
degradation rate of biodegradable Fe-based alloys. The strategy has been to introduce noble 
metallic alloying elements such as Pd, Pt, Au, Ag, W, and Si, which tend to cause a galvanic 
corrosion couple with Fe matrices resulting in enhanced degradation (178, 179, 188, 189). The 
noble element precipitates can be taken away from the implantation site if the biodegradable Fe 
alloyed with these alloying elements are used for cardiovascular applications. On the contrary, 
limited amount of blood and fluid exchange occurs in the areas associated with cranio-
maxillofacial bone defects. Among recently published in vivo studies of biodegradable Fe-based 
alloys, rat femoral implantation of pure Fe, Fe–10Mn–1Pd, and Fe–21Mn–0.7C–1Pd pins were 
used to assess the degradation and biocompatibility of the Fe alloys in bone tissue for up to 52 
weeks (181). Very little degradation was observed, and hence, consequently, no sign of toxicity 
was observed in the CT analysis and histology of the surrounding tissue. Analysis also showed 
that the in vitro degradation rate of Fe–21Mn–0.7C–1Pd alloy was reported as ~0.13mm/year 
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(180). Therefore, the present study introduced less corrosion resistant alloying elements, Ca and 
Mg, to induce higher corrosion to the corrosion resistant Fe system such that these alloys could 
result in faster degradation from the scaffold prior to the Fe-Mn matrix.  
Melting points of both Ca (842 °C) and Mg (650 °C) are low compared to that of Fe 
(1538 °C) and Mn (1246 °C). Due to this extreme difference in the melting points of Fe and Mn 
versus Ca and Mg, traditional gas-atomization of the alloy powders is unable to achieve the 
homogeneous solid solution of the nominal composition.  High energy mechanical alloying 
(HEMA) was therefore used to synthesize Fe-Mn-Ca and Fe-Mn-Mg since Ca and Mg do not 
have solubility in Fe or Mn. Homogeneous alloy powders of Fe-Mn-Ca and Fe-Mn-Mg were 
accordingly obtained showing no peaks of pure Ca or Mg in the X-ray diffraction pattern (Figure 
A.2).  
Binder-jet 3D-printed specimens of different compositions with irregular particle 
morphology can result in different open porosity. Different open porosity is expected to expose 
different surface area and affect the corrosion measurement. In order to avoid such 
inconsistencies, compacted pellets of Fe-Mn-Ca and Fe-Mn-Mg were used for the corrosion 
assessment to demonstrate the increase in degradation rates with addition of Ca and Mg in Fe-
Mn alloys.  As predicted by the CALPHAD calculation, the effect of adding Ca and Mg was 
demonstrated by the potentiodynamic polarization result showing an increased corrosion current 
density related to the amount of Ca and Mg in the solid solution as seen in Table A.1.  
Addition of Ca also caused higher Fe concentration in the ICP analysis of the extract 
media of 3DP Fe-Mn-1Ca compared to 3DP Fe-Mn (Table A.4). This observation is correlated 
with enhanced degradation properties due to the presence of Ca in Fe-Mn alloy demonstrated and 
valdidating the CALPHAD calculation and electrochemical corrosion test. 
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A.4.2 Binder-jet 3D printing 
Binder-jet 3D printing of biodegradable Fe alloys demonstrated the ability to enhance 
degradation rates due to higher exposed surface area of porous structure.  Binder-jet 3D printing 
results in micropores after sintering due to the low as-printed density (190). Chou et. al 
previously demonstrated an increase in degradation properties of Fe-30Mn mixtures after binder-
jet 3D printing (182). Moreover, these micropores create a rough surface finish which can 
improve osseointegration. For industrial applications, these micropores are infiltrated with the 
same or different material to improve corrosion resistance and mechanical properties.  Medical 
devices, made of inert metals such as titanium, also share the same dilemma requiring infiltration 
and smooth surface finish (191). On the other hand, development of a biodegradable Fe-based 
alloy is focused on increasing the corrosion rate, and micropores induced by binder-jet 3D 
printing are beneficial to enhance the degradation of biodegradable Fe-based scaffolds. When the 
potentiodynamic polarization data of compacted pellets and 3D printing samples were compared, 
3DP samples exhibited increased corrosion current density in both Fe-Mn and Fe-Mn-1Ca alloys 
(Table A.1 and A.3). The porous structure of 3DP Fe-Mn and Fe-Mn-1Ca enhanced degradation 
rate by exposing a larger surface area to the electrolyte.  
Insoluble oxide formation was observed in the micropores of 3DP Fe-Mn and Fe-Mn-1Ca 
after the potentiodynamic polarization test (Figure A.7). These observations convey that the 
presence of micropores from binder-jet 3D printing can increase the contact with electrolytes and 
enhance the degradation of biodegradable Fe-based alloy. 
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A.4.3 Indirect cytocompatibility of biodegradable Fe alloys 
Indirect cytocompatibility of biodegradable Fe alloys has been assessed using various types of 
cells such as fibroblast, smooth muscle cells, and osteoblasts depending on the target application 
(178, 179, 182). In this study, the cytocompatibility of 3DP Fe-Mn and Fe-Mn-1Ca alloys were 
investigated for their potential use as cranio-maxillofacial implants. Cranio-maxillofacial 
implants are placed in direct contact with bone tissues within the human body. As the material 
corrodes within the body, it releases metallic ions which may be harmful to cellular functions. 
Therefore, degradation products of these implants must be compatible with associated bone cells. 
For this reason, mouse pre-osteoblast MC3T3-E1 cells were used to test the cytocompatibility of 
possible implant materials. 
MTT assay results exhibited good cytocompatibility with 100%, 50%, 25%, and 10% 
extract media of 3DP Fe-Mn and Fe-Mn-1Ca, as shown in Figure A.10. ICP analysis on 100% 
extract exhibited ~5 ppm (equivalent to ~0.1 mM) Fe and Mn concentration as well as ~29 ppm 
(equivalent to ~0.7 mM) additional calcium concentration in 3DP Fe-Mn-1Ca extract. Ionic 
concentration of Fe and other alloying elements in the extract media is closely correlated with 
the cell viability. Purnama et al. reported the fibroblast cell count after dosing different 
concentration of FeCl2 and MnCl2 to check the tolerance of fibroblasts against the metal ion 
concentration (192). At 25 ppm (equivalent to ~0.5 mM) of MnCl2 and 150 ppm (equivalent to 
~3 mM) of FeCl2, the fibroblast cell count was halved. Unlike the fibroblast, MC3T3 pre-
osteoblasts tested here indicated that they were cytocompatible with 1mM concentration of FeCl2 
and MnCl2 (Figure A.11).  
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The metal ion concentration from 3DP Fe-Mn and Fe-Mn-1Ca reaches approximately 
10% of tolerable amounts (Table A.4 and Figure A.11). Hence, higher degradation rate can be 
pursued by altering the composition in the next development process.  
A.4.4 Mechanical properties 
Ultimate tensile strength of 3DP Fe-Mn (228.1 MPa) and Fe-Mn-1Ca (296.6 MPa) was higher 
than that of human cortical bone. 3DP Fe-based medical devices for cranio-maxillofacial 
application are anticipated to be implanted in semi-loaded or non-load bearing sites. Porous 
structure of 3DP Fe-Mn-1Ca with 52.1% open porosity resulted in brittle fracture during tensile 
testing. Ductility of 3DP Fe-Mn-1Ca needs to be improved to qualify for load-bearing bone 
implant applications that require toughness since both strength and ductility contribute to 
toughness. 3DP Fe-Mn with 39.1% open porosity exhibited higher ductility than 3DP Fe-Mn-
1Ca; this suggests that less porosity can improve the ductility of 3DP Fe-based alloys. 
Hermawan et al. reported UTS and elongation at fracture of rolled bulk Fe-35Mn as 550 MPa 
and 31% respectively (175), with the significantly higher strength as a result of the near-fully 
dense material compared to the porous 3DP material reported here. Electron beam-based or 
laser-based 3D fabrication can be a solution to achieve higher densification and mechanical 
properties since these techniques do not result in micropores due to instant particle to particle 
diffusion, melting and subsequent solidification. Also, 3DP Fe-based alloys can be infiltrated 
either with the same material, ceramic or biodegradable polymers to improve the toughness 




In this study, theoretical calculation was performed to predict an effect of introducing Ca and Mg 
on corrosion behavior of biodegradable Fe-Mn alloy. Fe-Mn-Ca and Fe-Mn-Mg alloys were 
synthesized and the sintered pellets of the alloys were analyzed in terms of corrosion and 
cytotoxicity properties. Furthermore, Fe-Mn and Fe-Mn-Ca exhibited good cytotoxicity results 
and thus were selected for binder-jet 3D printing studies. Based on the results, the main 
conclusions are listed as follows: 
(1) CALPHAD calculation exhibited an increase in corrosion rates of binary Fe-35Mn alloy 
by replacing Mn content with Ca and Mg. Synthesized powder of Fe-Mn-Ca and Fe-Mn-Mg 
exhibited ɤ-phase austenite and ɛ-phase martensite solid solution without distinct Ca or Mg peaks 
in X-ray diffraction patterns.  
(2) Sintered pellets of Fe-Mn-Ca and Fe-Mn-Mg demonstrated that the corrosion current 
density increased with Ca or Mg content in the potentiodynamic polarization testing validating 
the theoretical CALPHAD studies. The pellets exhibited good cytocompatibility after 1 and 3 
days culture of MC3T3 culture followed by live/dead cell viability assay. 
(3) 3D-printed specimens of Fe-Mn and Fe-Mn-1Ca presented 39.1 and 52.1% open porosity 
respectively.  Micro pores in size of ~5um diameter were observed under scanning electron 
microscopy. 
(4) The corrosion current density of 3D-printed Fe-Mn and Fe-Mn-1Ca was greater than that 
of sintered pellets. 3D-printed Fe-Mn-1Ca exhibited higher corrosion current density compared 
to 3D-printed Fe-Mn.  
(5) 3D-printed Fe-Mn and Fe-Mn-1Ca also exhibited good cytocompatibility with MC3T3 
cells assessed using both direct live/dead and indirect MTT cell viability assays. In terms of 
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mechanical properties, Fe-Mn-1Ca exhibited higher stiffness and brittle failure in tensile testing 
but higher UTS was observed in comparison to Fe-Mn. 
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